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1.1 Mental retardation
1.1.1 Definition and epidemiology
Mental retardation is a multifacetted disorder, of which a comprehensive definition
is difficult to give. The most widely used definition (American Psychiatric
Association, 1994) comprises three criteria: i. significantly subaverage general intel-
lectual functioning (IQ≤70) that is accompanied by i. significant limitations in
adaptive functioning in at least two of the following skill areas: communication,
self care, ability to live independently, social and interpersonal skills, use of public
services, decision taking, functional academic skills, work, leisure, health and safe-
ty and ii. onset before the age of 18 years.
Mental retardation is subdivided into several classes on the basis of the IQ. Most
commonly, the WHO classification and terminology are used (WHO, 1980) (Table 1).
In many studies, the prevalence of mental retardation has been estimated as
being close to 3%, with a prevalence of 0,5% for those with an IQ ≤ 50, which is in
good agreement with the theoretical prevalence rate. However, some investigators
reported a lower prevalence of 1-1,5% (Baird & Sadovnik, 1985; Matilainen et al.,
1995; Turner, 1996b; Claes, 1997). In the Netherlands, 1,87% of school age children
(≤12 years of age) attended schools for those with (severe) learning difficulties
(MLK and ZMLK: 1,54% and 0,33%, respectively) during the year 1996/1997
(Centraal Bureau voor de Statistiek, 1998, see Table 2). Though learning difficulties
can also be caused by psychiatric problems and environmental factors and are not
necessarily indicative of an IQ≤70 (Claes, 1997; Crow & Tolmie, 1998), there seems
n Chapter 1 - General introduction and aims of the study
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table 1
Classification of mental retardation (WHO, 1980)
Terminology IQ
Profound <20
Severe 20-35
Moderate 35-50
Mild 50-70
Borderline 70-85
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to be consensus that the most likely prevalence of mental retardation is 1,5%, and
that about 0,5% (range: 0,26 - 0,73%, Roeleveld et al., 1997) have an IQ of ≤50. In
contrast to “severe” forms of mental retardation, prevalence estimates vary widely
for mild mental retardation (range: 0,4 - 8,0%, Roeleveld et al., 1997). In accor-
dance with its high prevalence, in 1994, 8,1% of the health care expenditure in the
Netherlands (= Dfl 4.790.000.000,- = EUR 2.173.607.000,-) was spent for “Mental
Handicaps” as defined by the International Classification of Diseases (ICD), which
is far more than for all other ICD categories (Polder et al., 1997).
X-linked mental retardation n
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LOM = leer- en opvoedingsmoeilijkheden (children with specific needs)
MLK = moeilijk lerende kinderen (children with learning difficulties)
ZMLK = zeer moeilijk lerende kinderen (children with severe learning difficulties)
table 2
Male to female ratio in Dutch pupils, aged ≤12 years, according to schooltypes 
(for 1996/1997; Centraal Bureau voor de Statistiek, 1998)
All
schooltypes
Primary
schools
Specific
needs
(LOM)
Learning
difficulties
(MLK)
Severe
learning 
difficulties
(ZMLK)
Number of
pupils
1577475 1498986 32400 24311 5164
boys (%) 813138
(51,5)
759507
(50,7)
23722
(73,2)
14963
(61,5)
3134
(60,7)
girls (%) 764337
(48,5)
739479
(49,3)
8678
(26,8)
9348
(38,5)
2030
(39,3)
male to
female ratio
1,06 1,03 2,73 1,60 1,54
% of all
pupils
100 95,02 2,05 1,54 0,33
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1.1.2 Etiology
In the majority of cases the cause of mental retardation is unknown (Table 3)
(Hamel & Smeets, 1997). This is especially true in the category with an IQ>50,
mostly referred to as “mild” mental retardation, where interaction between genetic
and environmental factors is thought to play the most important role, while in
“severe” mental retardation (IQ≤50) more often a single recognizable and/or iden-
tifiable factor is present, which is of genetic origin in at least 50% of cases (Flint &
Wilkie, 1996). Two genetic syndromes are the commonest causes of mental retar-
dation: Down syndrome and the fragile X syndrome. Many others are rare to very
rare, not infrequently occuring in single families.
Since establishing the cause of mental retardation is of utmost importance for
prognosis, management and genetic counselling, it is justified to perform an exten-
sive and comprehensive diagnostic assessment of every single case of mental retar-
dation. This requires a multidisciplinary approach which ideally should combine
the expertise of several medical and paramedical specialties e.g. pediatrics, child
neurology, clinical genetics, psychology, and remedial education (Curry et al.,
n Chapter 1 - General introduction and aims of the study
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table 3
Etiologic classification of mental retardation (%)
IQ ≤50
“severe” MR
>50
“mild” MR
15 5-10Chromosomal abnormalities
20-25 5-10Monogenic disorders (including FRAXA)
10 5CNS malformations
MCA/MR syndromes
30-35 15Acquired disorders (pre-, peri- and postnatal)
20 60-65Unknown
MR = mental retardation
CNS = central nervous system
MCA = multiple congenital anomalies
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1997). Access to the highest levels of neuroimaging and neurophysiological facilities
and cytogenetic, metabolic and DNA laboratories is indispensable, preferably in an
institute which combines research and diagnostic services in the field in order to
promote timely implementation of research findings into clinical practice. When
confirmed by larger studies, the recent finding that at least 6% of idiopathic mental
retardation may be due to subtelomeric chromosomal rearrangements (Flint et
al., 1995) will have immediate practical diagnostic consequences. By simultaneous,
multilocus FISH analysis Ligon et al. (1997) detected five deletions in 200 patients.
In three selected families with syndromic or nonspecific mental retardation
Ghaffari et al. (1998) found a cryptic telomeric translocation employing a combi-
nation of CGH and FISH. In the near future, results of several similar microdele-
tion studies will become available thereby defining its real contribution to the
cause of mental retardation. In a recent paper, Battaglia et al. (1999) described the
results of a comprehensive assessment, as advised by Curry et al. (1997), in 120
patients of which 47 had “mild” and 73 “severe” mental retardation. Established
diagnoses like Down syndrome were exclusion criteria. Diagnoses could be made in
81% of which 42% was causal and 39% pathogenetic. Obviously, in the latter cate-
gory which included idiopathic MCA/MR, epileptic syndromes and isolated
lissencephaly sequence, the actual cause still needs to be resolved as is the case in
the remaining 19% without a diagnosis. Despite all our diagnostic and research
efforts, in the majority of patients with mental retardation there is still no etiologi-
cal diagnosis.
1.2 X-linked mental retardation
1.2.1 Epidemiology
Since a long time it has been noticed that among patients with mental retardation,
males outnumber females (Penrose, 1938). In the early seventies Lehrke (1972,
1974) was the first to hypothesize that this male excess could be due to mutations
in X-linked genes. He formulated two core hypotheses: i. “there are major genetic
loci relating to human intellectual functioning that are located on the X chromo-
some” and i. “these X-linked genes, if mutated, can lead to subnormal intellectual
functioning, including mental handicap”. Nowadays no one will question Lehrke’s
views, though in 1989 Bundey could still state that in male mental retardation
“there was no suggestion of a contribution by X-linked genes, once the fragile X
syndrome had been excluded”. Turner & Partington (1991) revived Lehrke’s
hypotheses and discussed - en passant - the scarcity of reports on autosomal non-
specific mental retardation, an observation that still holds up to now.
As illustrated in Table 2, this male excess is also apparent in Dutch pupils with
X-linked mental retardation n
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(severe) learning difficulties (MLK and ZMLK) with a male-to-female ratio of 1,60
and 1,54, respectively. In LOM-schools (special education for children with specific
educational needs and an IQ of >70), male excess is even more pronounced with a
male-to-female ratio of 2,73. In institutions for the mentally handicapped a similar
pattern is seen, with a male-to-female ratio of 1,37 (Ref. see Table 4).
These Dutch data seem to suggest that male excess is largest in the least severe
type of mental impairment, i.e. specific learning disabilities, and gradually drops
with increasing severity.
The prevalence of X-linked mental retardation has been estimated as 1,8/1000
males with a carrier frequency of 2,4/1000 females (Herbst & Miller, 1980). The
most frequent single entity in X-linked mental retardation is the fragile X syn-
drome (Martin & Bell, 1943; Lubs, 1969), with an estimated prevalence in
Caucasian males of 1/4000 (Turner, 1996a; Turner et al., 1996c; Crawford et al.,
1999) to 1/6000 (de Vries, 1997). The fragile X syndrome accounts at most for 15-
20% of X-linked mental retardation in males (Claes, 1997). Turner estimated that
20-25% of all male mental retardation and possibly 10% of mild mental retarda-
tion in females is due to X-linked genetic defects (1996b; Turner & Turner, 1974).
Since 1983 every 2 years an International Workshop on the fragile X and X-
linked mental retardation has been organised, the most recent one in 1997 in
Picton, Canada, while the next Workshop will be held in August 1999 in
Strasbourg, France. The conference reports appeared in (special) issues of the
American Journal of Medical Genetics with “XLMR genes: update 19--” (from
1990 and onwards) as the key article (Opitz & Sutherland, 1984; Turner et al.,
1986; Neri et al., 1988; Neri et al., 1991; Neri et al., 1992; Neri et al., 1994; Lubs et
n Chapter 1 - General introduction and aims of the study
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table 4
Number of patients in Dutch institutions for the mentally handicapped (1995)
Total 32.335
males (%) 18684 (57,8)
females (%) 13651 (42,2)
male to female ratio 1,37
Reference: Landelijke registratie zorg- en dienstverlening aan mensen met een ver-
standelijke handicap, 1996.
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al., 1996; Lubs et al, 1999). Data from 1992 and onwards are more or less compa-
rable and given in Table 5. X-linked mental retardation is divided into nonspecific
and syndromic (mental retardation without and with additional findings, respec-
tively). During the past few years, the number of clinical descriptions and mapping
reports dealing with X-linked mental retardation has increased steadily, but cloning
of the respective genes has lagged behind (Table 5). Apart from the above men-
tioned “XLMR genes updates”, the reviews on X-linked mental retardation of Glass
(1991), Schwartz (1993), Schrander-Stumpel et al. (1995b) are worth reading. In
their excellent review on recurrence risks in mental retardation Crow & Tolmie
(1998) sighed that all the research directed towards identifying X-linked genes has
“not greatly” assisted the clinical geneticist at present. Only very rarely, linkage
data could be used for genetic counselling and prenatal diagnosis (Mulley et
al.,1992a).
1.2.2 Nonspecific X-linked mental retardation
In the early eighties, nonspecific X-linked mental retardation was subdivided into
three groups: the fragile X syndrome, Renpenning syndrome and other forms
(Howard-Peebles, 1982; Tariverdian & Weck, 1982). At present, the fragile X syn-
drome and Renpenning syndrome are no longer considered as nonspecific, but as
syndromic and the other forms turned out to be extremely heterogeneous.
Nonspecific X-linked mental retardation is thought to be three times more preva-
lent than the fragile X syndrome (Turner, 1996a).
X-linked mental retardation n
16 n
table 5
Number of reported X-linked mental retardation conditions
Total Mapped Cloned
1992 77 (62; 15) 40 (26; 14) 2 (2; 0)
1994 127 (105; 22) 53 (35; 18) 15 (14; 1)
1996 147 (105; 42) 76 (34; 41) 19 (18; 1)
1998 178 (120; 58) 109 (53; 56) 23 (21; 2)
(62; 15) = (syndromic; nonspecific)
Note: “Syndromic” refers to the number of disorders, while “nonspecific” refers to the num-
ber of families ( = MRX numbers).
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This disorder can only be diagnosed if there are multiple cases in a family. This
stresses the importance of taking adequate family histories. The diagnosis depends
further on a thorough standardized clinical examination of affected patients,
preferably including a psychometric assessment (van Roosmalen et al., 1999),
appropriate additional investigations with exclusion of the fragile X syndrome,
linkage analysis resulting in a LOD score of ≥2 and - as final proof - detection of
the causative mutation (Kerr et al., 1991; Schwartz, 1993). Families with a LOD
score of ≥ 2,0 are given an official MRX number as identifier (Mulley et al., 1992b).
Up to now more than 65 MRX numbers have been given out, many of these in
overlapping regions of the X chromosome. Because of the nonspecific nature of the
mental retardation, pooling of data in order to enhance the power of the linkage
analysis is not possible (Mandel et al., 1992). For the same reason it is impossible to
infer from the combined data how many genes are actually involved in nonspecific
X-linked mental retardation, though the minimal number of genes can be calcu-
lated from the number of non-overlapping linkage intervals. Several estimates have
been published: Herbst and Miller (1980) suggested the existence of 7-19, Gedeon
et al. (1996) at least 8 and Claes (1997) 10-12 genes for nonspecific X-linked men-
tal retardation. To date 4 genes have been cloned, in which pathogenic mutations
have been found in nonspecific X-linked mental retardation: FMR2 (Gécz et al.,
1996; Gu et al., 1996), RabGDI1 (D’Adamo et al., 1998), OPHN1 (Billuart et al.,
1998) and PAK3 (Allen et al., 1998). However, these genes seem to account for
only a small proportion of the nonspecific X-linked mental retardation (Hamel et
al., 1994; Allingham-Hawkins et al., 1995; Bienvenu et al., 1998). Based on these
data, it is currently believed that up to 100 genes could be involved in nonspecific
X-linked mental retardation. Studying patients with nonspecific mental retardation
and structural X chromosomal abnormalities is another important way to localize
and clone genes (Mandel, 1994). The following observations are promising exam-
ples of this approach, which should eventually lead to the detection of genes for
both nonspecific and syndromic X-linked mental retardation. A deletion in Xp21.3
was found by Billuart et al. (1996) in a sporadic patient, in familial cases by
Raeymaekers et al. (1996) and Muroya et al. (1999). Lagerström-Fermér et al.
(1997) described a family with X-linked mental retardation and panhypopi-
tuitarism and a duplication of Xq25-q26. A duplication of Xq26-q27 in brothers
with neural tube defect, mental retardation and panhypopituitarism was reported
by Goerss et al. (1993) and later by Hol et al. (1998). Sloan-Béna et al. (1998) char-
acterised an inverted X chromosome with breakpoints in Xp11.2 and Xq21.3. Lossi
et al. (1998) described two patients with different X chromosomal inversions with
an apparently common breakpoint in Xq13.1 and Schröer et al. (1998) reported
their work on three females with three different X/autosome translocations all
involving Xp11. Van der Maarel et al. (1996) reported on the characterization of a
n Chapter 1 - General introduction and aims of the study
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gene in Xq13.1, which is disrupted by a balanced X;13 translocation in a mentally
retarded female. Kutsche et al. (1998) found a candidate gene in Xq26 as a result of
their study of a boy with an X/autosome translocation. In fact, FMR2 was cloned
through investigation of a boy with developmental delay and a submicroscopic
deletion near FRAXE (Gécz et a., 1996) and OPHN1 was cloned from the X chro-
mosomal breakpoint in an X/autosome translocation (Bienvenu et al., 1997;
Billuart et al., 1998). However, screening the X chromosome for submicroscopic
deletions by STS-PCR Brenan & Flint (1998) found none in 96 affected males,
concluding that submicroscopic deletions are a rare cause of mental retardation in
males. An increasing number of candidate genes is becoming available for testing in
linked families (positional candidate gene approach) and in not linked, but X-
linked compatible - usually smaller - families. This approach led to the identifica-
tion of causative mutations in the RabGDI1 (D’Adamo et al., 1998) and PAK3
(Allen et al., 1998) genes. Also the study of X-linked contiguous gene syndromes
can lead to the identification of (candidate) genes. Analysis of patients with DFN3
plus nonspecific mental retardation (Bach et al., 1992) led to the identification of
RSK4, a plausible candidate gene (Yntema et al., 1998). Through investigations in a
family with the combination of Alport syndrome, elliptocytosis, mental retardation
and midfacial hypoplasia (Jonsson et al., 1998) the candidate genes FACL4 (Piccini
et al., 1998) and AMMECR1 (Vitelli et al., 1999) were discovered. The deletions of
two patients with androgen insensitivity and mental retardation extending past
the AR gene were shown to include OPHN1 (Davies et al., 1997; Billuart et al.,
1998).
1.2.3 Syndromic X-linked mental retardation
The distinction between nonspecific and syndromic is not always clear. In its first
description, the fragile X syndrome was called nonspecific (Martin & Bell, 1943),
while now it is considered as the best known and most prevalent example of syn-
dromic X-linked mental retardation. Snyder & Robinson (1969) described a family
with nonspecific X-linked mental retardation. When reevaluating affected males of
this family, Arena et al.(1996) found a characteristic pattern of clinical symptoms.
These observations form a further strong argument for standardized evaluation of
patients and families (Kerr et al., 1991; Schwartz, 1993). It is clear, however, that
final conclusions on the number of gene defects involved in these disorders can
only be drawn when all relevant genes are known, because it is not unlikely that
heterogeneity is more common than hitherto assumed. XNP mutations were
detected in ATR-X (Gibbons et al., 1995). Later, XNP mutations were also found in
Juberg-Marsidi syndrome (Villard et al., 1996) and in Carpenter-Waziri syndrome
(Abidi et al., 1998). Similarly, L1CAM mutations have been found in HSAS, MASA
and X-linked spastic paraplegia (Schrander-Stumpel, 1995a). Conversely, X-linked
X-linked mental retardation n
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spastic paraplegia can be due to mutations in different genes: L1CAM, PLP
(Saugier-Veber et al., 1994) and a third locus on proximal Xq (Steinmuller et al.,
1997), which is compatible with the data of Claes (1997). Also, X-linked hydro-
cephalus is heterogeneous, with a second locus on Xp22 (Strain et al., 1997). More
surprisingly, a mutation in the RSK2 gene, defective in Coffin-Lowry syndrome
(Trivier et al., 1996) was reported in the MRX19 family with - by definition - non-
specific X-linked mental retardation (Merienne et al., 1999). For many of the syn-
dromic forms of X-linked mental retardation, precise map positions on the X chro-
mosome are not available (Table 5), mainly because single small families are con-
cerned. Diagnosing such syndromes in sporadic patients or even male siblings is
difficult but may be facilitated by the presence of biochemical markers as in MAOA
deficiency (Brunner et al., 1993) and X-linked mental retardation and isolated
growth hormone deficiency (Hamel et al., 1996). Recognizing a family with epilep-
sy and mental retardation limited to females (with male sparing) as an X-linked
disorder is not trivial (Ryan et al., 1997; Page, 1997).
Presently it is difficult to say which proportion of X-linked mental retardation is
accounted for by syndromic forms, but including the fragile X syndrome, this may
be true for up to 30-40%.
1.3 Aims of the study
Since many years, X-linked mental retardation has been studied in Nijmegen and
this has resulted in several PhD theses (Renier, 1983; Smeets, 1992; Smits, 1996; van
der Maarel, 1997). Within the Department of Human Genetics, where X-linked
mental retardation is one of the four main research projects, the interest has grad-
ually been shifting from the fragile X syndrome to other forms, and to nonspecific
X-linked mental retardation in particular. All four divisions of the Department
are involved in this research. The psychometric assessment of patients is performed
by educational child-psychologists of the Department of Child Neurology (Head
Prof.Dr.F.J.M.Gabreëls)
Since the subject is by far too complex, and - more importantly - in view of the
large number of patients and families required, cooperation with other research
institutes has been established and this led to the foundation of the European X-
linked mental retardation Consortium, consisting of groups from Berlin, Leuven,
Nijmegen, Paris and Tours. The long range goal of this Consortium is to elucidate
the molecular and cellular basis of X-linked mental retardation disorders, which is
a prerequisite for reliable diagnosis and genetic counselling in families with these
disorders and may, in some forms, pave the way to therapy. A report on all families
with nonspecific X-linked mental retardation known to the Consortium has
n Chapter 1 - General introduction and aims of the study
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recently been published (des Portes et al., 1999).
The present study aims to contribute to the elucidation of X-linked mental retar-
dation by reporting a number of clinically and genetically well characterised fami-
lies: 8 families with nonspecific (chapter 2) and 5 families with syndromic forms of
X-linked mental retardation (chapters 3,4 and 5, respectively).
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Nonspecific X-linked mental retardation
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2.1 Segregation of FRAXE in a large family:
clinical, psychometric, cytogenetic and molecular data
Ben C.J. Hamel,1 Arie P.T. Smits,1 Esther de Graaff,3 Dominique F.C.M. Smeets,1
Frans Schoute,1 Bert H.J. Eussen,3 Samantha J.L. Knight,4 Kay E. Davies,4 Claire
F.C.H. Assman-Hulsmans,2 and Ben A. Oostra3
1Department of Human Genetics and 2Department of Child Neurology, University Hospital, Nijmegen;
3Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands; and 4Institute of
Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, England
Summary
During an ongoing study on X-linked mental retardation we ascertained a large
family in which mild mental retardation was cosegregating with a fragile site at
Xq27-28. Clinical, psychometric, cytogenetic and molecular studies were per-
formed. Apart from mild mental retardation affected males and females did not
show a specific clinical phenotype. Psychometric assessment of 4 randomly selec-
ted affected individuals revealed low academic achievements with verbal and per-
formance IQ, ranging from 61-75 and from 70-82, respectively. Cytogenetically
the fragile site was always present in affected males and not always present in
affected females. With FISH the fragile site was located within the FRAXE region.
The expanded GCC repeat of FRAXE was seen in affected males and females
either as a discrete band or as a broad smear. No expansion was seen in unaffected
males whereas three unaffected females did have an enlarged GCC repeat.
Maternal transmission of FRAXE may lead to expansion or contraction of the
GCC repeat length, whereas in all cases of paternal transmission contraction was
seen. In striking contrast to the situation in fragile X syndrome, affected males
may have affected daughters. In addition, there appears to be no premutation of
the FRAXE GCC repeat since in the family studied here all males lacking the nor-
mal allele were found to be affected.
Introduction
The fragile X syndrome is the most common form of inherited mental retardation
(Fryns 1989). It is associated with a fragile site at Xq27.3, and at the molecular level
it is characterized by an unstable CGG repeat at the 5’ end of the FMR1 gene (Fu et
al. 1991; Oberlé et al. 1991; Verkerk et al. 1991; Yu et al. 1991; for review, see Oostra
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et al. 1993b). The mechanism of mutation is expansion of the CGG repeat in
patients and subsequent hypermethylation of the adjacent CpG island, resulting in
silencing of the FMR1 gene (Bell et al. 1991; Pieretti et al. 1991; Vincent et al.
1991). Diagnosis of the fragile X syndrome is now based on the determination of
the number of CGG repeats: normal alleles have a repeat length <50, premutation
alleles have 50-200 copies and in affected individuals full mutation alleles have
>200 repeats (Fu et al. 1991). In the majority of individuals with both a cytogenetic
expression of a fragile site at Xq27.3 and mental retardation, the fragile X syn-
drome is confirmed by identifying an increased CGG repeat in the FMR1 gene.
However, some families have been ascertained with fragile X expression but
without CGG amplification. Refined cytogenetic methods using FISH have allowed
differentiation of two other fragile sites, called “FRAXE” (Sutherland and Baker
1992; Flynn et al. 1993) and “FRAXF” (Hirst et al. 1993). Recently, the fragile site
FRAXE was cloned and in individuals with cytogenetic FRAXE expression amplifi-
cation of a GCC repeat was found (Knight et al. 1993). In normal individuals 6-25
copies of the GCC repeat were present with an average of 15 copies. In patients
expressing FRAXE, >200 copies of the GCC repeat were found. In these patients a
CpG island proximal to the GCC repeat was methylated, suggesting that methyla-
tion plays a role in the inactivation of a gene in the FRAXE region. This CpG
island is located 600 kb distal to the CpG island proximal to the FMR1 gene.
Very little is known about the clinical phenotype of FRAXE-positive individuals.
In the first paper describing FRAXE (Sutherland and Baker 1992) fragile-site
expression was reported in mentally normal individuals. In the families described
by Knight et al. (1993) almost all males who did express the fragile site FRAXE
were mildly mentally retarded. Carrier females were mentally normal. The expan-
ded GCC repeat of FRAXE was seen in affected males as well as in carrier females
and was unstable when passed through both the male and female lines. A contrac-
tion of the expanded GCC repeat was found when it was passed from an affected
father to his daughter, whereas expansion was mostly found when it was passed
from a carrier mother to her affected son (Knight et al. 1993).
In this paper we describe a large FRAXE family, in which FRAXE is cosegregating
with nonspecific mild mental retardation.
Subjects, Materials, and Methods
The family (fig.1) was ascertained from >80 families with fragile X expression.
The index patient II-5 was admitted for low backpain at the neurology department
and a fragile X screening was requested because of familial mild mental retarda-
tion. Eight affected males, five unaffected males, seven affected females and four
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unaffected females were examined by two of us (B.C.J.H., A.P.T.S.). Clinical pho-
tographs were taken and blood sampling was performed. Affected family members
were those who attended a special school for children with learning difficulties,
while the unaffected individuals received regular education.
Psychometry
Four patients (II-18, II-19, III-18, III-22) were psychometrically assessed by using
highly standardized tests. These patients were thought to be representative in terms
of schooling and intellectual and social functioning. For the intelligence test the
WAIS-R (Stinissen et al. 1970) was used for adults, and the WISC-R (Van Der
Steene et al. 1986) was used for children. Attention was scored with the test for sus-
tained attention (Bourdon and Vos 1988). The Bender Gestalt Test (Koppitz 1964)
and Visual Motor Integration Test (Beery 1989) were used to assess the
visual/motor skills. The academic achievements, including the prerequisites for
reading and writing, were scored with aspects of the Groninger School Onderzoek
(Kema and Kema-van Leggelo 1987) and with tests that are specifically designed to
assess the reading (Wiegersma 1971; Van Den Berg and Te Lintelo 1977; Brus and
Voeten 1979), writing (Struiksma et al. 1986) and arithmetic skills (Heesen et al.
1974; Ojeman 1977).
Cytogenetics
For cytogenetic analysis, peripheral lymphocytes were cultured for 92 h in medium
TC 199, supplemented with 5% FCS. Chromosome slides were made according to
routine procedures. One hundred metaphases of each individual were examined
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for the presence of a fragile chromosome after solid Giemsa staining. Potential
fragile chromosomes were photographed, destained, and subsequently GTG-band-
ed for evaluation.
In situ hybridization was performed according to the procedure of Kievits et al.
(1990) and Verkerk et al. (1992). Whole-cosmid DNA, c4.1 (Verkerk et al. 1991),
C1/C10 (containing marker Do33), and VK21 (Oostra et al. 1993b) was labelled
with the Bio-Nickkit (BRL). Biotinylated DNA specific for the X centromere
pBamX5 (Willard et al. 1983) was co-hybridized for X chromosome identifica-
tion. Each hybridization mix contained 2-4 ng cosmid probe/µl, 0.1 ng pBamX5/µl,
and 50-fold excess of competitor Cot-1 human DNA (BRL). This mix was dena-
tured and preannealed for 1 h at 37°C, followed by an overnight hybridization at
37°C. After the slides were washed to 1 × SSC at 65°C the probes were detected by
alternate layers of fluorescein-conjugated avidin (DCS Vector) and biotinylated
anti-avidin antibody (Vector), both diluted to 5 µg/ml in 4 × SSC with 0.5 %
blocking milk (Boehringer).
Slides were washed in 4 × SSC with 0.05 % Tween 20. Slides were rinsed in PBS
and mounted in antifading solution (2% DABCO/glycerol; Sigma) containing 0.03
µg propidium iodide/ml and 0.6 µg DAPI/ml. Microscopic analysis was performed
with a Leica Aritoplan microscope. For the slides stained with C1/C10, a Kodak
Ektachrome 400 ASA daylight film was used, while the slides stained with VK21
were captured by a cooled CCD camera in combination with Macprobe software
(Probemaster unit; PSI).
DNA analysis
Genomic DNA was isolated from leucocytes as described elsewhere (Miller et al.
1988), and 8 µg was digested to completion with either EcoRI (FRAXA) or HindIII
(FRAXE). The samples were separated on a 0.7% agarose gel and subjected to
Southern analysis using the probe pP2 (Oostra et al.1993a) and OxE20 (Knight et
al. 1993) for characterizing the FRAXA and FRAXE region, respectively. The probes
were labeled by the random oligonucleotide-priming method (Feinberg and
Vogelstein 1983). Before hybridization the labeled probe OxE20 was incubated
with 100 µg total human DNA for 2 h at 65°C. After 2 h prehybridization and
overnight hybridization, the filters were washed in 0.1 × SSC, 1% SDS at 65°C,
prior to exposure to X-ray film. Amplification of the GCC repeat was performed as
described elsewhere (Knight et al. 1993). PCR analysis of the FRAXA CGG repeat
was performed according to the procedure described by Fu et al. (1991). In order to
study DXS1691, a (CA)n repeat located 2.5 - 5.3 kb distal to the FRAXE CpG
island, 60 ng genomic DNA was amplified in a total volume of 10 µl consisting of 1
mM MgCl2, 0.2 mM each of dCTP, dTTP and dGTP, 0.025 mM dATP, 10 mM
Tris-Cl pH8.3, 15 mM KCl, 0.01 % gelatin, 4 µCi 32P-dATP, 2.5 U Taq polymerase
X-linked mental retardation n
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(BRL), 0.25 µM of primers F322 and F010, as described elsewhere (S.J.L.Knight,
unpublished results). The reactions were initially denatured for 4 min at 95°C, fol-
lowed by 33 cycles of 1 min at 95°C, 1 min at 65°C, and 1 min at 72°C. A final 4-
min extension was carried out at 72°C. The amplifications were performed on a
9600 thermocycler (Perkin-Elmer). The primer sequences were F322, 5’-GCAAT-
GATAATGTTGAGTTCTACC; and F010, 5’-CTCAAGACCAAACTTGAA-
GAAACC.
Results
Phenotype
Though some affected males had mild craniofacial anomalies, there was no consis-
tent clinical phenotype present in the affected individuals. Clinical information
on the affected family members is given in tables 1 and 2.
Patient III-1 (fig. 2) is a representative example of this family (fig.1) and will be
described in more detail. He was born at term, after an uneventful pregnancy and
delivery. Motor milestones were reached within normal limits; speech develop-
ment, however, was retarded. He attended a special school for children with severe
learning difficulties. Presently, he reads and writes with difficulty, but is unable to
complete forms (e.g.insurance). He works in a sheltered environment. He is
healthy, married and has three healthy sons. At the age of 34 years his height is 195
cm ( 97th centile), armspan 196 cm, weight 105 kg (>97th centile), occipito-frontal
circumference (OFC) 60,0 cm (>97th centile), ears 72 mm (97th centile), and tes-
ticular volume 25 ml (50th-90th centile). He has a long and narrow face, mild
midfacial hypoplasia, long and narrow ears, and a high-arched palate. His neck is
long. No other abnormalities were found, in particular no macro-orchidism or
hyperlaxity. The male patients II-4, II-5, II-19, III-1, III-3 and III-18 show some
resemblance to each other. However, patient III-1 also resembles his normal bro-
thers (III-2, 4, 5). For comparison, clinical information on some unaffected males
is given in table 3, while in figure 2 are seen the affected males II-5, III-1 and III-18,
the affected female II-18, and for comparison, the unaffected males III-2 and III-19
and the unaffected female III-21. Patient III-15 showed features of Turner syn-
drome (see below). The only living member of generation I (I-4) is mentally nor-
mal.
Psychometry
The overall intelligence of the tested patients was below average (total IQ <85).
Verbal intelligence was not significantly lower than performance intelligence. Three
patients (II-18, II-19, III-18) could be classified as severely impaired, on all tested
n Chapter 2 - Nonspecific X-linked mental retardation
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psychological functions as well as on the academic achievements (reading, writing
and arithmetics). The fourth patient (III-22) performed, in comparison with the
other patients, relatively well on the psychological functions and reading, whereas
writing and arithmetic skill were severely impaired (Table 4).
X-linked mental retardation n
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III-1 III-2
III-18 III-19
II-18 III-21
II-5
figure 2
Patients III-1, III-18, II-18, and II-5 and
unaffected family members III-2, III-19,
and III-21
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Cytogenetic analysis
A folate-sensitive fragile site at Xq27-28 was shown in all nine affected males (range
1-40%) and in none of the unaffected. Of the 7 affected females, 4 expressed a
folate-sensitive site at Xq27-28 (range 4-46%) and all 15 unaffected females were
fragile X negative. Patient III-15 has a 45, X/46,X,r(X)(92/8) karyotype. FISH
analysis of r(X) with X-specific probes showed the presence of Xp and the cen-
tromeric region (data not shown).
FISH analysis with cosmids C1/C10 located between FRAXA and FRAXE
(Oostra et al. 1993b) gave a signal proximal to the fragile site (fig.3a), whereas
probe VK21, which is located distally from FRAXE, showed a signal distal from the
fragile site (fig.3b). From these results it can be concluded that the fragile site
detected in this family is FRAXE.
n Chapter 2 - Nonspecific X-linked mental retardation
n 39
II-12 III-2 III-4 III-5 III-19
Age (years) 44 33 29 27 10
Height (cm) 172.5 (< 10) 186 (50-90) 187 (50-90) 185 (50-90) 152 (>90)
OFC (cm) 54.5 (10-50) 59 (>97) 59.5 (>97) 60 (>97) 54.5 (50)
Testes (ml) 25 (50-90) 25 (50-90) Not done 20 (50) 3-4 (50)
Long, narrow face – + – + –
Midfacial hypoplasia – + – – –
High-arched palate – + + – –
Long neck – – – – –
Prognathism – + – + –
Miscellaneous – – – – –
table 3
Selected Clinical Features (Centiles) of Unaffected Males
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DNA analysis
The CGG repeat in the FRAXA region was within the normal range in both unaf-
fected and affected members of this family. Southern analysis of the GCC repeat in
the FRAXE region was performed by HindIII digestion and subsequent hybridiza-
tion with the probe OxE20 (Knight et al. 1993). In unaffected individuals a band of
5.2 kb was detected (Fig. 4). In affected individuals the expansion in the GCC
repeat resulted in an enlarged HindIII fragment visible either as a discrete band or
as a smear. All nine affected males had smears, with increases in size of 800 bp (II-4
and II-5) to far >1000 bp (III-11). One of the males (II-10) appeared mosaic;
besides the smear, an additional band of 5.6 kb was visible after longer exposure. In
females, both discrete bands and smears were seen (fig. 1). Interestingly, only the
four females who showed a smear on the Southern blot (II-2, II-15, II-18, and 
III-20) had cytogenetic expression of the FRAXE site, whereas females who showed
a discrete band (I-4, II-6, III-6, III-14, and III-17) did not express this fragile site.
All individuals with an expanded GCC repeat were found to be mildly mentally
retarded, with the exception of the normal females I-4, II-6, and III-6, who showed
an increase of 900 bp, 800 bp and 400 bp, respectively. In contrast, the affected
female III-22 appeared to have a normal 5.2 kb HindIII fragment. The intensity of
this fragment was equal to the band found in her two normal sisters indicating that
she received two normal alleles. No smear was detected after longer exposure.
Linkage analysis with the CGG repeat in FRAXA, marker St14, and DXS1691 loca-
ted 2.5 - 5.5 kb distal from the FRAXE CpG island (S.J.L.Knight, unpublished
results), showed that she received the risk allele from her mother (data not shown).
Analysis of the GCC repeat of FRAXE by PCR showed that she had both a normal
allele consisting of 17 GCCs derived from her father, and a second allele consisting
of 25 GCCs. Thus, the enlarged repeat of approximately ~400 copies in the mother
has decreased to only 25 copies in the daughter.
The expanded GCC repeat was found to be unstable when transmitted to the off-
spring. Transmission through a female resulted in an expansion of the repeat in 12
out of 15 cases, whereas after transmission through males a decrease in length was
found in all 3 cases tested.
In one branch of this family (father II-10 and his daughters III-15, III-16, and
III-17) molecular findings were particularly remarkable. The affected female III-17
is the only daughter to receive an expanded GCC repeat from her mentally retard-
ed father (II-10). Daughter III-15 had Turner syndrome; her X-chromosome was
found to lack the GCC-repeat expansion and was therefore likely to have derived
from her mother. In DNA of the unaffected daughter III-16, only the normal 5.2 kb
HindIII fragment was detected; no additional smears or bands were seen, even
after a long exposure. The intensity of this normal band was equal to that of the
band found in her sisters, both known to possess only one normal maternal allele.
n Chapter 2 - Nonspecific X-linked mental retardation
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This suggested the presence of only one allele. To determine whether the daughter
III-16 had received the risk allele from her father, we tested DXS1691, a (CA)n
repeat 2.5 - 5.3 kb distal to the FRAXE GCC repeat. The risk allele, transmitted by
the father to his affected daughter, was transmitted neither to his daughter with
Turner syndrome nor to his normal daughter. Instead, only one allele appeared to
be present in III-16, suggesting that on the paternal X-chromosome the DXS1691
locus had been deleted. No abnormalities were detected in her karyogram.
Amplification of the CGG repeat of the FMR1 gene 600 kb upstream of the FRAXE
site revealed both a maternal and paternal allele, indicating that the deletion did
not extend into the CpG island of the FRAXA region. Preliminary results have
thus far indicated that the size of the deletion is 7.4 kb, beginning in the region of
the FRAXE HTF island and extending distally (S.J.L.Knight, unpublished results).
Discussion
In 1981 Daker et al. reported on two mentally normal brothers with fragile-site
expression at Xq27-28. Since then, several other fragile X- positive probands and
families without the CGG amplification of the FMR1 gene have been reported (see
Table 5, which includes the here-reported family K). FISH analysis has demon-
strated that the fragile site in the families C, D, H, J, and K was FRAXE and in the
families D, J, and K the FRAXE GCC amplification indeed was found; in families F
and I the fragile site appeared to be FRAXF. Only in families J and K is FRAXE
associated with mild mental retardation, whereas in family H all fragile X positives
are mentally normal. In family C 5 out of 10 fragile X positives were mentally
retarded, whereas in family D only the proband showed mild mental retardation.
The location of the fragile sites in two additional families E and G remains to be
determined.
X-linked mental retardation n
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figure 3
FISH analysis. In situ hybridization of
cosmid C1/C10 (a) and cosmid Vk21
(b) to chromosome preparations of an
affected member of the family. The X
chromosome-specific centromere probe
pBAMX5 was used for X chromosome
identification. Slides were recorded on
film (a) or digitized (b).
a b
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figure 4
Southern blot analysis of two branches of the FRAXE family. DNA was digested with
HindIII, and, after electrophoresis and subsequent blotting, the filters were hybridized with
the probe OxE20. The asterisk indicates a constant, aspecific band, visible in all lanes after
longer exposure.
A
II
III
kb
6.5 →
5.2 →
B
I
II
III
kb
*
6.1 →
5.2 →
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In our family K no specific and consistent clinical phenotype was found, apart
from mild mental retardation; this is in contrast to the fragile X syndrome, with its
Martin-Bell phenotype.
FRAXE seems to be rare. We have found 1 FRAXE family among >80 families
with fragile X expression. In general, FRAXE patients are not in need of medical
care, and so they do not come to our attention. Besides, with the present molecu-
lar-diagnostic practise fragile X positives other than FRAXA will be missed. This all
makes it, at present, impossible to estimate its frequency in the general population.
On formal testing of four representative patients, there appeared to be a tendency
for verbal IQ to be lower than performance IQ, whereas in the fragile X syndrome
the opposite is found (Brainard et al. 1991).
The expanded GCC repeat was found to be unstable upon transmission, similar
to the situation in transmission of the CGG repeat in the fragile X syndrome.
Reyniers et al. (1993) demonstrated that in fragile X males who have a full FRAXA
mutation in their lymphocytes a premutation and not a full mutation is present in
their sperm cells. By analogy, it is very likely that in FRAXE-expressing males a
smaller GCC repeat is present in sperm as compared to their lymphocytes.
(Preliminary results indicate that, in FRAXE, affected males indeed have a smaller
HindIII fragment in sperm cells, although the additional presence of a full muta-
tion could not be excluded.) In striking contrast to the situation in the fragile X
syndrome, however, FRAXE-expressing males may have affected daughters. These
daughters were found to lack cytogenetic expression of the FRAXE site, indicating
that their reduced repeat length did not allow expression of the fragile site.
Because of the size of this family, we could determine the transmission of the
GCC repeat by one individual to several children. We found that transmission
through the same person can result in both an increase and a decrease in repeat
length. The passage of the GCC repeat by the FRAXE-expressing female II-2 (330
copies) resulted in an increase to 400 copies in one affected son (III-3) and in a
decrease to 265 GCC copies in another affected son (III-1).
Knight et al. (1993) suggest that the mechanism of silencing in the FRAXE region
is the same as that in FRAXA: as soon as repeat number reaches a critical level,
methylation occurs, resulting in lack of mRNA and thereby causing the clinical
phenotype. In the family that we studied, we found that, similar to the FRAXA
mutation, all GCC repeats with a length >130 copies were methylated (data not
shown). In the fragile X syndrome a premutation can be transmitted through nor-
mal transmitting males. In striking contrast to the fragile X syndrome, however,
there appears to be no premutation of the FRAXE GCC repeat, since, in the family
that we studied, all males lacking the normal allele were found to be affected.
We identified a mosaic male (II-10) possessing both a small expansion of 120
GCCs as well as a large expansion of >760 copies. In contrast to the clinically unaf-
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fected mosaic male with a small amplification of 133 copies and a large amplifica-
tion of 866 copies, reported by Knight et al. (1993) this male was affected. A likely
explanation for the observed difference is the finding that both expanded repeats in
the affected male are methylated (data not shown), whereas the small fragment in
the mosaic described by Knight et al. (1993) is unmethylated.
There were two peculiar phenomena in this family. First, in the mentally
impaired female III-22 a fragment of 25 GCCs was present. Its length is at the
upper end of the normal range of 6-25 GCCs. The methylation pattern in this
female appeared to be normal and could therefore not be used to account for the
observed mental impairment. It is noteworthy that in the psychometry this patient
had the highest scores; her mental impairment might as well have another cause.
Second, there is a remarkable branch in this family, in which the instability in the
FRAXE region is clearly shown. An affected mosaic male (II-10) has three daugh-
ters and all three were different at the molecular level: one showed an expansion of
the GCC repeat of the paternal allele; a second had Turner syndrome, lacking the
paternal allele; and the third appeared to have a deletion, containing the GCC
repeat derived from the paternal allele. Despite the deletion, this female was men-
tally normal. There might be two explanations for this peculiar phenomenon. First,
it is possible that the presence of one normal allele resulted in normal develop-
ment. This may also explain the three mentally normal females (I-4, II-6, and III-6)
with an expanded GCC repeat. However, other females who also carry a normal
allele apart from the expanded GCC repeat are mentally retarded. The mental
retardation in these females with an expansion may be caused by skewed X inacti-
vation. Methylation analysis of the DNA isolated from their blood leucocytes
revealed that there was no skewed X inactivation (data not shown), but one should
be aware that the methylation pattern in blood lymphocytes may not be an accu-
rate representation of other tissues such as brain.
A second possibility is that the deletion found in this patient does not affect the
promoter of the gene that is otherwise silenced by the amplification of the GCC
and the subsequent methylation. Further studies will be required to determine the
exact length and location of the deletion, which in turn will enable us to learn
more about the mechanism by which mental retardation is caused in patients with
an expanded GCC repeat.
In conclusion, we have described a family in which amplification of a GCC
repeat in the FRAXE region is associated with mild mental retardation without a
distinct clinical phenotype. Remarkably, affected males may have affected daugh-
ters, and the absence of normal transmitting males suggests the absence of a pre-
mutation in FRAXE. Familial mild mental retardation warrants a specific search for
FRAXE.
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A No MR No MR 6-22 Not done Not done Not done
B No MR No MR 10-75 Not done Normal Not done
C Mild MR Mild MRc 13-42 FRAXE Normal Not done
D Mild MR No MR 26-35 FRAXE Normal Amplifi-
cation
E Mild MR No MR 14-40d Not done Normal Not done
F No MR No MR 5-14 FRAXFe Normal Not done
G Mild MRf No MR 12-40 Not done Normal Not done
H No MR No MR 14-28 FRAXE Normal Not done
I Moderate Moderate 2-26h FRAXF Normal Not done
MR MRg
J Mild MR Mild MR 1-24 FRAXE Normal Amplifi-
cation
K Mild MR Mild MR 1-46 FRAXE Normal Amplifi-
cation
table 5
Published Families with Fragile Site at Xq27.3 Other than FRAXA
Familya
Proband Others
% Fragile
Site
FISH
FRAXA CGG FRAXE GCC
Clinical Statusb DNA Analysis
a References are as follows:
A—Daker et al. (1981); B—Voelckel et al. (1989) and Oberlé et al. (1992, family 3);
C—Nakahori et al. (1991, family 5c), Dennis et al. (1992, family 1), and Flynn et al.
(1993); D—Nakahori et al. (1991, family 5b), Dennis et al. (1992, family 2), Flynn et
al. (1993), and Knight et al. (1993, family 2); E—Oberlé et al. (1991, PC family; 1992,
family 1) and Rousseau et al. (1991); F—Romain and Chapman (1992) and
Sutherland and Baker (1992); G—Oberlé et al. (1992, family 2); H—Sutherland and
Baker (1992); I—Hirst et al. (1993); J—Knight et al. (1993, family 1); and K—present
study.
b MR= mental retardation.
c Of 10 fragile X positives, 5 had MR.
d Folate-insensitive fragile site.
e Reference: J.Mulley (personal communication).
f XYY karyotype.
g Of five fragile X positives, two had MR.
h Possibly a folate-insensitive fragile site.
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Note added in proof
Knight et al. (1994) reported on families B and C (table 5); both exhibit GCC
repeat extension at the FRAXE locus, and the only mentally retarded patient in
family B is a fragile X-negative male with a 550-bp increase in size.
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2.2 A gene for nonspecific X-linked mental retardation
(MRX41) is located in the distal segment of Xq28
Ben C.J. Hamel1, Hannie Kremer1, Eveline Wesby-van Swaay2, Bellinda van den
Helm1, Arie P.T. Smits1, Ben A. Oostra2, Hans-Hilger Ropers1, Edwin C.M. Mariman1
1Department of Human Genetics, University Hospital, Nijmegen and 2Department of Clinical Genetics,
Erasmus University, Rotterdam, The Netherlands
Abstract
We report on a family in which nonsyndromal mild to moderate mental retarda-
tion segregates as an X-linked trait (MRX41). Two point linkage analysis demon-
strated linkage between the disorder and marker DXS3 in Xq21.33 with a lod
score of 2.56 at θ=0.0 and marker DXS1108 in Xq28 with a lod score of 3.82 at
θ=0.0. Multipoint linkage analysis showed that the odds for a location of the gene
in Xq28 vs Xq21.33 are 100:1. This is the fourth family with nonspecific X-linked
mental retardation with Xq28-qter as the most likely gene localization.
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figure 1
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Introduction
X-linked mental retardation (XLMR) occurs with a frequency of about 1/500
males, whereas 2.5/1000 women are carrier of a mutation for XLMR [Turner and
Turner, 1974; Herbst and Miller, 1980]. Neri et al. [1994] listed 127 different XLMR
conditions in 5 categories. The category “Nonspecific XLMR” contained 19 genes,
of which 18 have been mapped and 1 has been cloned (FRAXE). Several other
families with nonspecific XLMR have been reported since [Gendrot et al., 1994;
Baraitser et al., 1995; Lazzarini et al., 1995; Martinez et al., 1995]. Here we report
the results of linkage analysis of a large family with nonspecific XLMR, in which
the gene maps to the tip of the long arm (MRX41).
Materials and methods
Clinical report
In a three generation family (Fig. 1) eight males are mentally retarded. Pregnancy
and delivery were uneventful in all. The retardation became apparent in the first
years of live and was non-progressive. The mental retardation ranged from mild to
moderate, but it could not be quantified by IQ-testing (see below). None of the
affected males is institutionalized, but all attended special schools for children with
(severe) learning problems. They all live and work in a sheltered environment.
There was no consistent clinical phenotype other than the mental retardation.
Obvious neurological symptoms and signs were not present. Height, weight and
OFC were all within normal limits. Their behaviour is unremarkable.
Unfortunately, further investigations were refused by caretakers. All obligate and
possible carriers were of normal intelligence. Cytogenetic analysis of several affec-
ted males and molecular study of the FMR1 gene gave normal results.
Genetic analysis
From all patients and relevant family members venous blood was sampled and
DNA was isolated according to the procedure of Miller [1988]. Markers were
analysed by the amplification of 50 ng of genomic DNA with the appropriate
primers (GDB; Isogen Bioscience BV, The Netherlands). Amplification involved
35 cycles of 1 min at 94°C, 2 min at 55°C and 3 min 72°C, which was carried out in
a 15 µl reaction mixture containing 0.06 U Supertaq in 1 × Supertaq buffer (HT
Biotechnology Ltd, England) and in the presence of 32P-dCTP. Subsequently,
labeled fragments were separated on 6.6% denaturing polyacrylamide gels. After
electrophoresis, gels were exposed overnight to Kodak X-omat S film to visualize
the allelic bands.
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Linkage data were evaluated with the program LINKAGE [Lathrop et al., 1985,
version 5.1] using the Mlink and Linkmap options. Calculations were based on
complete penetrance and a disease allele frequency of 0.0001. Consecutive five-
point linkage analysis was performed to construct the multipoint map depicted in
Figure 2. Map locations, genetic distances and allele frequencies of the marker loci
were obtained from the Genome Database and from the report by Willard et al.
[1994]. The total length of the X chromosome was estimated at 220 cM.
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1.80
0.06
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0.42
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0.13
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table 1
Results of two-point linkage analysis.
LOD-scores θMarker Locus
0 0.1 0.2 0.3 0.4
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Results
From the pedigree and clinical data it can be concluded that we are dealing with a
nonspecific X-linked mental retardation.
To determine the location of the gene for nonspecific XLMR in the present fam-
ily, linkage analysis was performed with more than 30 highly polymorphic markers
distributed along the entire X chromosome. Of 24 informative markers, only three
gave a positive lod score at θ = 0.0 (Table I). A maximum lod score of Z = 3.82 was
obtained with marker DXS1108 and a lower but still significant lod score of Z =
2.56 with DXS3. Additional information about the exact location of the gene was
then pursued by the construction of a multipoint linkage map encompassing the
entire X chromosome (Fig.2). This showed that the odds for a location of the
responsible gene in Xq28 vs Xq21.33 are 100:1. Marker DXS1108 was completely
informative in our family, but for marker DXS3 the grandmother I.1 appeared to
be homozygous. A detailed haplotype analysis with two closely flanking markers
for DXS3, i.e. CHM and DXS990, further indicates genetic recombination between
this region and the disorder (data not shown). Therefore, we conclude that the
gene which is responsible for the nonspecific XLMR in the present family is located
distal to DXS52 in Xq28-qter, a region spanning about 3 Mb.
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figure 2
Multipoint linkage analysis with microsatellite markers along the entire X chromosome
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Discussion
So far, genes in three families with nonspecific X-linked mental retardation have
been assigned to the region Xq28-qter. The MRX3 gene [Gedeon et al., 1991] was
localised by linkage analysis to this region with a maximum lod score of 2.89 with
DXS52 at θ = 0.0. Affected males had upper moderate to mild intellectual disabili-
ty and the most prominent clinical trait was their aggressive and difficult-to-
manage behaviour. Female carriers were normal. In the family described by
Nordström et al. [1992] the gene was also assigned to the region Xq28-qter with a
maximum lod score of 2.52 with DXS52 at θ = 0.0. The three affected males
showed all profound and the three affected females moderate mental retardation.
Behavioural characteristics were not reported. In the third family [ Holinski-Feder
et al., 1995] no recombinants were found with the markers DXS52 and
STR9120/9121, locating the gene within a 3.5 Mb interval at Xq28 (Z = 2.8). No
alterations were detected in expressed sequences of two GABA-receptor subunits
adjacent to DXS52. Clinical data were not included in the abstract. In our family,
recombination with DXS52 defines the proximal limit to the localisation. Affected
males showed mild to moderate mental retardation and inconspicuous behaviour.
Clinical findings in the Gedeon et al.[1991] family, in the Nordström et al. [1992]
family and the family here reported renders pooling of the linkage data hazardous,
though the respective genetic defects are in the same region. Several XLMR syn-
dromes have been localised to the Xq28 region, such as the HSAS/MASA syn-
drome due to L1CAM gene mutations [Fransen et al., 1994], Waisman syndrome
[Gregg et al., 1991] and the Simpson-Golabi-Behmel syndrome [Xuan et al., 1993].
These findings point to the existence in the Xq28 region of a cluster of genes that
play a role in mental development. It remains to be seen whether these syndromic
forms of XLMR are allelic to the nonspecific forms of XLMR that we and others
assigned to the same region. In conclusion, we report on a 4th family with nonspe-
cific XLMR in which the gene is localised in the Xq28-qter region.
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Abstract
We report linkage data on a new large family with non-specific X-linked mental
retardation (MRX), using 24 polymorphic markers covering the entire X-chro-
mosome. We could assign the underlying disease gene, denoted MRX46, to the
Xq25-q26 region. MRX46 is tightly linked to the markers DXS8072, HPRT and
DXS294 with a maximum lod score of 5.12 at θ=0. Recombination events were
observed with DXS425 in Xq25 and DXS984 at the Xq26-Xq27 boundary, which
localises MRX46 to a 20.9 cM (12 Mb) interval. Several X-linked mental retarda-
tion syndromes have been mapped to the same region of the X chromosome. In
addition, the localisation of two MRX genes, MRX27 and MRX35, partially over-
laps with the linkage interval obtained for MRX46. Although an extension of the
linkage analysis for MRX35 showed only a minimal overlap with MRX46, it can
not be excluded that the same gene is involved in several of these MRX disorders.
On the other hand, given the considerable genetic heterogeneity in MRX, one
should be extremely cautious in using interfamilial linkage data to narrow down
the localisation of MRX genes. Therefore, unless the underlying gene(s) is char-
acterised by the analysis of candidate genes, MRX46 can be considered a new
independent MRX locus.
Introduction
X-linked mental retardation (XLMR) is considered to be the most frequent type of
mental handicap in males. It has been estimated that mutations in X chromosomal
genes account for 25 to 50 % of all cases of mental retardation.1 A small part of
XLMR can be attributed to recognisable syndromes and to date more than 100
X-linked mental retardation n
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XLMR syndromes (MRXS) have been described.2 More often, however, the mental
handicap is not associated with consistent phenotypic characteristics. This is
referred to as non-specific XLMR or MRX.
Linkage analyses in individual families with MRX have currently shown over 50
loci on the X chromosome which are clustered in eight non-overlapping regions.3,4
The inclusion of the FRAXE mental retardation gene5 and the RAB-GDI gene6
suggests a minimum of 10 X-linked genes which are involved in non-specific men-
tal retardation. In this report, we present a large family with non-specific X-linked
mental retardation and the mapping of the underlying gene to Xq25-q26, a region
that has rarely been implicated in MRX.
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figure 1
Five generation family with MRX. Twenty-seven family members, including 10 affected
males, were available for DNA study. Haplotypes of the linked markers in Xq25-q26 and
the recombined markers delimiting the probable gene location are shown. Deduced haplo-
types from subjects who had died are shown between brackets. The disease chromosome is
indicated by a black bar.
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Patients and methods
Clinical report
The family (fig 1) was ascertained when IV.7 was referred for genetic counselling.
The pedigree included 12 mentally retarded males in three generations, nine of
whom were clinically examined. In order to determine the mental status of these
patients, the following intelligence tests, standardised for school-aged children,
were used: (1) the Wechsler Intelligence Scale for Children Revised (WISC-R),7,8
(2) the Coloured Progressive Matrices (CPM),9,10 (3) the Revised Amsterdam Child
Intelligence Test (RAKIT),11 and (4) McCarthy Scales of Children’s Abilities.12 The
RAKIT and McCarthy Scales were applied to assess intellectual functioning below
an equivalent of 6 years.13 Scores of all tests were transferred into age equivalents
according to the classification of the American Association of Mental Deficiency
(AAMD).14 Cytogenetic analysis and molecular study of the FMR1 gene was per-
formed in several patients. In III.28 the diagnostic tests included cerebral CT-scan
and metabolic screening. Informed consent was obtained in all instances.
DNA analysis
DNA from 26 relatives was isolated from peripheral blood lymphocytes, according
to the procedure by Miller et al.15 In order to determine the most likely location of
the gene, linkage analysis was performed with highly polymorphic markers dis-
tributed along the X chromosome. Analysis of these markers involved amplification
by polymerase chain reaction (PCR) carried out in a 96 well Thermal Cycler (MJ
Research Inc, Waterston, MA). Each reaction contained 100 ng genomic DNA, 30
ng of each of the primers, in 15 µl 1 × Supertaq buffer (50 mmol/l KCl, 1.5 mmol
MgCl2,10 mmol/l TrisHCl, pH 9.0, 0.1 % Triton X-100, 0.01 % (w/v) gelatin) in the
presence of 32PdCTP with 0.06 U Supertaq (HT Biotechnology Ltd, England).
Amplification was achieved by 35 cycles of one minutes at 94°C, two minutes at
55°C, and three minutes at 72°C with the locus specific primer pairs registered in
the Genome Database (http://gdbwww.gdb.org/gdb/). The radiolabelled PCR prod-
ucts were mixed with 15 µl sample buffer (95 % formamide, 20 mmol/l EDTA, 0.05
% xylene cyanol, 0.05 % bromophenol blue), heated to 95°C for two minutes and,
and 4 µl of this mixture was separated on a 6.6 % denaturing polyacrylamide gel.
Subsequently, the gel was dried and exposed overnight to Kodak XOMAT film to
visualise the separated allelic bands.
Two point linkage analyses of the 24 polymorphic markers and the disease locus
were performed with the MLINK option of the computer program LINKAGE (ver-
sion 5.03)16-18 on the basis of X-linked recessive inheritance with full penetrance.
The relative order of marker loci was obtained from the Genome Database and the
Report of the Sixth International Workshop on X Chromosome Mapping.19
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Results
Clinical report
In all patients, pregnancy and delivery were uneventful. The mental retardation was
noticed during early childhood and appeared non-progressive. None of them had
convulsions. All patients were either institutionalised or living and working in a
sheltered environment. Physically they were all healthy. Their behaviour was nor-
mal, except for the brothers III.24, III.26 and III.28 who were described as difficult
to control, chaotic, and autistic-like, and III.16 who showed obsessive behaviour.
III.11 died at the age of 11 during heart surgery. He was attending a special educa-
tion school. Obligate carriers were all normal. Results of the clinical measurements
and psychometric studies are summarised in tables 1 and 2, respectively.
Only minor anomalies were noted in some of the affected males. II.18 (fig 2A)
was seen at the age of 65 years. He was short statured. Hypertelorism, a fleshy
nose, full lower lip, kypholordosis, and lower leg varices were noticed. III.12 (fig
2B) showed no abnormalities except for lower leg varices when seen at the age of
57 years. III-13 (fig 2C) was examined at the age of 54 years. Except for a left sided
hydrocele no abnormalities were detected. III.15 (fig 2D) and III-16 (fig 2E)
showed no abnormalities on examination at the age of 47 and 38, respectively. III-
20 (fig 2F) was examined at the age of 44 years. A left sided hydrocele and a large
hyperpigmented spot on the back were seen. III.24 showed a highly arched palate,
short and broad neck, and flat feet on examination at the age of 34 years. He was
X-linked mental retardation n
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figure 2
Faces of affected males. (A) II.18 at 65 years,
(B) III.12 at 57 years. (C) III.13 at 54 years,
(D) III.15 at 47 years, (E) III.16 at 38 years,
(F) III-20 at 44 years.
(Photographs reproduced with informed
consent).
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short statured. Ophthalmological examination of III.26 at the age of 29 years
showed hypertelorism, myopia gravis ODS, and some lenticular opacities. In III.28
hypertelorism and myopia gravis OD, resulting in amblyopia and divergent stra-
bismus, was seen on ophthalmological examination. The degree of mental retarda-
tion in the affected family members tested varied from mild to profound. It is con-
cluded that pedigree structure and clinical data are fully compatible with a diagno-
sis of non-specific X-linked mental retardation.
DXS1060 – ∞ – 1.93 – 0.91 – 0.08 0.19 0.19
GHGxG – ∞ – 2.05 – 1.01 – 0.16 0.13 0.17
DXS443 – ∞ – 1.96 – 1.14 – 0.42 – 0.11 0.01
DMD – ∞ – 6.04 – 4.01 – 2.07 – 1.03 – 0.39
DXS538 – ∞ 0.02 0.40 0.52 – 0.35 0.10
DXS7 – ∞ – 0.68 – 0.29 – 0.15 – 0.26 – 0.29
DXS1003 – ∞ – 6.34 – 4.30 – 2.34 – 1.26 – 0.53
ALAS2 – ∞ – 2.23 – 1.19 – 0.35 – 0.04 0.02
DXS453 – ∞ – 5.46 – 3.72 – 2.05 – 1.12 – 0.49
DXS559 – ∞ – 2.07 – 1.34 – 0.77 – 0.49 – 0.23
DXS986 – ∞ – 2.07 – 1.34 – 0.77 – 0.49 – 0.23
DXS3 – ∞ – 0.79 – 0.39 – 0.23 – 0.30 – 0.28
DXS178 – ∞ – 2.07 – 1.34 – 0.77 – 0.49 – 0.23
Col4A5 – ∞ – 2.07 – 1.34 – 0.77 – 0.48 – 0.23
DXS424 – ∞ – 1.96 – 1.14 – 0.42 – 0.11 0.01
DXS1001 – ∞ – 0.96 – 0.25 0.21 0.27 0.15
DXS425 – ∞ 0.14 0.96 1.31 1.09 0.57
DXS8072 4.43 3.99 3.54 2.60 1.63 0.66
HPRT 5.12 4.70 4.26 3.32 2.28 1.12
DXS294 4.95 4.51 4.04 3.07 2.03 0.96
DXS984 – ∞ 2.14 2.34 2.10 1.53 0.81
FraXAc2 – ∞ 0.09 0.28 0.35 0.28 0.16
DXS1113 – ∞ – 0.06 0.15 0.25 0.22 0.13
DXS1108 – ∞ – 0.06 0.15 0.25 0.22 0.13
table 3
Lod scores between MRX46 and markers spread along the X chromosome 
(in order from Xpter to Xqter)
θ
0.000 0.050 0.100 0.200 0.300 0.400
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DNA analysis
For the initial analyses, 23 markers spread along the X chromosome were geno-
typed on 12 potentially informative family members. The family was informative
for all tested markers. Once tentative linkage with HPRT and DXS294 was
obtained, another marker in the region, DXS8072, was typed and more affected
and unaffected family members were genotyped for the linked markers (26 rela-
tives in total). Table 3 presents the results of the two point linkage analysis with the
lod scores for the MRX locus and each marker locus. The proximal locus DXS425
at Xq25 and the more distal locus DXS984 at the Xq26-q27 boundary recombined
with the disease in the family, delimiting the probable gene location. Significant lod
scores were obtained with markers DXS8072, HPRT, and DXS294, indicating that
the genetic defect responsible for the disease in this family is located in Xq25-q26,
with a maximum lod score of 5.12 at θ=0 (at HPRT). A reconstruction of the hap-
lotypes of the markers in the Xq25q26 region is shown in fig 1.
Discussion
We have presented a new family with recessive non-specific X-linked mental retar-
dation and assigned the causative genetic defect, MRX46, to Xq25-q26. This region
is estimated to comprise a genetic distance of 20.9 cM20 and a 12 Mb region on the
physical map.19
Seven XLMR syndromes have been assigned to X chromosomal segments over-
lapping the linkage interval for MRX46 (Fig. 3). Huang et al 21 reported on a fami-
ly with an X-linked mental retardation disorder (MRXS5), including Dandy-
Walker malformation, basal ganglia disease, and seizures. Börjeson-Forssman-
Lehmann syndrome (BFLS)20,22,23 is characterised by severe mental retardation,
microcephaly, hypogonadism, obesity, short stature, and distinct facial anomalies
including large ears, prominence of the supraorbital ridge, and ptosis. Malmgren et
al 24 reported a family with severe X-linked mental retardation syndrome, linked to
DXS294 at Xq26. This so-called Gustavson syndrome includes microcephaly, severe
mental retardation, optical atrophy with decreased vision or blindness, severe hear-
ing defect, characteristic facial features, spasticity, seizures, and restricted joint
mobility. The patients die during infancy or early childhood.25 Cowchock syn-
drome, an X-linked motor-sensory neuropathy type II with deafness and mental
retardation has been mapped between DXS425 and HPRT.26,27 Recently, some of us
described a family presenting with varying degrees of mental retardation in con-
junction with isolated growth hormone deficiency.28 The underlying genetic defect
for this disorder could be assigned to the Xq24-q27.3 region. Interestingly, in a
recent report an unrelated family with similar symptoms is described in which the
n Chapter 2 - Nonspecific X-linked mental retardation
n 65
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genetic defect is localised to the same region.29 In this family X-linked recessive
panhypopituitarism (XPH) is associated with a duplication of the DXS102 locus,
suggesting that this phenotype is caused by a gene dosage effect. Lesch-Nyhan syn-
drome (OMIM 308000) is another well known syndrome with MR, caused by
mutations in the HPRT1 gene. It can not be ruled out that one of the genes
involved in these MR syndromes is also causative in MRX46, but given the pro-
nounced distinctive features of each syndrome, it is difficult to imagine how muta-
tions in one such gene may cause (severe) non-specific MR.
Very recently, two novel MRX loci encompassing Xq26, MRX27, and MRX35,
have been uncovered by linkage analysis in apparently unrelated families from the
United Kingdom and Belgium, respectively.30-32 MRX27 has been localised to the
Xq24-q26 region with flanking recombination events in affected males at DXS424
and DXS102, which spans all but the distal portion of the MRX46 linkage interval
(fig 3).31 MRX35 maps to Xq22-q26 with flanking markers DXS178 and HPRT.32
DNA samples from this family (kindly provided by Professor J P Fryns and Dr P
Raeymaekers) allowed us to assign DXS8072 as the distal flanking marker in
MRX35. Hence, the overlap between MRX46 and MRX35 comprises a region of
less than 2 cM at the Xq25-q26 boundary (fig 3). If the same gene is involved in the
three MRX families that map to Xq26, the region to search for candidate genes
would be significantly reduced. However, given the genetic heterogeneity of MRX
one should be extremely cautious of using interfamilial linkage data to narrow
down the localisation of MRX genes. This is especially true since MRX46 seems to
differ from MRX27 and MRX35 in that the variability and severity of the mental
handicap is more pronounced and, yet, carrier females never exhibit any mental
impairment. Therefore, the whole Xq26 band has to be considered for identifica-
tion of candidate genes for the family presented here. According to the physical
map of Pilia et al 33, five genes for which the complete coding region is known are
located in this region (fig 3). In addition, the human transcript map34
(http://www.ncbi.nlm.nih.gov/SCIENCE96/) reports more than 50 expressed
sequence tags for this region. Unfortunately, expression data for the corresponding
genes are not available and it is therefore not possible at this stage sensibly to select
likely candidate genes for MR from this gene pool.
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2.4 Four families (MRX43, MRX44, MRX45, MRX52) with non-
specific X-linked mental retardation: clinical and psycho-
metric data and results of linkage analysis
Ben C.J.Hamel1, Arie P.T.Smits1, Bellinda van den Helm1,2, Dominique
F.C.M.Smeets1, Nine V.A.M. Knoers1, Tanja van Roosmalen3, Geert H.J.Thoonen3,
Claire F.C.H.Assman-Hulsmans3, Hans-Hilger Ropers1,4, Edwin C.M.Mariman1,
and Hannie Kremer1
1Departments of Human Genetics, 2Neurology and 3Child Neurology, University Hospital, Nijmegen,
The Netherlands. 4Max Planck Institute for Molecular Genetics, Berlin, Germany
Abstract
Four families are described in which mental retardation segregates in an X-linked
fashion. Mental retardation was the only consistent clinical finding in all affected
males. The degree of retardation varied from mild to profound both between and
within families. Linkage analysis localized the genetic defect of MRX43 to
Xp22.31-p21.2, MRX44 to Xp11.3-p11.21, MRX45 to Xp11.3-p11.21, and MRX52
to Xp11.21-q21.33 with LOD scores of >2 at θ = 0.0 in all 4 families.
Introduction
It has long been known that males with mental retardation (MR) outnumber
females with MR [Penrose, 1938]. This excess of affected males is attributed to a
considerable contribution of mutated X-linked genes [Lehrke, 1972]. In recent
years, significant progress has been made in the clinical and genetic delineation of
X-linked mental retardation (XLMR). The last update of XLMR [Lubs et al., 1996]
listed 147 different XLMR conditions, 42 of which are in the category nonspecific
XLMR. It has been proposed to assign a serial MRX number to each family with
nonspecific XLMR in which linkage analysis demonstrates a LOD score of 2 or
more for one or several X-linked markers [Mulley et al., 1992]. This does not 
necessarily reflect the number of genes involved in XLMR, because for many fami-
lies the disease locus has been mapped in overlapping regions. Gedeon et al. [1996]
hypothesized a minimum of eight discrete MRX genes, including FRAXE, on the
basis of non-overlapping regions defined by linkage analysis. We report the results
of clinical examination, psychometric assessment, and linkage analysis in four
additional families with nonspecific XLMR.
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Patients and methods
The four families were ascertained through referrals for either genetic counseling
or diagnostic work-up. Informed consent was obtained in all instances. Most
patients were examined by 2 of us (BCJH and NVAMK). Clinical photographs and
blood samples were obtained. Cytogenetic analysis and molecular testing of the
FMR1 gene was performed in at least one patient per family.
Psychometry
Mental retardation is defined as significant subaverage general intellectual func-
tioning (IQ≤70) (criterion A), significant limitations in adaptive functioning (cri-
terion B) and onset before age 18 (criterion C)[American Psychiatric Association,
1994]. To determine the level of intellectual functioning, all patients were psycho-
metrically assessed by using at least one of three highly standardized tests; (1) a
Dutch adaptation of the Wechsler Intelligence Scale for Children Revised (WISC-
R) [Wechsler, 1974; Van der Steene et al., 1986], (2) the Colored Progressive
Matrices (CPM) [Raven, 1965; Van Bon, 1986], and (3) the Revised Amsterdam
Child Intelligence Test (RAKIT) [Bleichrodt et al., 1984] and the McCarthy Scales
of Children’s Abilities (MOS) [Van der Meulen & Smrkovsky, 1985]. The RAKIT
and MOS were applied when floor effects on the WISC-R were imminent.
Visual/motor skills were assessed using the Visual Motor Integration Test [Beery,
1989]. Scores were translated into age equivalents according to the classification of
the American Association of Mental Deficiency [Grossman, 1977]. Adaptive func-
tioning was examined by the Adaptive Functioning Scale for Mentally Retarded
[Kraijer & Kema, 1994]. Academic functioning included word reading [Mommers,
1974], writing accuracy and arithmetic. Based on qualitative analyses, the aca-
demic performances were translated into didactic age equivalents (dae), which
represent the number of months a person received education. A dae of 30 months
(i.e. 3 years of education) was used as a criterion of minimal academic proficiency,
being the cut-off between adequate and inadequate [Dumont, 1984; Ruijssenaars,
1992; Struiksma & Mildenberg, 1985].
Genetic analysis
Venous blood was sampled from patients and relevant family members and DNA
was isolated according to the procedure of Miller et al. [1988]. Microsatellite mar-
kers were analysed by the amplification of 50 ng of genomic DNA using specific
primers (GBD; Isogen Bioscience BV, The Netherlands). Amplification involved
polymerase chain reaction (PCR) 35 cycles (1 min at 94°C, 2 min at 55°C, and 3
min at 72°C) carried out in a 15-µl reaction mixture containing 0.06 U Supertaq in
1 × Supertaq buffer (HT Biotechnology Ltd, England) and 32P-dCTP. Subsequently,
n Chapter 2 - Nonspecific X-linked mental retardation
n 73
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a levels of mental and adaptive functioning, transferred into age equivalents:
+ = > 10-9 years (= borderline and above; IQ-range ± 70-84 and above);
± = 8-3 and 10-9 years (= mild; IQ range 50/55 - 70);
– = 5-7 to 8-2 years (= moderate; IQ range 35/40 - 50/55);
– – = 3-2 to 5-6 years (= severe; IQ range 20/25 - 35/40);
– – – = < 3-2 years (= profound; IQ range < 20/25).
b levels of academic functioning, transferred into didactic age equivalents (dae):
+ = > 30 months (= adequate);
± = 1-29 months (= inadequate);
– = 0 months (= unable).
# = assessed on the basis of retrospective data
* = no data available
MRX43 III-1 – – – – – – – – – –
III-3 – – + ± ± ± –
III-8 – – – unable – – – – – – – –
MRX44 III-5 – – – – – – – –
III-6 – – unable – – – – – –
III-8 – - – – – – –
MRX45 III-7# – – * * – * * *
III-10# – – * * – * * *
IV-3 – – – – ± + ± ±
IV-4 – – – – ± + + +
IV-9 ± – + ± + + +
IV-15 – – – – ± + + +
IV-17 – – – – ± + ± ±
V-9 – – – – ± + + +
V-18 – – – – – ± ± –
VI-2 – – – – – – – – – –
MRX52 III-3 – – unable – – – – – –
III-7 – – – unable unable – – – – – –
III-9 – – – ± ± ± ±
IV-8 – * – – – – –
table ii
Summary of psychometric data
CasesFamily Intelligencea Non-verbal
reasoninga
Visual/
motor skillsa
Adaptive
functioninga
Academic achievement
Readingb Writingb Arithmeticb
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labeled fragments were separated in 6.6% denaturating polyacrylamide gels. After
electrophoresis, gels were exposed overnight to Kodak X-Omat film to visualize the
PCR products. Linkage data were evaluated with the program LINKAGE [Lathrop
et al., 1985, version 5.1] using the Mlink option. Calculations were based on the
assumption of complete penetrance and a disease allele frequency of 0.0001. Map
localizations, genetic distances, and allele frequencies of the marker loci were
obtained both from the Genome Database and from the reports of Nelson et al.
[1995] and Dib et al. [1996].
Results
The pedigrees, including haplotypes, of the four families and photographs of
affected males are shown in Figures 1 through 22. Cytogenetic analysis and mole-
cular study of the FMR1 gene gave normal results in all tested patients. In all four
families, pedigree structure and clinical data are fully compatible with a diagnosis
of nonspecific XLMR. Clinical measurements are summarized in Table I, and a
summary of the psychometric data is provided in Table II. In Tables III to VI the
noninformative markers are not shown.
n Chapter 2 - Nonspecific X-linked mental retardation
n 75
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MRX43 Clinical report
This family (Fig.1) was ascertained when III-7 was referred for genetic counseling
because of MR in two brothers, a maternal uncle and a maternal cousin. The
maternal uncle, II-3, died at age 52 of myocardial infarction. Reportedly, he was
moderately retarded with unremarkable behavior.
In all affected males, pregnancy and delivery were uneventful. All were late in
motor and speech development. Their retardation was recognized in early child-
hood and was nonprogressive. All required special education and lived in a shel-
figure 1
MRX43: pedigree and haplotypes. The cosegregating haplotype has been marked by a
black bar. Filled symbols represent male patients with MR.
proefschrift BH def.  05-11-1999 10:58  Page 76
n Chapter 2 - Nonspecific X-linked mental retardation
n 77
tered environment. None was institutionalized, although III-1 and III-8 stayed in a
day care home. General health was good. All obligate and possible carriers were of
normal intelligence.
The propositus, III-3 (Fig.2), was examined at age 40. As an adolescent he was
treated for epilepsy. He showed normal behavior. Obesity, large head and perior-
bital fullness, wide palpebral fissures and full lower lip were noted. His brother, III-
8 (Fig.3), was seen at the age of 30 years. He was still on anticonvulsive therapy for
epilepsy. He showed normal behavior. Periorbital fullness, wide palpebral fissures
and an upper central incisor gap were noted. The maternal cousin, III-1 (Fig.4),
was 37 years old when seen. His behavior was normal. Obesity, large head, perior-
bital fullness, wide palpebral fissures and full lower lip were noted.
The overall intellectual capacities varied from moderate to profound retardation.
All three scored better on adaptive functioning, and predicted mild to severe limi-
tations. Therefore, all three patients could be classified as mentally retarded. Only
patient III-3 was able to read and write.
Linkage analysis was performed with 34 highly polymorphic markers evenly dis-
tributed along the entire X chromosome (Table III). Significant LOD scores were
only obtained for a single region of the X chromosome. A maximum LOD score of
2.23 at θ = 0.0 was obtained with marker DXS985. To locate the genetic defect
more accurately, haplotypes were constructed with markers from the relevant
region. In this way, DXS987 and DMD were identified as the closest flanking mark-
ers, thus defining the region Xp22.31-p21.2, which spans an approximate distance
of 25 cM.
fig. 2 fig. 3 fig. 4
figure 2
MRX43: patient III-3. Note periorbital fullness, wide palpebral fissures, and full lower lip.
figure 3
MRX43: patient III-8. Note periorbital fullness and wide palpebral fisures.
figure 4
MRX43: patient III-1. Note periorbital fullness, wide palpebral fissures, and full lower lip.
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DXS1060
GHGXg
DXS987
DXS1195
DXS999
DXS443
DXS451
DXS989
DXS1202
DXS1048
DXS1218
DXS1061
DXS985
DXS992
DMD
DXS7
DXS1003
DXS426
ALAS2
DXS453
DXS559
DXYS1
DXS3
DXS178
DXS456
COL4A5
DXS425
HPRT
DXS294
DXS984
DXS292
FRAXAc2
DXS1113
DXS1108
– ∞
– ∞
– ∞
2.17
2.06
2.06
2.06
2.17
2.17
2.17
n.i.
0.12
2.23
2.17
– ∞
– ∞
n.i.
n.i.
n.i.
– ∞
– ∞
– ∞
n.i.
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
n.i.
– ∞
– ∞
– ∞
0.95
0.95
1.06
1.97
1.87
1.87
1.87
1.97
1.97
1.97
n.i.
0.10
2.03
1.97
0.60
– 0.79
n.i.
n.i.
n.i.
– 1.44
– 1.61
– 1.44
n.i.
– 1.44
– 1.07
– 2.06
– 0.79
– 0.79
0.49
0.49
n.i.
– 0.79
– 0.79
– 0.79
1.09
1.09
1.17
1.76
1.68
1.68
1.68
1.76
1.76
1.76
n.i.
0.08
1.82
1.76
0.74
– 0.31
n.i.
n.i.
n.i.
– 0.89
– 0.82
– 0.89
n.i.
– 0.89
– 0.57
– 1.25
– 0.31
– 0.31
0.64
0.64
n.i.
– 0.31
– 0.31
– 0.31
1.03
1.03
1.08
1.34
1.28
1.28
1.28
1.34
1.34
1.34
n.i.
0.04
1.38
1.34
0.70
0.03
n.i.
n.i.
n.i.
– 0.39
– 0.17
– 0.39
n.i.
– 0.39
– 0.17
– 0.53
0.03
0.03
0.63
0.63
n.i.
0.03
0.03
0.03
0.80
0.80
0.82
0.90
0.86
0.86
0.86
0.90
0.90
0.90
n.i.
0.00
0.92
0.90
0.52
0.11
n.i.
n.i.
n.i.
– 0.15
0.07
– 0.15
n.i.
– 0.15
– 0.02
– 0.20
0.11
0.11
0.47
0.47
n.i.
0.11
0.11
0.11
0.46
0.46
0.46
0.44
0.42
0.42
0.42
0.44
0.44
0.44
n.i.
– 0.01
0.45
0.44
0.27
0.09
n.i.
n.i.
n.i.
– 0.04
0.11
– 0.04
n.i.
– 0.04
0.03
– 0.05
0.09
0.09
0.25
0.25
n.i.
0.09
0.09
0.09
table iii
Results of two-point linkage analysis in MRX43
LOD scores
Marker 0.0 0.05 0.1 0.2 0.3 0.4
n.i. = not informative
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MRX44 Clinical report
The family MRX44 (Fig.5) was ascertained when III-10 was referred for genetic
counseling regarding the possibly X-linked mental retardation in her family. Two
affected males with moderate mental retardation, II-3 and II-10, died at age 59 and
63, respectively. Nonprogressive mental retardation was noticed during childhood
in all affected males in the 3rd generation. All but one were institutionalized, and
III-5 lived in a sheltered environment. Their general health was good. All obligate
and possible carriers were of normal intelligence.
The propositus, III-5 (Fig.6), was examined at age 30. His behavior has always
been difficult with outbursts of (sexual) aggression and self-mutilation. Synophris,
lateral deviation of the nose, high nasal bridge and large head were noted.
His brother, III-2 (Fig.7), died because of acute myeloid leukemia at age 51
before he could be examined. Reportedly he was moderately retarded and had a
behavior that was difficult to control. His maternal cousin, III-6 (Fig.8), was seen at
age 45. His behavior is characterized by aggressive outbursts. He was wearing hear-
ing devices for hearing loss, which was conductive on the left and sensorineural on
the right side. Mild central facial palsy and mild right-sided hemiatrophy were
noted. Otherwise his physical examination was unremarkable. The other maternal
cousin, III-8 (Fig.9), was seen at age 41. He showed normal behavior. Except for
preauricular tags and bilateral pes cavus, his physical examination was normal.
Intellectual capacities and level of adaptive functioning were moderately to
severely impaired. Hence, the three tested patients could be classified as mentally
retarded. Only III-6 showed a higher adaptive than intellectual functioning. None
of the patients was able to read, write or solve simple arithmetic problems.
In this family 38 highly polymorphic markers were used for linkage analysis
(Table IV). Significant LOD scores were obtained for a single region. A maximum
LOD score of 2.90 at θ = 0.0 was obtained with marker DXS1204. Haplotype con-
struction indicated that DXS1003 and ALAS2 were the closest flanking markers,
which defines the region to Xp11.3-p11.21 and spans an approximate distance of
10 cM.
n Chapter 2 - Nonspecific X-linked mental retardation
n 79
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figure 5
MRX44: pedigree and haplotypes. The cosegregating haplotype has been marked by a
black bar. Haplotypes of I-1 and I-2 were deduced. Filled symbols represent male patients
with MR.
fig. 6 fig. 7 fig. 8 fig. 9
figure 6
MRX44: patient III-5. Note synophris, lateral deviation of the nose, and high nasal bridge.
figure 7
MRX44: patient III-2.
figure 8
MRX44: patient III-6.
figure 9
MRX44: patient III-8.
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n Chapter 2 - Nonspecific X-linked mental retardation
n 81
DXS1060
GHGXg
DXS443
CYBB
DXS1110
MAO B
DXS538
DXS1055
DXS1003
DXS337
DXS6941
DXS573
DXS1204
ALAS2
PGK1P1
DXS339
DXS453
DXS559
DXS6673E
DXS986
DXYS1
DXS3
DXS990
DXS178
COL4A5
DXS424
DXS1001
HPRT
DXS294
DXS984
FRAXAc2
DXS1108
– ∞
– ∞
– ∞
0.90
– ∞
– ∞
0.90
– ∞
0.87
1.62
1.10
1.62
2.90
– ∞
– ∞
– ∞
– ∞
0.87
1.62
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
0.90
– ∞
– ∞
0.90
– ∞
– ∞
– ∞
– 1.91
– 1.91
– 2.33
0.81
– 0.05
0.26
0.81
0.09
0.78
1.51
0.99
1.51
2.66
0.19
0.30
1.37
0.30
0.78
1.51
– 0.90
– 1.03
– 0.37
– 0.37
– 2.00
– 2.07
0.81
– 0.37
– 0.05
0.81
– 0.37
– 3.91
– 0.65
– 1.12
– 1.12
– 1.26
0.72
0.04
0.46
0.72
0.46
0.68
1.40
0.87
1.40
2.40
0.32
0.36
1.42
0.36
0.68
1.39
– 0.50
– 0.51
0.05
0.05
– 1.20
– 1.26
0.72
0.05
0.04
0.72
0.05
– 2.51
– 0.21
– 0.45
– 0.45
– 0.37
0.52
– 0.11
0.54
0.52
0.57
0.48
1.14
0.62
1.14
1.86
0.10
0.14
1.17
0.14
0.48
1.13
– 0.32
– 0.08
0.26
0.26
– 0.51
– 0.54
0.52
0.26
– 0.11
0.52
0.26
– 1.24
0.06
– 0.16
– 0.16
– 0.01
0.30
– 0.34
0.46
0.30
0.40
0.27
0.83
0.36
0.83
1.25
– 0.26
– 0.22
0.75
– 0.22
0.27
0.81
– 0.35
0.08
0.21
0.21
– 0.20
– 0.21
0.30
0.21
– 0.34
0.30
0.21
– 0.61
0.08
– 0.04
– 0.04
0.09
0.09
– 0.30
0.27
0.09
0.14
0.09
0.45
0.11
0.45
0.60
– 0.36
– 0.36
0.27
– 0.36
0.09
0.44
– 0.25
0.09
0.08
0.08
– 0.05
– 0.05
0.09
0.08
– 0.30
0.09
0.08
– 0.23
0.03
table iv
Results of two-point linkage analysis in MRX44
LOD scores
Marker 0.0 0.05 0.1 0.2 0.3 0.4
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MRX45 Clinical report
The family MRX45 (Fig.10) was ascertained when V-18 was referred for further
investigations of his mental retardation. Not much is known about the past medi-
cal history of patients from the 3rd and 4th generation, however all those deter-
mined to be affected showed nonprogressive mental retardation during childhood.
V-18 and VI-2 were institutionalized, whereas the others obtained special school-
ing, worked and lived in a sheltered environment. III-7 and III-10 were not clini-
cally examined. IV-9 and VI-2 were tested and examined, but not included in the
linkage analysis. Obligate carriers were said to be normal; the possible carrier V-9
had special schooling.
The propositus, V-18 (Fig.11), was examined at age 31 years. He had simple and
large ears, clinodactyly of fifth fingers, relatively large hands and flat feet. His
behavior was unremarkable. At the time of examination the two brothers, IV-3
(Fig.12) and IV-4 (Fig.13), were 66 and 64 years old, respectively. They had simple
and large ears and relatively large hands. Their behavior was normal. IV-9 was
seen at age 49. He was a shy and solitary man with an asthenic build. Highly arched
palate, high nasal bridge, and simple, prominent, relatively large ears were noted.
The brothers, IV-15 (Fig.14) and IV-17 (Fig.15), were 68 and 58 years old, respec-
tively, when seen. Both had simple and large ears, relatively large hands and large
testes. Their behavior was unremarkable. VI-2 (Fig.16) was seen at age 28. Short
stature, highly arched palate, and full lips were noted. He behaved normally.
The overall intellectual capacities of the tested patients were rated as below aver-
age. Similar results were found on adaptive functioning. Therefore, all 10 patients
could be classified as mentally retarded, varying from mild to severe. All except IV-
9 and V-18 showed a higher adaptive than intellectual functioning. All tested
patients except for VI-2 were able to read and write, and all except V-18 and VI-2
were able to solve simple arithmetic problems.
Twenty-eight highly polymorphic markers were used for linkage analysis (Table
V). Significant LOD scores were obtained for a single region. A maximum LOD
score of 3.99 at θ = 0.0 was obtained with marker DXS337. With haplotype con-
struction, DXS1003 and ALAS2 were identified as the closest flanking markers,
which defines the region of linkage to Xp11.3-p11.21 and spans an approximate
distance of 10 cM.
n Chapter 2 - Nonspecific X-linked mental retardation
n 83
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fig. 11 fig. 12
fig. 15 fig. 16
fig. 13 fig. 14
figure 11
MRX45: patient V-18. Note simple and large ears.
figure 12
MRX45: patient IV-3. Note simple and large ears.
figure 13
MRX45: patient IV-4. Note simple and large ears.
figure 14
MRX45: patient IV-15. Note simple and large ears.
figure 15
MRX45: patient IV-17. Note simple and large ears.
figure 16
MRX45: patient VI-2. Note full lips.
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DXS1060
GHGXg
DXS443
DMD
DXS7
DXS538
DXS1003
DXS337
DXS6941
DXS573
DXS1039
DXS1204
ALAS2
PGK1P1
DXS339
DXS453
DXS559
DXS3
DXS178
COL4A5
DXS424
DXS1001
HPRT
DXS294
DXS984
FRAXAc2
DXS1113
DXS1108
– ∞
– ∞
– ∞
– ∞
0.52
– ∞
– ∞
3.00
0.58
2.99
1.40
3.99
– ∞
– ∞
– ∞
1.47
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– 2.49
– 3.42
– 0.60
– 3.52
0.43
– 2.77
1.85
2.73
0.50
2.73
1.21
3.64
0.47
– 1.35
1.43
1.27
1.71
1.65
– 0.47
– 2.39
– 1.96
– 2.47
– 2.38
– 0.93
– 1.34
– 0.04
– 3.09
– 0.35
– 1.44
– 2.12
– 0.36
– 2.21
0.35
– 1.54
1.84
2.43
0.42
2.46
1.02
3.27
0.61
– 0.83
1.47
1.07
1.74
1.66
0.00
– 1.49
– 1.16
– 1.58
– 1.35
– 0.43
– 0.63
0.12
– 1.76
0.10
– 0.57
– 1.01
– 0.17
– 1.05
0.20
– 0.56
1.49
1.80
0.28
1.86
0.65
2.47
0.58
– 0.39
1.23
0.68
1.48
1.38
0.31
– 0.70
– 0.50
– 0.74
– 0.49
– 0.03
– 0.10
0.18
– 0.63
0.39
– 0.20
– 0.50
– 0.09
– 0.48
0.09
– 0.19
0.96
1.13
0.16
1.20
0.33
1.61
0.40
– 0.18
0.85
0.33
1.05
0.96
0.30
– 0.33
– 0.22
– 0.32
– 0.13
0.11
0.08
0.14
– 0.16
0.40
– 0.04
– 0.21
– 0.03
– 0.16
0.03
– 0.03
0.42
0.49
0.07
0.55
0.09
0.75
0.18
– 0.07
0.43
0.08
0.55
0.49
0.15
– 0.12
– 0.08
– 0.10
0.00
0.12
0.10
0.07
0.02
0.26
table v
Results of two-point linkage analysis in MRX45
LOD scores
Marker 0.0 0.05 0.1 0.2 0.3 0.4
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MRX52 Clinical report
This family MRX52 (Fig.17) was ascertained when IV-8 was referred for a diag-
nostic work-up of mental retardation. In all affected males, pregnancy and delivery
were uneventful and nonprogressive mental retardation was noted in childhood.
III-3, III-7 and III-8 were institutionalized, III-9 lived and worked in a sheltered
environment, and IV-8 lived at home. III-9 (Fig.18) was not clinically examined.
Their behavior was fairly unremarkable and general health was favorable. III-8
(Fig.19) died suddenly at the age of 46 years of unknown cause, although he had a
nasal septal abscess at the time of death. Reportedly, he was moderately retarded.
Obligate and possible carriers were all mentally normal. The propositus, IV-8
(Fig.20), was initially clinically evaluated at the age of 2 years. Diagnostic tests
including metabolic screening, karyotyping, EEG, BAER, cerebral computed
tomography-scan, and ophthalmological evaluation were normal. FMR1 mutation
analysis was normal at age 9. At age 6 he suffered facial injuries and a pelvic frac-
ture from an auto accident. Apart from traumatic sequelae, physical examination
was rather unremarkable. III-3 (Fig.21) was evaluated at age 46. Febrile convulsions
at the age of 4 years led to long-term use of antiepileptic drugs. At age 32 his left
testis was removed because of cryptorchidism. Down-slanting palpebral fissures,
midfacial hypoplasia, and clinodactyly of fifth fingers were noted on examination.
III-7 (Fig.22) was seen at age 41. Examination showed down-slanting palpebral fis-
sures, midfacial hypoplasia, low set and posteriorly angulated ears, lordosis and
scoliosis, bilateral hallux valgus and flat feet.
Intellectual and adaptive functioning was below average in all four patients.
Thus, all are mentally retarded, ranging from moderate to profound. The only
child in this study, IV-8, was moderately retarded. In III-3 and III-9, higher adap-
tive than intellectual functioning was seen. Only III-9 was able to accomplish basic
academic tasks.
In this family, 36 highly polymorphic markers were tested (Table VI) in linkage
analysis. Significant LOD scores were obtained for a single region. A maximum
LOD score of 3.14 at θ = 0.0 was obtained with marker DXS559. Haplotypes were
constructed and ALAS2 and DXS3 were identified as the closest flanking markers,
which defines the region of linkage to Xp11.21-q21.33 and spans an approximate
distance of 19 cM.
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Discussion
We have found significant genetic linkage to specific regions of the X chromo-
some in four families with X-linked mental retardation. Because affected males in
each of the four families did not share consistent clinical findings apart from their
MR, nonspecific XLMR is an appropriate diagnosis. Obligate carriers in all families
were of normal intelligence. Based on three criteria for mental retardation, all 20
patients from the four families were classified as mentally retarded. The degree of
mental retardation varied within each family, ranging from mild to profound.
In 14 cases (70%), the level of adaptive functioning was higher than the intellec-
tual capacities. Sattler [1988] attributed this phenomenon to a more objective
assessment of intelligence as compared to the more subjective assessment of adap-
tive functioning. The latter is dependent on the reliability of the informant. Another
possible explanation is that intellectual functioning demands more of abstract rea-
soning than adaptive functioning. This explanation is supported by the perfor-
mances on academic functioning tasks, in which the pragmatical knowledge is better
than the procedural knowledge. More specifically, patients performed better in solv-
ing problems they met in daily activities (e.g. using money in a correct way), than in
solving problems outside a pragmatical context (e.g. addition sums). Nevertheless,
fig. 18 fig. 19
fig. 22
fig. 20 fig. 21
figure 18
MRX52: patient III-9.
figure 19
MRX52: patient III-8.
figure 20
MRX52: patient IV-8.
figure 21
MRX52: patient III-3. Note down-slanting palpebral fissures and
midfacial hypoplasia.
figure 22
MRX52: patient III-7. Note down-slanting palpebral fissures, mid-
facial hypoplasia, and low set ears.
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DXS1060
DXS987
DXS451
CYBB
DXS1003
ALAS2
PGK1P1
DXS339
DXS559
DXS441
DXS1225
DXS1197
DXS986
DXS346
DXS738
DXS1002
DXS3
DXS454
DXS178
DXS1106
DXS424
DXS1001
HPRT
DXS294
DXS984
FraXac2
DXS1113
DXS1108
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
0.57
1.84
3.14
2.10
1.02
1.29
1.24
1.00
1.00
0.37
– ∞
– ∞
– 0.52
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
0.46
– 0.36
– 1.31
– 1.68
– 3.24
– 0.32
1.33
0.50
1.68
2.87
1.92
0.93
1.18
1.14
0.90
0.90
0.36
– 0.20
0.34
– 0.34
0.05
0.07
0.08
– 0.04
0.44
0.47
– 2.07
– 2.23
0.41
0.08
– 0.75
– 1.10
– 1.91
0.13
1.41
0.43
1.50
2.58
1.74
0.83
1.06
1.04
0.79
0.79
0.35
0.25
0.73
– 0.23
0.47
0.49
0.29
0.38
0.64
0.66
– 1.21
– 1.19
0.35
0.32
– 0.27
– 0.50
– 0.79
0.39
1.23
0.29
1.14
1.98
1.33
0.62
0.81
0.80
0.57
0.57
0.30
0.52
0.88
– 0.09
0.68
0.70
0.36
0.56
0.67
0.68
– 0.44
– 0.34
0.22
0.27
– 0.06
– 0.20
– 0.31
0.37
0.89
0.14
0.73
1.34
0.87
0.39
0.51
0.51
0.35
0.35
0.23
0.50
0.74
– 0.02
0.60
0.62
0.25
0.44
0.49
0.49
– 0.11
– 0.01
0.10
0.13
0.02
– 0.05
– 0.09
0.21
0.46
0.04
0.30
0.68
0.36
0.17
0.19
0.19
0.15
0.15
0.13
0.32
0.44
0.01
0.38
0.38
0.09
0.20
0.20
0.21
0.02
0.08
0.01
table vi
Results of two-point linkage analysis in MRX52
LOD scores
Marker 0.0 0.05 0.1 0.2 0.3 0.4
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abstract reasoning is important as it sets the limitations of adaptive function.
The genetic defect in the MRX43 family was assigned to Xp22.31-p21.2. Several
other nonspecific XLMR-families have been mapped to this region in addition to
several syndromic and metabolic XLMR conditions [Lubs et al., 1996].
Raeymaekers et al. [1996] (MRX34) and Billuart et al. [1996] described nonspecif-
ic MR male patients with microdeletions in Xp22.1-p21.3 at DXS1218. The present
state of knowledge precludes conclusions as to whether we are dealing with differ-
ent or similar genetic defects in all these disorders. However, the Xp22-p21 region
harbors many XLMR assignments, and it is likely that more than one XLMR gene
is to be found in this region. The MRX43 patients resemble the patients who have
been described by Atkin et al. [1985]. Common findings are MR, macrocephaly,
large ears, periorbital fullness and full lower lip. Clark and Baraitser [1987] and
Baraitser et al. [1995] described similar patients who differed from those described
by Atkin in that the former have tall stature and no hypertelorism. However, link-
age studies have not been performed in these families, therefore it is inconclusive
whether these are separate forms of XLMR.
Families MRX44 and MRX45 mapped to the same interval, as do many other
nonspecific XLMR-families and known XLMR-syndromes [Lubs et al., 1996].
Family MRX52 maps to an even larger segment of the pericentromeric region,
therefore it overlaps with more assignments of nonspecific and syndromic XLMR
conditions [Lubs et al., 1996]. A candidate gene (DXS6673E) for XLMR has been
identified at Xq13.1 [van der Maarel et al., 1996]. Davies et al. [1997] argued for the
existence of a contiguous gene syndrome consisting of androgen insensitivity and
mental retardation in Xq11.2-q12, implicating a gene for nonspecific XLMR that
lies close to the androgen insensitivity gene. Again, it is too early for conclusions,
but the pericentromeric region will likely contain several XLMR genes.
The four new MRX map assignments presented here do not increase the theo-
retical (minimum) number of genes for nonspecific XLMR as calculated by
Gedeon et al. [1996]: MRX43 overlaps with MRX2 and MRX44, and MRX45 and
MRX52 overlap with MRX1. In the absence of specific phenotypic or biochemical
markers, it is unlikely that the positional cloning approach will be able to lead any
further than regional mapping of putative XLMR-genes. Testing of candidate
genes, either from known contiguous gene syndromes or from X;autosome translo-
cations associated with MR or from the increasingly available number of mapped
and expressed sequence-tagged-sites, is much more likely to be successful [Mandel,
1994]. However, the study of single families with nonspecific XLMR is worthwhile
for at least two reasons. First, testing of candidate genes will be more efficient by
the positional candidate gene approach and second, reliable linkage data is useful in
genetic counseling of the involved families, especially for carrier testing and prena-
tal diagnosis.
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Abstract
We report linkage analysis in a new family with nonspecific X-linked mental retar-
dation, using 27 polymorphic markers covering the entire X-chromosome. We
could assign the underlying disease gene, denoted MRX65, to the pericentromeric
region, with flanking markers DXS573 in Xp11.3 and DXS990 in Xq21.33. A max-
imum LOD score of 3.64 was found at markers ALAS2 (Xp11.22) and DXS453
(Xq12) at θ=0. Twenty-five of the 58 reported MRX families are linked to a region
that is partially overlapping with the region reported here. Extension of the pedi-
gree showed a number of unaffected distant relatives with haplotypes cor-
responding to the disease locus. Apparently, a new mutation in a female is
causative for the disease in the family reported here. Furthermore, we show the
importance of the combining clinical, cytogenetic, and molecular studies since
one of the family members, expected to be affected by the same genetic defect, has
a 48,XXXY karyotype.
Introduction
X-linked mental retardation (XLMR) is clinically variable and genetically hetero-
geneous. Fifty-eight families with nonspecific XLMR (MRX) are listed in a review
by Lubs et al. [1999]. Since only three genes for MRX have been identified, FMR2
[Gecz et al., 1996], GDI1 [D’Adamo et al., 1998] and oligophrenin-I [Billuart et al.,
1998], the vast majority of genes are not known. Twenty-five of the 58 reported
families show linkage to the Xp11-q21 region [Lubs et al., 1999]. The large number
X-linked mental retardation n
94 n
proefschrift BH def.  05-11-1999 10:59  Page 94
of families mapping to this region suggests either a clustering of MRX genes or the
existence of one or a few genes that are frequently mutated. We report yet another
family with nonspecific XLMR (MRX65) that maps to the pericentromeric region.
Haplotype analysis shows that a de novo mutation in one of the females is
causative for the condition in this family.
Patients and methods
Clinical report
The family (Fig. 1) was ascertained when IV-15 was referred for genetic coun-
selling. Initially a branch of the family with six affected males in three generations
was tested (Fig. 1A). In order to determine the mental status of the patients sus-
pected for mental retardation, we employed the three criteria form the DSM-IV
definition of mental retardation [American Psychiatric Assocation (APA), 1994]: 1)
intelligence: IQ of 70 or lower; 2) significant limitations in adaptive functioning; 3)
onset before the age of 18 years. In order to be able to establish a qualitative
description of intellectual functioning, intelligence tests, standardized for school-
aged children, were used: the Wechsler Intelligence Scale for Children, Revised
(WISC-R) [Wechsler, 1974; van der Steene et al., 1986] and the Revised Amsterdam
Child Intelligence Test (RAKIT) [Bleichrodt et al., 1984]. Initially, all patients sus-
pected for mental retardation were assessed with subtests of the WISC-R. If these
proved to be too difficult and a floor effect threatened, we exchanged them for the
RAKIT. The second criterion was measured with a Dutch questionnaire [Kraijer
and Kema, 1994a, 1994b]. The age of onset was obtained by anamnestic informa-
tion. Scores were translated into age equivalents according to the classification of
the American Association of Mental Deficiency (AAMD) [Grossman, 1977].
Once tentative linkage was established, genealogical research lead to an extended
pedigree with two additional affected males (III-5 and IV-22), one of whom had
already died (Fig. 1B).
DNA analysis
DNA from 19 family members, isolated from peripheral blood lymphocytes
according to the procedure of Miller et al. [1988], was used for linkage analysis
with 27 highly polymorphic markers distributed along the X-chromosome. Once
linkage was established, 33 additional relatives were tested for the linked markers.
Analysis of the markers involved amplification by polymerase chain reaction
(PCR). Each reaction contained 100 ng genomic DNA and 30 ng of each primer, in
15 µl Supertaq buffer (50 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl pH 9.0, 0.1%
Triton X-100, 0.01% (w/v) gelatin) in the presence of 32P-dCTP with 0.06 U
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fig. 1
Five-generation family with MRX. Fifty-two family members were available for linkage
analysis. A: Original part of the family that is used for linkage analysis. Haplotypes of some
of the linked markers in Xp11.3-q21.33 and the recombined markers delineating the prob-
able gene location are shown. Deduced haplotypes from deceased individuals are repre-
sented between brackets. The disease chromosome is indicated by a black bar. B: Extended
part of the family, showing that a recent mutation in the small branch has to be causative
for the disease. Only the haplotypes for the linked markers from Figure 1A are shown. The
solid (III-5) and hatched (IV-22) symbols indicate that the mental retardation in these
males is not due to mutation at the MRX65 locus. Obligate carrier females are indicated by
half open circles.
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Supertaq (HT Biotechnology LTD, Cambridge, England). Amplification was
achieved by 35 cycles of 1 min 94°C, 2 min 55°C and 3 min 72°C with locus-spe-
cific primers registered in the Genome Database (http://gdbwww.gdb.org/gdb/).
The radiolabeled PCR products were mixed with 15 µl sample buffer (95% for-
mamide, 20 mM EDTA, 0.05% bromophenol blue) heated to 95°C for 2 min and 4
µl of this mixture was separated on a 6.6% denaturing polyacrylamide gel.
Subsequently, the gel was dried and exposed overnight to Kodak X-OMAT film to
visualize the separated allelic bands.
Two-point linkage analyses of 27 polymorphic markers and the disease locus,
tested in 19 family members, were performed with the MLINK option of the com-
puter program LINKAGE (version 5.03) [Lathrop et al., 1984, 1985; Lathrop and
Lalouel, 1984] on the basis of X-linked recessive inheritance with full penetrance.
The relative order of marker loci was obtained from the Genome Database and the
report of the Sixth International Workshop on X-Chromosome Mapping [Nelson
et al., 1995].
Results
Results of clinical measurements and psychometric studies are summarized in
Table I. Pregnancy and delivery of patients IV-6, IV-10, IV-14, and V-1 were
uneventful, whereas no information is available for patients III-14 and III-15. The
mental impairment was noticed during early childhood and appeared nonpro-
gressive. None of them had had convulsions and all had normal vision and hearing.
All appeared to have relatively poor speech. Physically they were all healthy.
Individual IV-10 was institutionalized and V-1 attended a special school for chil-
dren with severe learning difficulties, while the others were living and working in a
sheltered environment. Some showed chaotic behaviour and aggressive outbursts.
Only minor anomalies were noted in some of the affected males. Macrocephaly
and obesity were observed in one and four patients, respectively. Small testes were
observed in four of the patients (III-14, III-15, IV-6, and IV-10), but no exact mea-
surements were available. The level of mental impairment varied from moderate to
borderline. In all patients there was a tendency to score better in performance than
in verbal intelligence tests. The male with borderline impairment (IV-14) had nor-
mal scores in performance tests, but showed mild mental retardation according to
verbal tests. Since no consistent features other than mental retardation were seen, it
was concluded that pedigree structure and clinical data were fully compatible with
a diagnosis of nonspecific X-linked mental retardation.
For the initial analysis, markers chosen at regular distance on the whole X-chro-
mosome were genotyped on 19 family members. Table II presents the results of the
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DXS1060 – ∞ – 0.22 0.42 0.76 0.67 0.38
DMD – ∞ – 2.78 – 1.51 – 0.49 – 0.14 – 0.08
DXS538 – ∞ – 2.78 – 1.51 – 0.49 – 0.14 – 0.08
DXS7 – ∞ – 0.51 0.14 0.51 0.45 0.20
MAO A – ∞ 1.05 1.35 1.32 0.96 0.45
DXS1003 1.74 1.62 1.48 1.16 0.77 0.32
DXS426 1.44 1.34 1.23 0.96 0.62 0.24
DXS6941 – ∞ 0.40 0.58 0.61 0.49 0.28
DXS573 – ∞ 2.05 2.05 1.71 1.18 0.54
ALAS2 3.64 3.37 3.08 2.43 1.67 0.79
DXS339 1.82 1.68 1.53 1.21 0.85 0.45
DXS453 3.64 3.37 3.08 2.43 1.67 0.79
DXS559 1.82 1.68 1.53 1.21 0.85 0.45
DXS986 2.04 1.88 1.71 1.32 0.87 0.36
DXS3 2.34 2.14 1.93 1.47 0.95 0.39
DXS990 – ∞ 1.23 1.32 1.15 0.80 0.34
DXS1231 – ∞ 2.07 2.08 1.76 1.23 0.57
DXS178 – ∞ 1.79 1.83 1.56 1.09 0.49
Col4A5 – ∞ 1.77 1.80 1.51 1.04 0.46
DXS424 – ∞ 0.78 0.90 0.80 0.53 0.19
DXS425 – ∞ – 2.42 – 1.56 – 0.76 – 0.36 – 0.12
HPRT – ∞ – 5.84 – 3.82 – 1.93 – 0.94 – 0.35
DXS294 – ∞ – 3.69 – 2.51 – 1.36 – 0.72 – 0.30
DXS984 – ∞ – 2.20 – 1.36 – 0.60 – 0.23 – 0.06
FRAXAc2 – ∞ 0.12 0.32 0.40 0.34 0.20
DXS1113 – ∞ – 1.00 – 0.70 – 0.40 – 0.22 – 0.10
DXS1108 – ∞ – 1.78 – 0.79 – 0.02 0.23 0.22
table ii
Lod Scores Between MRX65 and Markers Spread along the X-Chromosome 
(in Order from Xpter to Xqter)
θ
Marker 0.000 0.050 0.100 0.200 0.300 0.400
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two-point linkage analysis in the small branch of the family (Fig. 1A), between
the MRX locus and each marker locus. Two regions with positive LOD scores were
found. The relatively low LOD score in combination with haplotype analysis (data
not shown) makes the localization of the genetic defect in the region between the
MAO A and DXS6941 loci unlikely. Thus, the candidate region was defined by the
proximal locus DXS573 at Xp11.3 and the more distal locus DXS990 at Xq21.33. A
maximum LOD score of 3.64 was calculated for the markers ALAS2 and DXS453 at
θ = 0. A reconstruction of the haplotypes in the pericentromeric region is shown in
Figure 1A.
In order to narrow down the linkage interval for MRX65, extensive genealogical
studies were performed, which revealed an extended pedigree with two additional
affected relatives (Fig. 1B). Individual III-5 had already died. He was said to have
attended special education school and to have suffered from perinatal asphyxia.
Unfortunately no other data on this patient were available. Patient IV-22 was
attending special education school because of learning disabilities.
Members from the extended part of the family were tested for the markers that
showed linkage in the original branch. Haplotype analysis revealed seven unaf-
fected males with the same haplotype in the linked region as the affected individu-
als in the original part of the family. This suggests that a new mutation occurred in
II-3 and caused the disease in six of her male descendants. Consequently, the
reported mental impairment of III-5 and IV-22 has another etiology, in III-5 most
likely the perinatal asphyxia. Interestingly, IV-22 DNA analysis clearly showed two
allelic bands for most markers tested. Karyotype analysis in all 15 cells tested
revealed that the patient has 48 chromosomes (48,XXXY). The extended part of the
family was excluded from the linkage analysis. Haplotypes of the markers tested are
shown in Figure 1B.
Discussion
We have presented a new family (MRX65) with recessive nonspecific X-linked
mental retardation and assigned the gene to a 45-cM interval between Xp11.3-
q21.33, delimited by the markers DXS573 and DXS990.
Although some of the patients showed features that have also been reported in
XLMR syndromes, these characteristics were found not to be consistent through-
out the family. Macrocephaly, small testes, and obesity were reported in one, four,
and four of the six affected males, respectively. Therefore, the disease segregating in
this family is a nonspecific X-linked mental retardation condition, which makes it
the twenty-sixth family linked to the pericentromeric region. In approximately
half of the reported MRX families in which linkage studies are performed, the
X-linked mental retardation n
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causative gene is located in this chromosomal segment. This suggests either a clus-
tering of genes involved in X-linked mental retardation, or the existence of a few
such genes that are frequently mutated. The results described in this paper provide
evidence for a recent mutation in MRX65. An argument for a high mutation rate in
a major MRX gene in this region is provided by the relatively small size of the
linked families. Moreover, extensive genealogical studies that date back to the 18th
century have failed so far to identify a common ancestor in the Nijmegen MRX
families (A.P.T. Smits et al., unpublished observations).
The present study underlines the importance of the combination of clinical,
cytogenetic, and molecular analysis. Due to the high prevalence of mental retarda-
tion in the general (male) population, extension of pedigrees might result in inclu-
sion of false positive individuals (i.e., III-5 and IV-22) who were initially thought to
be cases of nonspecific X-linked mental retardation. Only the combination of mol-
ecular and cytogenetic investigations revealed that their mental handicap was not
due to a mutation at the MRX65 locus.
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Note (added in proof)
The family described here is the same as family F91-09 described in the article of
Billuart et al. (1998). Although the oligophrenin-1 gene is located within the link-
age interval, no mutations were found in family MRX65.
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CHAPTER 3
Syndromal X-linked mental retardation
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3.1 Mental retardation, congenital heart defect, cleft palate,
short stature and facial dysmorphism: a new X-linked 
multiple congenital anomalies/mental retardation 
syndrome: clinical description and molecular studies
Ben C.J.Hamel1, Edwin C.M.Mariman1, Sylvia E.C. van Beersum1, Anneke
M.J.Schoonbrood-Lenssen2, and Hans-Hilger Ropers1
1Department of Human Genetics, University Hospital, Nijmegen and 2Institute for the Mentally
Retarded “Pepijnklinieken”, Echt , The Netherlands
Abstract
We report on two brothers and their two maternal uncles with severe mental
retardation, congenital heart defect, cleft or highly arched palate, short stature
and craniofacial anomalies consisting of microcephaly, abnormal ears, bulbous
nose, broad nasal bridge, malar hypoplasia and micrognathia. Three of the four
patients died at an early age. The mother of the two brothers had an atrial septal
defect. She is assumed to be a manifesting carrier of a mutant gene, which is
expressed in her two sons and two brothers. By multipoint linkage analysis it is
found that the most likely location of the responsible gene is the pericentromeric
region Xp21.3-q21.3 with DMD and DXS3 as flanking markers. Maximum infor-
mation is obtained with marker DXS453 (Z = 1.20 at θ = 0.0).
Introduction
X-linked mental retardation (XLMR) is an important cause of mental handicap.
Opitz [1986] calculated the prevalence of all XLMR at 1/296 for both sexes on the
basis of the fragile X data and the assumption that fragile X comprises about 40%
of all XLMR. In at least 80 X-linked disorders listed in McKusick’s catalogue
[McKusick, 1990] clinical manifestations include mental retardation. Glass [1991]
reviewed the nosology, molecular findings and the genetic counselling of XLMR.
Neri et al. [1992] compiled 77 X-linked conditions, which have mental retardation
as a primary or major manifestation. Out these 62 are syndromal and 15 belong to
the “apparently non-specific or non-syndromal X-linked mental retardation” cate-
gory. In 40 out of these 77 conditions, most of which have been reported in a single
family, the underlying gene has been regionally assigned.
We report on a family with an X-linked syndrome consisting of multiple con-
n Chapter 3 - Syndromal X-linked mental retardation
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genital anomalies and mental retardation (MCA/MR), which to the best of our
knowledge has not been described before.
Clinical reports
The family (Fig. 1) was ascertained in 1984 by our late colleague Ben ter Haar,
when IV-7 was referred for genetic counselling, because his two brothers (IV-6
and IV-8) and two maternal uncles (III-3 and III-9) were mentally retarded. The
parents of these four patients are non-consanguineous and healthy; however, III-4
had a successful correction of an atrial septal defect at age 22.
Patient IV-6
Information on this patient is derived from his medical records and from pho-
tographs (Figs. 2-4). He was born in 1962 at 41,3 weeks after an uneventful preg-
nancy and delivery. Birthweight was 1,950 g (<3rd centile). He had a long and
narrow face, broad nasal bridge, bulbous nose, malar hypoplasia, prognathism,
abnormally modelled and protruding ears, a small mouth with submucous cleft
palate and cleft uvula, clinodactyly of 5th fingers and long and slender feet. A sys-
tolic heart murmur was heard. Cyanosis, microcephaly, short stature and psy-
figure 1
Pedigree.
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chomotor retardation became apparent in the course of time. Cardiac catheterisa-
tion documented a tetralogy of Fallot. Neurologic examination showed spasticity.
At age 8 years he had a developmental age of 2 years. Institutionalization followed.
He died at age 11 because of aspiration. Autopsy confirmed the tetralogy of Fallot
and revealed brain atrophy (900 g; 1200 g is normal for his age). The following
investigations had normal results: routine clinical chemistry, radiology of the skull
fig. 2 fig. 3 fig. 4
fig. 5 fig. 6 fig. 7 fig. 8
figure 2
Patient IV-6 at age 5 months. Note the bulbous nose, malar hypoplasia, dysmorphic and
protruding ears and small mouth.
figure 3
Patient IV-6 at age 8 years.
figure 4
Patient IV-6 (right) at age 11 years. Note the severe cyanosis. Patient IV-8 (left) at age 3
years. Note the changing phenotypes
figure 5
Patient IV-8 at age 1 month. Note similar facial features as in patient IV-6 and III-3.
figure 6
Patient IV-8 at age 7 months.
figure 7-8
Patient IV-8 at age 20 years. Note the changing phenotype.
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and vertebral column and an intravenous urography, EEG, echo-encephalography,
fundoscopy and examination of unbanded chromosomes.
Patient IV-8
Information on this patient is from his medical records, photographs (Figs. 4-8),
and clinical examination.
He was born in 1970 at 42 weeks after an uneventful pregnancy and delivery.
Birthweight was 2,750 g (3rd centile) and OFC 32 cm (3rd centile). He had a long
and narrow face, broad nasal bridge, bulbous nose, malar hypoplasia, abnormally
modelled ears, a small mouth with a highly arched palate and clinodactyly of 5th
fingers. A systolic heart murmur was heard. He remained microcephalic and
became short statured. Severe psychomotor retardation was diagnosed in his first
year of life and he became institutionalized shortly thereafter. Cardiac catheterisa-
tion showed an atrial septal defect, ventricular septal defect and overriding aorta,
possibly a pentalogy of Fallot. Neurologic examination confirmed presence of spas-
ticity. He had no useful speech. Puberty developed normally. On examination at
age 20 years a severely retarded man was seen. Height was 161 cm (<3rd centile),
weight 37 kg (<3rd centile) and OFC 51.5 cm (<3rd centile). He had a long and
narrow face, sunken eyes, malar hypoplasia, abnormally modelled and protruding
ears, a small mouth with a highly arched palate, micrognathia, clinodactyly of 5th
fingers, slender hands and feet, mild coronal hypospadias, normal testes and hyper-
tonicity with mild flexioncontractures of elbows and knees. Routine clinical chem-
istry, radiology of the skull and vertebral column, EEG, EMG, echo-encephalogra-
phy, fundoscopy and high resolution G- and Q-banded chromosomes were all
normal. Cytogenetically no fragile sites at Xq27-28 were noted. A CT scan of the
brain showed microencephaly.
Patient III-3
Information on this patient stems from history and photographs (Figs. 9,10);
medical records were no longer available. He had microcephaly, short stature and
psychomotor retardation. He died at age 6,5 years because of his congenital heart
defect.
Patient III-9
Information on this patient is from history only. He had microcephaly, cleft palate
and cyanosis from birth due to a congenital heart defect. He died at age 22 days.
Patient III-4
The mother of IV-6 and IV-8 had a successful correction of an atrial septal defect
(ASD). Otherwise she is healthy and on examination has no abnormalities. High
X-linked mental retardation n
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resolution G- and Q-banded chromosomes were normal.
In the possible carriers III-6 and her daughter IV-13 echocardiography revealed
no relevant abnormalities.
A summary of the distinct clinical manifestations of the four patients is given in
Table I, the curves for height and weight of IV-6 and IV-8 in Figure 11.
Molecular investigations
Methods
Peripheral blood samples were obtained from II-3, III-4, III-5, III-10, IV-7 and
IV-8 and genomic DNA was extracted from these samples according to the proce-
dure of Miller et al. [1988]. In order to determine the most likely location of the
gene, linkage analysis was performed with highly polymorphic marker loci dis-
tributed along the X chromosome (Fig. 12). Analysis of these markers involved
PCR amplification using the locus-specific primer pairs registered in the Genome
DataBase. The PCR reaction was carried out in a 96 wells Thermal Cycler (MJ
Research, Inc., Waterston, MA) using Taq DNA polymerase (Perkin Elmer,
Vaterstetten, Germany) under the conditions described by Weber and May [1989].
32P-dCTP was included during PCR in order to label the amplification products.
The amplified allelic DNA fragments were separated on a 6.5% denaturing poly-
acrylamide gel. Subsequently, the gel was dried and exposed overnight to Kodak X-
ray film to visualize the separated allelic bands. Multipoint linkage analysis was per-
formed with the LINKMAP option of the program LINKAGE, version 5.10
[Lathrop et al., 1985] on the basis of X-linked recessive inheritance with full pene-
trance and with an estimated disease-gene frequency of 0.0001. Data from consec-
fig. 9 fig. 10
figure 9
Patient III-3 at age 6 months. Note similar facial features as in patients IV-6 and IV-8.
figure 10
Patient III-3 at age 2-3 years.
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figure 11
The curves for height and weight of patients IV-6 and IV-8.
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utive five-point linkage analyses were combined to give the results shown in Fig. 12.
The relative order of marker loci and the genetic distances between them was
obtained from the Genome DataBase and from the literature [Lafrenière et al.,
1991; Huang et al., 1992; Murray et al., 1992; Donnely et al., 1993; Schlessinger et
al., 1993].
Results
With the present family pairwise linkage analysis cannot result in a regional assign-
ment of the underlying gene on the X chromosome, since the maximum obtain-
able LOD-score is limited to Z = 1.20. Therefore, we have performed multipoint
linkage analysis with 19 informative microsatellite markers distributed along the
entire X chromosome (Fig. 12). Our results show that the gene is most likely loca-
ted in the pericentromeric region Xp21.3-q21.3 between DMD and DXS3. The
relative odds for location in the pericentromeric area, the region of Xp distal from
n Chapter 3 - Syndromal X-linked mental retardation
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Growth and development
Prenatal growth retardation + +
Postnatal growth retardation + +
Mental retardation + + +
Spasticity + + +
Craniofacial
Microcephaly + + + +
Long, narrow face + + +
Bulbous nose + + +
Malar hypoplasia + + +
Abnormal ears + + +
Small mouth + + +
Highly arched/cleft palate + + – +
Others
Slender hands and feet + +
Clinodactyly + +
Congenital heart defect + + + +
table i
Clinical manifestations in the four patients.
IV-6 IV-8 III-3 III-9
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DMD and the region of Xq distal from DXS3 are 80:16:1. Maximal information on
co-segregation with the disorder was obtained with marker DXS453 (Z = 1.20 at 
θ = 0.0). Recombination was observed between marker locus DXS426 and the dis-
order, but because of the low informativity content of the family, we are not able to
further discriminate between the distal or proximal region of the p21.3-q21.3 inter-
val as the more likely location for the gene.
figure 12
Multipoint linkage analysis with markers along the X chromosome. The linkage map of
Mulley et al. [Donneley et al., 1993; Schlessinger et al., 1993] was used as a frame for the
location of the various marker loci supplemented with the mapping data of Murray et al.
[1992]. The dashed lines correspond to lod scores of Z=1 (location score = 4.6) and Z=-2
(location score = -9.2).
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Discussion
The occurrence in one family of mental retardation and a similar pattern of multi-
ple congenital anomalies in four males, connected through a woman, with exclu-
sion of a visible chromosomal rearrangement as its cause, justifies the conclusion
that we are dealing with an X-linked MCA/MR syndrome. The congenital heart
defect (ASD) of the mother of two of the patients adds weight to this conclusion
and is explained as a manifestation of her carrier state. A review of the literature
and a search in the computerised syndrome identification programmes POSSUM
and LDDB failed to reveal similar cases. However, it is noteworthy that the clinical
anomalies overlap some previously published X-linked MCA/MR syndromes.
d’Ercole [1976] described an X-linked recessive syndrome with mental retarda-
tion, microcephaly, congenital heart disease and short stature in three males. The
congenital heart disease was present in two of the three patients: total anomalous
pulmonary venous return with atrial septal defect in one and atrial septal defect in
the other. However, other findings differ from those of our cases: all 3 lacked pal-
pable adipose tissue, had an asymmetric face and none had a cleft palate, though all
3 had a highly arched palate. Furthermore the photograph in his article shows a
clearly different facial phenotype from that of to our cases. Golabi et al. [1984]
reported an X-linked MCA/MR syndrome in three male patients who share with
our patients the mental retardation, microcephaly and short stature in all three and
an atrial septal defect in two of them. Otherwise, however, they differ from our
patients in many ways: triangular face, dry and brittle hair, hearing loss and normal
palate in all three and macrodontia in two of them. Similarly the syndromes pub-
lished by Grix et al.[1975], Toriello et al.[1985] and Chudley et al.[1988] are clear-
ly different from that in our cases, despite some overlap. Some of the congenital
anomalies in our patients are so-called midline defects (cleft palate, tetralogy of
Fallot, hypospadias). Opitz and Gilbert [1982] have suggested that the midline is a
developmental field. Toriello and Higgins [1985] reported on a family in which
each patient had a different congenital malformation belonging to the midline
defects, possibly caused by an X-linked mutation. Whether the midline is involved
in the syndrome we describe, remains an open question.
In the two patients, who could be followed for a longer period of time, a chang-
ing phenotype, as has been reported for several syndromes now [Allanson et al.,
1985; Hennekam et al., 1990], could clearly be documented: e.g. in patient IV-6 the
increase of the facial “coarseness” and the appearance of a short philtrum and den-
tal malocclusion and in patient IV-8 also the increase of the facial “coarseness”, the
change of the shape of the face from round to long and narrow and the increasing
protrusion of the ears.
The genetic counselling in this family is straightforward. However, possible car-
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riers are left with risk calculation and prenatal ultrasound surveillance with special
emphasis on the detection of a congenital heart defect. The need for a reliable
method for carrier detection and prenatal diagnosis is obvious, but clearly this
family is too small to reach a significant LOD-score in linkage studies. In order to
determine the location of the gene, multipoint linkage analysis was performed in
the present family with 19 highly polymorphic marker loci. This showed that, like-
ly, the gene is located at the region p21.3-q21.3 (Fig. 12). In addition to the clinical
analysis, it indicates that the present disorder is not identical to various syndromic
and non-syndromic forms of MR, which previously have been mapped to the distal
regions of Xp and Xq [Glass, 1991; Mulley et al., 1992; Neri et al., 1992]. On the
other hand, many of the X-linked MR loci have been mapped to the pericen-
tromeric region. On the basis of our present molecular analysis those loci cannot
be further distinguished from the present disorder. The same is true for the X-
linked cleft palate locus [Moore et al., 1987; Gorski et al., 1992].
In conclusion, we report on a family in which two brothers and two maternal
uncles show an almost identical MCA/MR syndrome with an X-linked recessive
inheritance which has not been described before. Molecular studies reveal that the
most likely location of the responsible gene is the pericentromeric region Xp21.3-
q21.3.
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3.2 X-linked mental retardation associated with cleft
lip/palate maps to Xp11.3-q21.3
Liesbeth E.Siderius,1 Ben C.J.Hamel,2 Hans van Bokhoven,2 Frank de Jager,3
Bellinda van den Helm,2 Hannie Kremer,2 Josien A. Heineman-de Boer,4 Hans-
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Abstract
A family is described in which X-linked mild to borderline mental retardation is
associated with cleft lip/palate. Linkage analysis showed a maximum LOD score of
Z = 2.78 at θ = 0.0 for the DXS441 locus with flanking markers DXS337 and
DXS990, defining the region Xp11.3-q21.3 with a linkage interval of 25 cM.
Introduction 
Facial clefting occurs in more than 25 X-linked syndromes (OMIM, POSSUM,
LDDB). In about half of these syndromes patients are also mentally retarded (Table
I). Here we report a family in which mental retardation (MR) associated with cleft
lip/palate segregates in an X-linked fashion, and give results of linkage analysis. The
combined clinical and linkage data suggest that this could be a novel entity.
Materials and methods
Clinical report
The family (Fig.1) was ascertained when IV-3 was referred. All affected males were
born after an uneventful pregnancy and delivery. Nonprogressive developmental
retardation was noted during early childhood. Results of cytogenetic analysis and
molecular study of the FMR1 gene in III-9, IV-3 and IV-8 were normal. Clinical
data are summarized in Table II.
The propositus, IV-3, (Fig.2) was born with a unilateral cleft lip/palate. He
attended a school for mentally retarded children. His behavior is unpredictable
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with aggressive outbursts. His IQ was measured at 60. At 10 years he had normal
height, weight, OFC and span. We noted corrected cleft lip/palate, long face, broad
nasal tip, synophrys, low posterior hairline and small retractile testes. Cerebral
MRI was normal.
His cousin, IV-8, (Fig.3) was born with preaxial polydactyly of the right hand. At
age 7 years, bilateral orchidopexy was performed for retractile testes of normal
size. His IQ was 80. He attended a school for children with learning difficulties and
is working in a sheltered environment. His behaviour was uncontrollable and he
had a short attention span. At age 21 years a long face, broad nasal tip, thoracic sco-
liosis and large hands were noted. Height and OFC were normal.
Their maternal uncle, III-9, (Fig.4) was born with bilateral cleft lip/palate, and a
mild mental handicap. On examination a long face, broad nasal tip, corrected cleft
lip/palate and large hands were noted. Height and OFC were normal.
figure 1
Pedigree of the family. Haplotypes are shown, which have been constructed from informa-
tive markers in the region Xp11.3-q21.3. Haplotypes of deceased persons of the second
generation were deduced. The cosegregating haplotype has been marked by a black bar
(Cyrillic version 2.0). Filled symbols represent patients with MR with and without CL/P.
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fig. 2 fig. 3 fig. 4
figure 2
Patient IV-3. Note corrected right-sided cleft lip, long face, broad nasal tip and synophrys.
figure 3
Patient IV-8. Note long face and broad nasal tip.
figure 4
Patient III-9. Note corrected bilateral cleft lip, long face, and broad nasal tip.
Height, cm 142,5 (50) 184 (50) 175 (10-50)
Weight, kg 34,7 (50-90) – –
OFC, cm 55,5 (50-90) 54,2 (10-50) 54 (10-50)
earlength, cm 5,6 (25) – –
OCD, cm 8,8 (75-97) – –
ICD, cm 3,3 (75-97) – –
THL, cm 17,0 (75-97) 20,2 (>97) 20,5 (>97)
table ii
Summary of clinical findings (centiles)
IV-3 IV-8 III-9
OFC = occipitofrontal circumference
OCD = outer canthal distance
ICD = inner canthal distance
THL = total hand length
– = not recorded
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Genetic analysis
Venous blood was obtained from all three patients and relevant relatives and DNA
was isolated according to the procedure of Miller et al. [1988]. Microsatellite mar-
kers were analysed by the amplification of 50 ng of genomic DNA using specific
primers (GDB; Isogen Bioscience BV, The Netherlands). Amplification involved
35 cycles of 1 min at 94°C, 2 min at 55°C, and 3 min at 72°C, which was carried out
in a 15 µl reaction mixture containing 0.06 U Supertaq in 1 × Supertaq buffer (HT
Biotechnology Ltd, England) and in the presence of 32P-dCTP. Subsequently,
labeled fragments were separated in 6.6% denaturing polyacrylamide gels. After
electrophoresis, gels were exposed overnight to Kodak X-Omat S film to visualize
the allelic bands. Linkage data were evaluated with the program LINKAGE
[Lathrop et al., 1985, version 5.1] using the Mlink option. Calculations were based
on the assumption of complete penetrance and a disease allele frequency of 0.0001.
Map locations, genetic distances, and allele frequencies of the marker loci were
obtained from the Genome Database and from the report of Fain et al. [1995].
Apart from marker DXS1169, markers DXS262 and DXS472 were used to search
for deletions. Reactions were carried out in a 50 µl volume containing 250 ng
DNA, 250 ng of the appropriate primers, 0.5 mM dNTPs and 0.1 U Supertaq in
Supertaq buffer. Amplification involved 35 cycles of 1 min 94°C, 1 min 55°C, and 1
min 72°C with an initial denaturation step of 6 min at 94°C and a final extension
step of 10 min at 72°C. Products were electrophoresed in 1.5 % agarose gels in 1 ×
TAE, stained with ethidium bromide and visualized under UV illumination.
Results
Given the pedigree structure, X-linked inheritance is very likely. To determine the
location of the underlying genetic defect, linkage analysis was performed with 27
highly polymorphic markers more or less evenly distributed along the entire X
chromosome. Details on these markers, their location and the LOD scores obtained
are given in Table III. Crossovers were found with all informative markers from the
Xp11-pter and the Xq24-qter intervals, although due to the small size of the family,
these intervals could not be formally excluded as the site of the defect. No recom-
bination and LOD scores above 2 were obtained with 5 markers from the proximal
Xq. The highest LOD score of Z = 2.78 at θ = 0.0 was obtained with the marker
DXS441. Haplotypes were constructed with markers from the relevant region
(Fig.1): DXS337 and DXS990 were the closest flanking markers, defining a linkage
interval of 25 cM.
To investigate the possible involvement of this locus in the family described here,
we used 2 markers from the CPX critical interval to screen for a deletion. Each of
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these markers, DXS262 and DXS472 as well as marker DXS1169, was present in
patient IV-3 indicating that there is no gross deletion surrounding the CPX locus.
Discussion
The three described patients share mild to borderline MR, minor facial anomalies
and two had cleft lip/palate. Whether preaxial polydactyly and cryptorchidism are
part of the phenotype, or occur coincidentally, will remain unresolved until the
description of more patients allows for better delineation. Linkage analysis demon-
strated localization of putative gene(s) in Xp11.3-q21.3. In II-4, the markers
DXS426 and PGK1P1 were not informative. Testing of other markers will allow a
more accurate determination of the recombination site in III-9 and narrow down
the linkage interval. Four X-linked disorders with facial clefting map to the same
pericentromeric region. The first is Aarskog-Scott syndrome, which maps to
Xp11.22 and is characterized by short stature, brachydactyly, hypertelorism, shawl
scrotum, mental retardation in about 1/3 of cases, and, occasionally, cleft lip/palate.
Cleft palate with ankyloglossia maps to Xq21 [Moore et al., 1987; Forbes et al.,
1996], ATR-X to Xq13.3 with mutations in the XNP-gene [Gibbons et al., 1995]
and the syndrome described by Hamel et al. [1994] is provisionally assigned to
Xp21.3-q21.3. These three syndromes involve cleft palate without cleft lip, and the
latter two also have MR. However, clinically they are quite different from the
patients described here. In particular, the degree of MR in ATR-X is much more
severe and its facial characteristics are obviously different. Tabor et al. [1983]
reported on a boy with a large deletion in Xq13-q21.3 involving the CPX region,
who had cleft lip/palate in addition to severe MR with agenesis of the corpus callo-
sum and choroideremia. In this family we did not find a gross deletion surround-
ing the CPX locus. Five syndromes combining MR and facial clefting have not yet
been mapped. The syndrome described by Ladda et al. [1993] (MIM 301815) com-
prising congenital contractures, ectodermal dysplasia, clefting and MR has many
traits which distinguish it from the family presented here. The same holds true for
Lenz syndrome (MIM *309800) comprising microphthalmia, skeletal, urogenital
and cardiovascular malformations, MR and facial clefting. Reish et al. [1997] and
Vasquez et al. [1979] have also described unmapped syndromes with MR and facial
clefting. The former is a complex multiple congenital anomalies/MR syndrome
involving many organs/tissues, while the latter resembles very much Wilson-Turner
syndrome (MRXS6, MIM *309585), but differs from the syndrome that segregates
in this family. Another as yet unmapped entity is the W syndrome (MIM 311450)
[Bottani and Schinzel, 1993], which differs from the family reported here by the
presence of median cleft upper lip and “boxer-like” facial appearance.
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DXS1060
GHGXg
DXS443
DMD
DXS538
DXS1003
DXS337
DXS426
PGK1P1
DXS559
DXS441
DXS1002
DXS1168
DXS1169
DXS3
DXS990
DXS458
DXS178
Col4A5
DXS1001
DXS424
HPRT
DXS294
DXS984
FraXAc2
DXS1113
DXS1108
– ∞
– ∞
n.i.
– ∞
– ∞
– ∞
– ∞
1.26
0.79
2.39
2.78
2.48
2.39
2.48
1.26
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
n.i.
– ∞
– ∞
– 1.97
– 0.62
n.i.
– 0.25
– 2.52
– 1.30
0.14
1.15
0.76
2.12
2.52
2.22
2.24
2.22
1.15
0.14
1.24
– 0.62
– 0.04
– 1.72
– 1.60
1.01
– 0.24
– 1.31
n.i.
– 1.42
– 2.82
– 1.23
– 0.22
n.i.
– 0.03
– 1.48
– 0.63
0.31
1.04
0.72
1.85
2.25
1.94
2.07
1.94
1.04
0.31
1.29
– 0.22
0.34
– 0.92
– 0.80
1.13
0.01
– 0.52
n.i.
– 0.83
– 1.72
– 0.65
– 0.04
n.i.
0.11
– 0.59
– 0.19
0.31
0.80
0.61
1.27
1.67
1.37
1.66
1.37
0.80
0.31
1.07
– 0.01
0.47
– 0.26
– 0.15
1.03
0.19
0.09
n.i.
– 0.29
– 0.74
– 0.41
– 0.09
n.i.
0.11
– 0.22
– 0.08
0.19
0.54
0.46
0.68
1.07
0.77
1.17
0.77
0.54
0.19
0.72
– 0.00
0.35
– 0.01
0.07
0.77
0.21
0.26
n.i.
– 0.05
– 0.29
– 0.22
– 0.13
n.i.
0.07
– 0.05
– 0.03
0.06
0.27
0.26
0.16
0.46
0.23
0.60
0.23
0.27
0.06
0.33
– 0.01
0.15
0.04
0.09
0.41
0.14
0.20
n.i.
0.03
– 0.07
table vi
Results of two-point linkage analysis in MRX52
LOD scores
Marker 0.0 0.05 0.1 0.2 0.3 0.4
n.i. = not informative
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Several hitherto unmapped X-linked syndromes with facial clefting, but without
MR have been described: Abruzzo and Erickson (MIM 302905) [1977] reported a
CHARGE-like syndrome with CP; Gorlin et al. [1970] (MIM 311900) described a
family with Pierre Robin sequence, heart malformation and clubfoot, and Chitayat
et al. [1991] (MIM 311895) published a family with Pierre Robin sequence and
facial and digital anomalies. An X-linked tetra-amelia syndrome with multiple
malformations [Gershoni-Baruch et al., 1990] (MIM 301090) includes cleft
lip/palate, while X-linked lethal multiple pterygium syndrome [Tolmie et al., 1987]
(MIM 312150) has cleft palate as a component manifestation. All affected patients
in the latter two syndromes died perinatally and their mental status is therefore
unknown, although in the X-linked tetra-amelia syndrome brain malformations
were present. However, all of these syndromes differ clearly from the patients
described here. Several X-linked mental retardation (XLMR) disorders without
facial clefting map to the same Xp11.3-q21.3 region, as well as many nonspecific
XLMR families [Lubs et al. 1996]. How much locus and/or allelic heterogeneity
exists in this pericentromeric region still has to be established. The question
whether in this family we are dealing with a gene with pleiotropic effect or a con-
tiguous gene syndrome remains to be answered. However, since pure X-linked cleft
lip/palate has not been described, we favour the former. Davies et al. [1997] argue
for the presence of a contiguous gene syndrome including an XLMR gene in Xq11-
q12. Although a candidate gene for XLMR in Xq13.1 was described by van der
Maarel et al. [1996] no obvious candidate genes for mental retardation plus cleft
lip/palate are characterized.
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CHAPTER 4
Metabolic X-linked mental retardation
Contents of chapter 4
4.1 Familial X-linked mental retardation and isolated growth hormone deficiency:
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4.1 Familial X-linked mental retardation and isolated
growth hormone deficiency: clinical and molecular 
findings
Ben C.J.Hamel1, Arie P.T.Smits1, Barto J.Otten2, Bellinda van den Helm1, Hans-
Hilger Ropers1, Edwin C.M.Mariman1
1Department of Human Genetics, and 2Department of Paediatrics, University Hospital, Nijmegen, The
Netherlands
Abstract
We report on several members of a family with varying degrees of X-linked men-
tal retardation (XLMR), isolated growth hormone deficiency (IGHD) and infan-
tile behaviour but without other consistent phenotypic features. Male patients
continued to grow until well into their twenties and reached heights ranging from
135 to 159 cm. Except one, all female carriers were mentally normal; their adult
heights ranged from 159 to 168 cm. By linkage studies we have assigned the
underlying genetic defect to the Xq24-q27.3 region, with a maximum lod score of
Z = 3.26 at θ = 0.0 for the DXS294 locus. The XLMR-IGHD phenotype in these
patients may be due to pleiotropic effects of a single gene or it may represent a
contiguous gene syndrome.
Introduction
X-linked mental retardation (XLMR) is an important cause of mental handicap.
Opitz [1986] calculated the prevalence of all XLMR at 1/296 for both sexes. Neri et
al.[1994] listed 127 conditions with XLMR, including various nonspecific forms. In
contrast, X-linked isolated growth hormone deficiency (IGHD) is very rare
[Phillips and Cogan, 1994, Perez Jurado and Argente, 1994]. IGHD has been
reported in combination with agammaglobulinemia at Xq21.3-q22, the site of the
X-linked agammaglobulinemia (XLA) gene [Duriez et al., 1994]. Growth hormone
deficiency has also been described in a boy with a dup(X)(q13.3-q21.2) [Yokoyama
et al., 1992], and Ogata et al.[1992] have hypothesized on the localization of
growth gene(s) in the pseudoautosomal region. Moreover, growth hormone defi-
ciency is one manifestation in patients with X-linked recessive panhypopituitarism,
a rare but well-defined genetic condition [Phelan et al., 1971,, Schimke et al., 1971,
Zipf et al., 1977].
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While there are forms of XLMR that are associated with short stature [Neri et al.,
1994], the combination of XLMR with IGHD has not been described yet. Here we
report on a family in which mental retardation and IGHD co-segregate as an X-
linked trait. Linkage studies have assigned the underlying gene(s) to the distal half
of Xq thereby indicating that we are dealing with a ‘novel’ disorder.
figure 1
Pedigree of the family with X-linked mental retardation and isolated growth hormone
deficiency. Haplotypes are shown, which have been constructed from informative markers
in the region Xq24-q28. The co-segregating haplotype has been marked by a cross-hatched
bar.
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Materials and methods
Clinical report and family history
A four generation family included eight male patients with variable mental retar-
dation and short stature (Fig. 1). The propositus (III-9) had been examined in
1976 by an endocrinologist at the age of 28 years when the diagnosis of IGHD was
made. He was born at term, after an uneventful pregnancy and delivery. Motor
development was normal. He attended a special school for children with learning
difficulties and thereafter worked in a sheltered environment. At the age of about
13 years he weighed 32 kgs at a height of 127 cm. There were no health com-
plaints. He shaved once or twice a week, and had regular erections and ejaculations.
Remarkebly he had continued to grow into his twenties. Age at pubarche is
unknown. On examination height was 155 cm. Besides mild gynaecomastia, no
other abnormality was seen; in particular he had normal external genitalia, with a
testicular volume of 20 mls. Laboratory investigations gave normal results for cor-
tisol, thyroxine, T3, testosteron, LH and FSH. GH concentrations before and after
insuline induced hypoglycaemia were all below 1 mU/L. Radiographs of the skull
showed a small sella turcica. He had an adult bone age. When seen again at the age
of 45 years (Fig. 2), he showed an infantile behaviour. Results of physical and labo-
ratory examination are given in Tables I and II.
II-6 died for unknown reasons at the age of 18 years. He was mildly mentally
retarded and attained a height of 143 cm.
II-7 died at the age of 72 years because of leucaemia. Reportedly he was mentally
dull and had a height of 158 cm.
II-8 died at the age of 51 years because of food aspiration. He had been institu-
tionalized because of his mental retardation. His height was 135 cm. At autopsy the
sella turcica and the pituitary gland appeared very small; the latter weighed 170 mg,
while the normal mean adult weight is about 600 mg [Kovics and Horvath, 1986].
Patients III-3, III-6, III-7 and IV-6 were all born at term after an uneventful
pregnancy and delivery.
III-3 was severely growth retarded and attended a special school for children
with learning difficulties. At the age of 20 years he had a height age of 10 years and
a bone age of 12 years. He continued to grow into his twenties. Psychometric test-
ing (WAIS) at the age of 47 years revealed a total IQ of 81 (verbal: 89, perfor-
mance: 74). When seen at the age of 50 years (Fig. 3), he used antiepileptic therapy,
though he had not had convulsions for a long time. Otherwise he was healthy. His
behaviour was infantile. He lived and worked in a sheltered environment. Results of
physical and laboratory examination are given in Tables I and II.
III-6 was also short statured and attended a special school for children with
learning difficulties. At the age of 16 years he had a height age of 8 1/2 years and a
n Chapter 4 - Metabolic X-linked mental retardation
n 133
proefschrift BH def.  05-11-1999 11:01  Page 133
X-linked mental retardation n
134 n
bone age of 10 years. He reached his final height in his twenties. When seen at the
age of 45 years (Fig. 4), he lived and worked in a sheltered environment and did not
have any health problems. He showed an infantile behaviour. Results of physical
and laboratory examinations are given in Tables I and II.
III-7 had, as the first in his family, postaxial polydactyly of both hands.
Postnatally he was operated for a possible duodenal stenosis. He also was short
statured. He was institutionalized for his mental retardation. At the age of 11 years
he had a height age of 7 years and a bone age of 5 years. At age 16, he weighed 33
kg at a height of only 130 cm, but he, too, continued to grow into his twenties. He
was seen at the age of 39 years (Fig. 5). There were no particular health problems.
Results of physical and laboratory examinations are given in Tables I and II.
IV-6 had a birth weight of 4,500 g. Motor milestones were reached within nor-
mal limits. Gradually he became short statured with truncal obesity and a puffy
face, as seen in hypothalamic disorders. At the age of 4 years, he weighed 20 kg and
his height was 100 cm. He attended a special school for children with learning dif-
ficulties. In course of time many investigations were performed with normal results
for thyroid function, cortisol, LH/FSH/TSH/prolactine after LH-RH and TRH
stimulation. L-DOPA and arginine GH stimulation tests gave maximal GH levels of
6 mU/L, thereby providing clear evidence for a total GH deficiency. Cerebral CT-
scan was normal and radiographs of the skull showed a small sella turcica. At the
age of 9 years and 8 months his bone age was 7,9 years. At the age of 10 years GH
replacement therapy was started. Because of secondary hypothyroidism during
GH therapy, thyroxine was supplemented at the age of about 14 years. At the age of
15 years he had not yet entered puberty. He showed an infantile behaviour. Results
of physical and laboratory examinations just before the start of GH treatment are
given in Tables I and II.
fig. 2 fig. 3 fig. 4 fig. 5
figure 2
Patient III-9 at the age of 45 years.
figure 3
Patient III-3 at the age of 50 years.
figure 4
Patient III-6 at the age of 45 years.
figure 5
Patient III-7 at the age of 39 years.
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Figure 6 shows height growth curves of patients II-7, II-8, III-9 and IV-6.
Obligate carriers (I-2, II-2, II-4, III-10) and carriers identified by linkage analysis
with flanking markers (III-2, III-5) had heights ranging from 159 to 168 cm, i.e. at
or above the 10th centile; they were all mentally normal with the exception of III-2
who attended a special school for children with learning difficulties and remained
unmarried.
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III-3 III-6 III-7 III-9 IV-6
age (yr) 50 45 39 45 9,5
height (cm) 144(<3) 159(<3) 156(<3) 155(<3) 125,8(<3)
span (cm) 145 162 155 157 nd
OFC (cm) 52,4(<3) 54(10-50) 52,6(<3) 53,5(3-10) 52(10-50)
ears (mm) 74(75-97) 65(75) 65(75) 69(75-97) nd
testes (ml) 20(50) 20(50) 15(10-50) 20(50) pp
gothic palate + + + – –
dental crowding + + + – –
gynaecomastia + + + + –
normal external
genitalia + + + + +
clinodactyly + + + – –
mild scoliosis + – + – –
table i
Summary of selected clinical findings (centiles)*
*OFC = Occipito-Frontal Circumference
+ = present
– = not present
nd = not done
pp = prepubertal
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Linkage studies
Blood sampling was performed and genomic DNA was extracted from all available
family members [Miller et al., 1988]. Genotyping with microsatellite markers
(Table III) involved PCR amplification of 50 ng genomic DNA in 15 µl 1 ×
SupertaqR buffer [10 mM Tris-HCl pH 9.0, 50 mM KCl, 1.5 mM MgCl2, 0.1%
Triton X-100, 0.01% (w/v) gelatin] in the presence of 32P-dCTP with 0.06 U
SupertaqR (HT Biotechnology Ltd, England). Amplification was achieved by 35
cycles of 1 min at 94°C, 2 min at 55°C and 3 min at 72°C with the appropriate
X-linked mental retardation n
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somatomedin C nmol/L 12-48a 3.5 10.3 6.7 9.7 8.2
testosteron nmol/L 10-25 36 13 27 18.2 <2b
estradiol nmol/L 0.03-0.11 0.08 0.06 0.08 0.03 nd
prolactin mE/L 100-700 nd 310 500 140 310
T4 nmol/L 54-154 67 91 93 72 90
free T4 pmol/L 9-17 nd 10.3 11 nd 12.1
TSH mE/L 0.4-4.0 3.5 1.94 1.89 nd 3.8
Cortisol µmol/L morning nd nd nd 0.60 0.22
0.19-0.55
table ii
Summary of laboratory investigations*
normal
values III-3 III-6 III-7 III-9 IV-6
*nd = not done
a = in all 5 patients : <3rd centile for age
b = normal for his age (prepubertal)
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primers (Genome Database; Isogen Bioscience, The Netherlands). Subsequently,
the labeled amplification products were separated by electrophoresis on 6.6%
denaturing polyacrylamide gels. To visualize the allelic bands, gels were dried and
exposed overnight to Kodak X-OMAT S film. Lod score calculations were per-
formed with the Mlink option of the program LINKAGE version 5.10 [Lathrop et
al., 1985]. Complete penetrance was assumed and the disease gene frequency was
estimated at 0.00001. Allele frequencies for each of the markers were assumed as
reported in GDB.
figure 6
Height growth curves of patients II-7, II-8, III-9 and IV-6.
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DXS1060
GHGXg
DXS443
DXS451
DMD
DXS538
DXS7
MAO A
DXS1003
ALAS2
DXS453
DXS559
DXS3
DXS1231
DXS178
COL4A5
DXS425
DXS424
HPRT
DXS294
DXS984
DXS1227
DXS292
DXS548
FRAXAc2
DXS1113
G6PD
DXS1108
– ∞
– ∞
– 0.20
– ∞
– ∞
– ∞
– 0.20
– ∞
– ∞
– ∞
– ∞
– ∞
0.22
– ∞
– ∞
– ∞
– ∞
– ∞
n.i.
3.26
1.88
2.46
n.i.
n.i.
– ∞
– ∞
n.i.
n.i.
– 3.22
– 0.08
– 0.17
– 0.54
– 1.48
– 1.08
– 0.17
– 0.92
– 0.26
– 0.74
– 0.64
– 0.74
0.21
– 5.06
– 4.20
– 0.88
0.99
– 0.08
n.i.
2.98
1.74
2.28
n.i.
n.i.
– 1.68
– 1.48
n.i.
n.i.
– 1.88
0.11
– 0.15
– 0.07
– 0.98
– 0.59
– 0.15
– 0.62
0.21
– 0.46
– 0.37
– 0.46
0.19
– 3.34
– 2.54
– 0.50
1.04
0.12
n.i.
2.68
1.60
2.08
n.i.
n.i.
– 0.69
– 0.71
n.i.
n.i.
– 0.72
0.19
– 1.10
0.25
– 0.55
– 0.22
– 0.10
– 0.31
0.51
– 0.21
– 0.13
– 0.21
0.15
– 1.73
– 1.06
– 0.37
0.82
0.22
n.i.
2.06
1.27
1.65
n.i.
n.i.
0.05
– 0.10
n.i.
n.i.
– 0.21
0.15
– 0.06
0.29
– 0.33
– 0.09
– 0.06
– 0.15
0.49
– 0.08
– 0.03
– 0.08
0.11
– 0.87
– 0.37
– 0.44
0.46
0.18
n.i.
1.38
0.90
1.17
n.i.
n.i.
0.25
0.10
n.i.
n.i.
– 0.00
0.08
– 0.03
0.19
– 0.16
– 0.03
– 0.03
– 0.05
0.31
– 0.02
0.00
– 0.02
0.06
– 0.34
– 0.06
– 0.32
0.12
0.10
n.i.
0.66
0.47
0.62
n.i.
n.i.
0.21
0.11
n.i.
n.i.
table iii
Results of two-point linkage analysis*
LOD scores (θ)
Marker 0.0 0.05 0.1 0.2 0.3 0.4
*n.i. = not informative
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Results
Clinical examination revealed facial anomalies in some but not in all of the patients
(Table I and Figs. 2-5). In adult patients, gynaecomastia was seen. All patients were
short and mentally retarded, ranging from a severe impairment necessitating
admission to an institute for the mentally handicapped, to dull mentality. On the
average, untreated patients reached their final height, ranging from 135 to 159 cm,
at the age of 24 to 25 years (Fig. 6). In all examined patients, the behaviour was
considered infantile, and laboratory investigations revealed total IGHD (Table II).
In several patients high resolution G- and Q-banded chromosomes were normal
and the FRAXA CCG repeat size was normal.
Linkage analysis was performed with 28 highly polymorphic microsatellite mark-
ers distributed more or less evenly along the entire X chromosome. In Table III, the
markers are listed in the Xpter→Xqter order based on the recent map of Fain et al.
[1995]. Significant lod scores were only obtained with markers DXS294, DXS984
and DXS1227 indicating that the responsible genetic defect is located in the distal
part of Xq. The maximum lod score was Z = 3.26 at θ = 0.0 for marker DXS294. To
locate the genetic defect more accurately, haplotypes were constructed with mark-
ers from the relevant region (Fig. 1). In this way, DXS425 and FRAXA were defined
as the closest proximal and distal markers, respectively, spanning a distance of 40
cM and thereby excluding involvement of the FRAXE gene. Thus, our results
demonstrate that the genetic defect underlying mental retardation and growth
hormone deficiency in this family is located in Xq24-q27.3.
Discussion
X-linked mental retardation with IGHD has, to our knowledge, not yet been
described before.
Many XLMR genes have been regionally assigned [Neri et al., 1994]. Those
assigned to Xq24-q27.3 concern well-described syndromes, metabolic and neuro-
muscular disorders, which are clinically clearly different from what is seen our
patients [Neri et al., 1994]. Of the nonspecific forms, MRX6 maps to Xq26 and
clinically it combines mental retardation with short stature, “coarse” face with
other facial anomalies and stubby hands [Kondo et al., 1991]. It is not stated
whether the small body size was due to growth hormone deficiency or to other
causes. X-linked recessive panhypopituitarism is excluded in our family because
clinical and endocrinological examinations gave no evidence for general hypothal-
amic/hypophyseal dysfunction other than lack of growth hormone. Likewise, the
small sella turcica as well as the size reduction of the pituitary gland seen in one
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patient on autopsy is compatible with an isolated deficiency of growth hormone
producing cells, which account for most cells of the adenohypophysis [Kovics and
Horvath, 1986]. IGHD has been described previously in combination with XLA.
XLA or Bruton type agammaglobulinemia is due to mutations in the BTK gene,
which is located in the Xq21.3-q22 interval [Duriez et al., 1994]. Our patients did
not have an apparent increased susceptibility for infections, but, more importantly,
the localization of the involved gene(s) in this family is in a different region of the
X chromosome. Yokoyama et al. [1992] and Ogata et al. [1992] provide evidence
for the presence of genes involved in GH regulation to Xq13.3-q21.2 and the
pseudoautosomal region on the distal Xp, respectively. Our study suggests that the
Xq24-q27.3 interval contains gene(s) involved in mental development and in GH
regulation. The gene(s) underlying X-linked IGHD has (have) not been mapped
yet. Therefore at least formally, it is possible that in the family reported here, such a
gene is involved, as well as a hitherto not described gene for XLMR. For that reason
we cannot rule out the possibility that the combination of XLMR and IGHD seg-
regating in this family as a Mendelian trait is a contiguous gene syndrome resulting
from a microdeletion spanning two closely linked genes in the distal long arm of
the X-chromosome. In the absence of independent evidence for the existence of
separate genes for XLMR and IGHD in the relevant Xq24-q27.3 interval, however,
the alternative i.e. that the XLMR-IGHD phenotype is due to pleiotropic effects of
a single gene defect, may be more plausible. Indeed, one form of XLMR with short
stature has been mapped to the same interval [Kondo et al., 1991]. Unfortunately,
the wide linkage interval does not yet allow reliable carrier detection and prenatal
diagnosis.
Only the youngest patient had GH replacement therapy, with apparent success.
All his untreated affected relatives continued to grow into their twenties, which can
at least partly be explained by the severely retarded bone age, and entered puberty
without treatment. Their final heights ranged from 135 to 159 cm. A similar range
was found by Wit et al.[1996] when pooling literature and personal data on final
height of untreated patients with severe IGHD and spontaneous puberty.
Untreated adult GH deficiency exhibits a whole array of metabolic effects ranging
from reduced bone mineral content to increased cardiovascular mortality.
Impaired psychological well-being has been reported as well. GH replacement ther-
apy can totally or partially alleviate these clinical consequences and is therefore
advisable in adult GH deficient patients [Jorgensen et al., 1994, de Boer et al.,
1995]. In adequately treated IGHD-patients puberty will occur at normal age and
final height may approach target height [Wit et al., 1996].
In conclusion we report on a family in which a hitherto unreported combination
of MR and IGHD cosegregates in an X-linked fashion. Linkage studies suggest a
location of the responsible gene(s) in the Xq24-q27.3 interval. The regional assig-
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ment of the genetic defect in this family is a first step towards the elucidation of the
underlying gene(s) and the causative mutation(s).
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CHAPTER 5
Neuromuscular X-linked mental retardation
Contents of chapter 5
5.1 Localization of the gene (or genes) for a syndrome with X-linked mental
retardation, ataxia, weakness, hearing impairment, loss of vision and a fatal
course in early childhood (Hum Genet 98:513-517, 1996)
5.2 A new X-linked neurodegenerative syndrome with mental retardation, blindness,
convulsions, spasticity, mild hypomyelination, and early death maps to the
pericentromeric region (J Med Genet 36:140-143 and 654 (correction), 1999)
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5.1 Localization of the gene(s) for a syndrome with X-linked
mental retardation, ataxia, weakness, hearing impairment,
loss of vision and a fatal course in early childhood.
H. Kremer1, B.C.J. Hamel1, B. van den Helm1, W.F.M. Arts2, I.J. de Wijs1, E.A.
Sistermans1, H.-H. Ropers1, E.C.M. Mariman1,
1Department of Human Genetics, University Hospital, Nijmegen, 2Department of Neurology, Westeinde
Hospital, The Hague, The Netherlands.
Abstract
Linkage analysis is described in a family with X-linked mental retardation, ataxia,
weakness, floppiness, delayed motor development, absence of deep tendon reflex-
es, hearing impairment and loss of vision (MIM no. 301835). The disease has a
fatal course due to the susceptibility of the patients to infections, especially of
the respiratory tract. Clinical signs indicate the impairment of the posterior
columns, peripheral motor and sensory neurons and the second and eighth cra-
nial nerves and/or their nuclei. The involvement of the posterior columns of the
spinal cord is further suggested by the almost complete absence of myelinated
fibers therein. We localized the responsible gene(s) to Xq21.33-q24 between
DXS1231 and DXS1001 with a maximum lod score of 6.97. The proteolipid pro-
tein gene, which codes for two myelin proteins of the central nervous system and
is located in this region, was considered as a candidate gene for this disorder.
However, no mutations were found in the protein-coding part of this gene.
Introduction
X-linked syndromes with mental retardation form part of the more than 120 dif-
ferent X-linked mental retardation conditions described so far (for review see
Arena and Lubs 1991; Glass 1991; Neri 1994). The majority of the syndromic forms
of X-linked mental retardation have been assigned to specific regions of the X-
chromosome by cytogenetic studies and linkage analysis (Neri 1994). A number of
them have been shown to be monogenic and the gene involved has been identified
i.e. the fragile X syndrome (Verkerk et al. 1991), Norrie disease (Berger et al. 1992;
Chen et al. 1992), adrenoleukodystrophy (Mosser et al. 1993), Menkes disease
(Chelly et al. 1992, Mercer et al. 1992; Vulpe et al. 1992), and DMD (Monaco et al.
1986). Recently, the gene coding for monoamine oxidase type A has been identified
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as the cause of the mental impairment with behavioral disturbance (Brunner et al.
1993). Other syndromes might be contiguous gene syndromes.
We performed linkage analysis in a family with a syndromic developmental
delay, previously described by Arts et al. (1993, MIM no. 301835, Fig. 1). Patients
show a combination of a number of the following symptoms: mental retardation,
an early onset floppiness, weakness, ataxia, deafness, delayed motor development,
nystagmus, loss of vision and susceptibility to infections, especially of the respira-
tory tract. Flaccid tetraplegia and areflexia appear later. Infections were the cause of
death before the age of 6 years in 11 of 12 boys. The oldest patient, now 16 years of
age, has become nearly blind owing to optic atrophy and lives in an institute for the
visually and mentally handicapped. Clinical signs indicate the impairment of the
posterior columns, peripheral motor and sensory neurons and the second and
eighth cranial nerves and/or nuclei. The central nervous system (CNS) of one
patient could be examined at autopsy. In the posterior columns of the spinal cord,
myelin was found to be almost completely absent whereas no abnormalities were
seen in the brainstem and in the gray and white matter of the cerebral and cerebel-
lar hemispheres. A number of dorsal nerve roots that could be examined showed
the same abnormalities as the posterior columns. Biochemical or immunological
defects could not be detected in patients. Carriers may suffer from perceptive hear-
ing loss, ataxic diplegia, extensor plantar reflexes, hypotonia, hyperreflexia or low
deep tendon reflexes.
Linkage analysis has enabled us to assign regionally the gene(s) responsible for
this condition to Xq21.33-q24, between the markers DXS1231 and DXS1001.
Materials and methods
Analysis of DNA markers
For the typing of the DNA markers, genomic DNA was isolated from peripheral
blood according to the method of Miller et al. (1988). Fifty nanogram of genomic
DNA was amplified in a 15 µl reaction mixture containing 1 × Supertaq buffer [10
mM TRIS-HCL pH 9.0, 50 mM KCL, 1.5 mM MgCl2, 0.1% Triton X-100, 0.01%
(w/v) gelatin], 200 µM of each dATP, dGTP, dTTP and 2.5 µM dCTP, 0.6 µCi
[α32P]dCTP (10 mCi/ml, 3000 Ci/mmol), and 0.06 U Supertaq (HT Bio-
technology, England). The initial denaturation of 5 min at 94°C was followed by 35
cycles of 94°C for 1 min, 55°C for 2 min and 72°C for 3 min. After the cycles there
was a final extension of 6 min at 72°C (method modified from Weber and May
1989). Amplification was performed in a 96-well thermal cycler (M.J. Research).
Samples were analysed on a 6.6% polyacrylamide gel (19:1 acrylamide:N,N’-
methylene bisacrylamide) containing 8.3 M urea, 1 × TBE (100 mM TRIS-borate,
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KAL
DXS443
DXS451
DMD
DXS538
DXS7
ALAS2
PGK1P1
DXS339
DXS559
DXS441
CHM
DXS1002
DXS3
DXS454
DXS1231
DXS178
DXS1106
DXS1105
COL4A5
DXS456
DXS424
DXS1001
DXS425
HPRT
DXS984
DXS548
FraXA
F8
DXS1108
Xp22.32
Xp22.13
Xp22.13
Xp21.3-p21.1
Xp11.3
Xp11.4-p11.3
Xp11.21
Xq12
Xq12
Xq13.1
Xq13.2-q13.3
Xq21.2
Xq21.2-q21.31
Xq21.33
Xq21.33
Xq21.33-q22.1
Xq22.1
Xq22.2
Xq22.3
Xq22.3
Xq22.3-q23
Xq23
Xq24
Xq26-q27.1
Xq26.1
Xq27.1
Xq27.3
Xq27.3
Xq28
Xq28
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
3.69
6.97
6.84
5.38
5.77
4.23
– ∞
– ∞
– ∞
– ∞
0.48 
– ∞
– ∞
– ∞
– 0.36
0.70
– 2.20
– 2.47
– 0.69
– 1.01
– 0.13
– 1.28
– 0.03
– 1.22
– 0.58
– 0.63
0.55
0.89
2.84
– 1.00 
2.98
5.57
5.45
4.18
4.36
3.57
2.01
3.13
0.70
– 0.23 
0.36
1.05
– 2.32
– 2.96
0.07
0.77
– 0.98
– 1.05
– 0.01
– 0.50
0.51
– 0.37
0.27
– 0.47
0.30
0.11
0.69
0.87
2.23
– 0.33 
2.26
4.08
3.94
2.95
2.96
4.24
1.97
2.68
0.81
0.40
0.25
1.01
– 0.97
– 1.68
0.13
0.57
– 0.44
– 0.42
0.17
– 0.26
0.58
– 0.07
0.29
– 0.19
0.38
0.21
0.47
0.48
1.45
– 0.06 
1.53
2.53
2.35
1.78
1.73
1.99
1.47
1.96
0.54
0.47
0.16
0.71
– 0.39
– 0.94
0.07
0.29
– 0.16
– 0.11
0.16
– 0.11
0.38
0.00
0.18
– 0.05
0.19
0.09
0.18
0.09
0.61
0.03
0.78
1.06
0.85
0.76
0.70
1.05
0.76
1.05
0.19
0.30
0.07
0.33
– 0.13
– 0.40
table 1
Two-point lod scores of the markers tested.
LOD-scores for θ =Marker Locus
0 0.1 0.2 0.3 0.4
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2 mM EDTA, pH 8.3) at 60W for 3-4 hr. The gels were dried and bands were visu-
alized by overnight exposure on Kodak X-OMAT S film.
Sequence analysis
Amplification of the exons of the proteolipid protein (PLP) gene by the poly-
merase chain reaction was performed as described by Gencic et al. (1989).
Fragments were cycle sequenced and analysed on an ABI 373 automatic sequencer,
according to the protocol of the manufacturer (ABI, Forster City, USA).
Statistical analyses
Linkage data were evaluated with the subroutine Mlink of the Linkage program
(version 5.1; Lathrop and Lalouel 1984). Complete penetrance and a frequency of
0.00001 for the disease allele were assumed for the calculations. The locations of
the markers, their genetic distances and allele frequencies were used as given by
Nelson et al. (1995) and the Genome Data Base.
Results and discussion
The family with an X-linked mental retardation syndrome (Arts et al. 1993) was
analyzed for cosegregation with a set of highly polymorphic markers from loci
distributed along the entire X-chromosome. The results of two-point linkage
analysis are summarized in Table 1.
No recombination was found for the marker loci distal to DXS1231 and proxi-
mal to DXS1001 (Fig.1, Table 1) with a maximal lod score of 6.97, θmax=0,00 for
the marker DXS1106. There was no indication for linkage with markers from other
parts of the X chromosome. Thus, the XLMR gene(s) responsible for the disease in
the present family can be assigned to the Xq21.33-q24 interval between DXS1231
and DXS1001, which has an estimated length of about 20 Mb (Nelson et al. 1995).
The PLP gene, which encodes two major components of the CNS myelin, PLP
and DM20 (Nave et al. 1987), is located in Xq22.1 (Mattei et al. 1986), and is thus
within the interval to which the present syndrome has been assigned. Mutations in
the PLP gene have been found in a number of patients with Pelizaeus-Merzbacher
disease (PMD, MIM no. 312080), an X-linked disorder with dysmyelination of the
cerebral white matter (Gencic et al. 1989; Hudson et al. 1989; Trofatter et al. 1989).
In addition, mutations in the PLP gene have been described in families with X-
linked spastic paraplegia type 2 (SPG2; MIM no. 312900; Saugier-Veber et al.
1994). SPG2 shares several clinical features with PMD including nystagmus, cere-
bellar ataxia and pyramidal syndrome. Dysmyelination was also observed in one of
the patients described here, but it was confined to the posterior columns of the
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spinal cord. Besides dysmyelination, symptoms common to the present syndrome
and PMD/SPG2 are mental retardation, hypotonia, nystagmus, optic atrophy and
abnormal brainstem and somatosensory evoked potentials. The present syndrome
and PMD/SPG2 differ with respect to peripheral nerve involvement, hearing defect
and the recurrent infections that occur only in the present X-linked mental retar-
dation syndrome, whereas pyramidal and extrapyramidal signs, microcephaly and
laryngeal stridor, which are characteristics of PMD/SPG2, are not observed. Despite
these differences, the common symptoms suggest that PLP is a candidate gene for
the present syndrome.
To screen the PLP gene for the presence of a mutation we directly sequenced the
seven exons of the PLP gene of one of the patients (Diehl et al. 1986). No indica-
tions for mutations in the translated regions of the PLP gene were detected.
However, a mutation might be present in the regulatory sequences which were not
analyzed. PMD-like clinical features have also been described in a patient with a
duplication of the PLP gene (Cremers et al. 1987; cf. Ellis and Malcolm 1994). To
rule out the possibility that in our family too, the disorder is due to gene duplica-
tion, the copy number of the PLP gene was tested in two patients. Hereby we
excluded that the present syndrome is due to amplification of the PLP gene in the
affected males.
The syndrome described in this study resembles the X-linked mental retardation
with aphasia described by Wilson et al. (1992). Linkage analysis in the family with
the latter disorder does not exclude the region between DXS1231 and DXS1001.
Patients suffer from hypotonia and frequent infections especially of the respiratory
tract, which also is typical of the present mental retardation syndrome.
Furthermore, delayed myelination was shown by MRI scanning of one of the
patients. This overlap in symptoms might indicate allelism of both disorders or
they might be contiguous gene syndromes. Of the other X-linked mental retarda-
tion conditions that have been assigned to a region overlapping with that of the
present disorder (see Neri 1994), there is some clinical resemblance with the Mohr-
Tranebjaerg syndrome (MIM no. 304700, Tranebjaerg et al. 1995) regarding ataxia,
psychomotor development, deafness and visual impairment. A more detailed map-
ping and, eventually, candidate gene analysis is necessary to give insight in the
question of the allelism or overlap of genes involved in the described syndromes.
Clinically, the present condition has most features in common with the infantile X-
linked ataxia and deafness syndrome described by Schmidley et al. (1987; MIM no.
301790). However, since the latter condition has not been assigned to a specific
region of the X chromosome, no conclusions can be drawn concerning allelism or
overlap of a gene (or genes) involved in both syndromes.
Despite our inability to find mutations or duplications of the PLP gene, a role of
this gene in the etiology of the syndrome we studied cannot be ruled out until
X-linked mental retardation n
150 n
proefschrift BH def.  05-11-1999 11:01  Page 150
analysis of the regulatory sequences of the gene in patients with the present syn-
drome has been completed. Exclusion of allelism of the present syndrome and
those resembling it clinically awaits further mapping studies.
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5.2 A new X-linked neurodegenerative syndrome with 
mental retardation, blindness, convulsions, spasticity,
mild hypomyelination, and early death maps to the 
pericentromeric region
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Hans-Hilger Ropers1,5, Hannie Kremer1, Edwin C.M.Mariman1
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Abstract
We report on a family with an X-linked neurodegenerative disorder, consisting of
mental retardation, blindness, convulsions, spasticity and early death.
Neuropathological examination revealed mild hypomyelination. By linkage analy-
sis, the underlying genetic defect could be assigned to the pericentromeric region
of the X chromosome with a maximum lod score of 3.30 at θ = 0.0 for the
DXS1204 locus and DXS337 and PGK1P1 as flanking markers.
X-linked mental retardation (XLMR) comprises a heterogeneous group of disor-
ders with an estimated cumulative birth prevalence of 1/600 males.1 This high fre-
quency, as well as clinical, genetic and recent molecular findings, indicate that
there are numerous X-linked genes which control the development of the central
nervous system as well as its cognitive and adaptive functioning. In his recent
update of XLMR genes Lubs et al2 have listed 105 disorders with mental retardation
and other associated features. Many of these have neurological symptoms.2-4 Here,
we report on a family with an apparently new X-linked neurodegenerative disorder
with early lethality which maps to the pericentromeric region of the X chromo-
some.
Materials, methods and results
The family (fig 1) was ascertained when IV-10 was referred for genetic counselling.
At that time all patients had been dead for at least 20 years. Therefore, the clinical
information had to be retrieved from limited medical records, which were only
available for IV-5, IV-7 and IV-8. Necropsy was performed on IV-7 and IV-8. The
neuropathology was re-evaluated for this study.
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Genetic analysis
From relevant members of the family venous blood was sampled and DNA was
isolated according to the procedure of Miller et al.5 DNA from patient IV-7 could
only be isolated from a postmortem specimen. Markers were analysed by the
amplification of 50 ng of genomic DNA with the appropriate primers (GDB,
Isogen Bioscience BV, The Netherlands). Amplification involved 35 PCR cycles of
one minute at 94°C, two minutes at 55°C, and three minutes 72°C, which was car-
ried out in a 15 µl reaction mixture containing 0.06 U Supertaq in 1 × Supertaq
buffer (HT Biotechnology Ltd, England) and in the presence of [α32P]dCTP.
Subsequently, labelled fragments were separated on 6.6% denaturing polyacry-
lamide gels. After electrophoresis, gels were exposed overnight to Kodak X-Omat S
film to visualize the allelic bands. Linkage data were evaluated with the program
LINKAGE6 using the Mlink option. Calculations were based on complete pene-
trance and a disease allele frequency of 0.0001. Map locations, genetic distances,
and allele frequencies of the marker loci were obtained from the Genome Database
and from the reports of Nelson et al7 and Dib et al.8
Clinical report
In IV-5, IV-7 and IV-8, pregnancy and delivery had been uneventful and all were
born with bilateral pes calcaneovalgus. The first neurological signs were noticed at
about the age of 3 months. From that age, the disorder took a progressive course
with gradual loss of vision, development of spastic tetraplegia and scoliosis, con-
vulsions, secondary microcephaly, unexplained febrile episodes, severe mental
retardation, and failure to thrive. There was neither stridor nor nystagmus. Hearing
was apparently normal. The zygosity status of the twins IV-7 and IV-8 is unknown.
Proband IV-5 was born at 38 weeks’ gestation with a weight of 3000 g and OFC
of 36 cm. Apart from bilateral pes calcaneo-valgus which was treated conservative-
ly, no other anomalies were noticed. Gradually the above mentioned signs and
symptoms, bilateral flexion contractures of proximal interphalangeal joints, and
bilateral strabismus became apparant. The OFC at 12 months was 44 cm and at 21
months 45 cm. He never sat, crawled nor had any speech. At the age of about 1 year
his mother reported loss of interest in his environment and loss of some skills, like
reaching for toys. He underwent several additional investigations. Ophthal-
mological examination showed pale fundi, the EEG showed an epileptic focus in
the left frontotemporal region, and skeletal age was retarded. Unbanded chromo-
somes were normal. He died at the age of 29 months during a febrile episode.
IV-7 died at the age of 16 ‰ months to aspiration pneumonia. There were no
records on further investigations. Born at 36 weeks’ gestation with a weight of
about 2500 g his twin brother IV-8 went about the same course as the proband. He
died at the age of 26 months, also from aspiration pneumonia. Ophthalmological
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examination showed pale fundi; the EMG was normal, and so were the unbanded
chromosomes. Metabolic analysis revealed no abnormalities. Lysosomal enzymes
(in 1971) were normal.
Obligate and possible carriers were all functioning normally.
Pathology report
In patients IV-7 and IV-8 the brain appeared small for age (900 and 980 gr.; normal
mean weight about 1000 and 1050 gr. respectively). Only minor abnormalities
were noted on macroscopic examination: relatively thin gyri and a somewhat grey
color of the white matter in IV-7; relatively delicate optic nerves and corpus callo-
sum and slightly enlarged lateral ventricles in IV-8. The spinal cords were not avail-
able for further examination. Microscopically, in both patients the cerebral and
cerebellar white matter showed areas of mild myelin pallor with a gradual transi-
tion to the normal white matter (fig 2). The subcortical white matter was relatively
spared. The myelin pallor was neither accompanied by infiltration of inflammato-
ry cells (including macrophages) nor by a remarkable loss of oligodendroglial cells,
A B
figure 2
(A) Histological section of the frontal cerebral cortex and white matter of patient IV.7; the
white matter shows a gradual decrease in myelin staining from the subcortical to the more
central area. (B) Higher magnification of central white matter shows evenly distributed
oligodendroglial cells with small, round, dark nuclei (see arrows) and absence of inflam-
mation ( combined Luxol Fast Blue and Hematoxylin-Eosin (LFB-HE) staining).
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while gliosis was mild or absent. In both patients, the central tegmental tract
showed pronounced spongy changes (fig 3). A similar change was focally present in
the centre of the occipital lobe and around the central nuclei. Histochemical stain-
ing for the detection of storage of metabolic products was negative. Apart from
aspiration pneumonia in both patients, necropsy did not show conspicuous abnor-
malities in other organs. The brain pathology in the two brothers was categorised
as mild hypomyelination.
Linkage data
Pedigree and clinical findings suggest that we are dealing with a novel X-linked
neurodegenerative disorder with mental retardation, blindness, convulsions, spas-
ticity, mild hypomyelination, and early death.
To determine the location of the gene(s) involved, linkage analysis was per-
formed with 34 highly polymorphic markers distributed along the entire X chro-
mosome (table 1). Significant lod scores were obtained only with markers from the
pericentromeric region. A maximum lod score of 3.30 at θ = 0.0 was obtained
with marker DXS1204. To locate the genetic defect more accurately, haplotypes
were constructed with markers from the relevant region (fig 1). In this way,
DXS337 and PGK1P1 were defined as closest flanking markers, spanning a distance
of about 13 cM. Thus, our results show that the genetic defect underlying the neu-
rodegenerative disorder in this family is located in the pericentromeric region of
the X chromosome, Xp11.3-q12.
B B
figure 3
(A) Histological section of the dorsal part of the pons in patient IV.7; note the symmetrical,
spongy change in the area of the central segmental tract (see arrows). (B) Higher magnifi-
cation of this tract shows pronounced microvacuolar change without gliosis or inflamma-
tory infiltrate ( combined LFB-HE staining).
proefschrift BH def.  05-11-1999 11:02  Page 158
n Chapter 5 - Neuromuscular X-linked mental retardation
n 159
DXS1060
GHGXg
DXS443
DMD
DXS7
DXS538
MAO A
DXS1003
DXS337
DXS426
DXS6941
DXS573
DXS1204
ALAS2
AR
PGK1P1
DXS339
DXS453
DXS559
DXYS1X
DXS3
DXS458
DXS454
DXS178
COL4A5
DXS456
DXS424
HPRT
DXS294
DXS984
DXS292
FRAXAc2
DXS1113
DXS1108
– ∞
– ∞
– ∞
n.i
– ∞
– ∞
0.37
– ∞
– ∞
0.83
n.i
2.86
3.30
2.43
n.i
– ∞
0.29
– ∞
– ∞
– ∞
0.38
– ∞
0.38
n.i
– ∞
0.35
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– ∞
– 2.12
– 0.82
– 0.86
n.i
0.67
– 1.70
0.33
0.89
0.60
0.76
n.i
2.61
3.00
2.21
n.i
0.29
0.26
0.80
1.23
– 0.55
0.34
– 0.18
0.34
n.i
0.67
0.31
0.16
– 1.65
– 0.18
– 0.18
– 0.26
0.45
– 2.33
– 2.71
– 1.29
– 0.38
– 0.62
n.i
0.80
– 0.92
0.30
1.00
0.94
0.69
n.i
2.35
2.69
1.98
n.i
0.46
0.23
0.90
1.34
– 0.34
0.31
– 0.01
0.31
n.i
0.80
0.28
0.35
– 0.88
– 0.01
– 0.01
– 0.07
0.58
– 1.26
– 1.63
– 0.56
– 0.09
– 0.41
n.i
0.75
– 0.27
0.24
0.89
0.98
0.53
n.i
1.80
2.05
1.51
n.i
0.49
0.18
0.80
1.24
– 0.20
0.24
0.06
0.24
n.i
0.75
0.22
0.41
– 0.27
0.06
0.06
0.04
0.51
– 0.37
– 0.69
– 0.22
– 0.02
– 0.27
n.i
0.55
– 0.03
0.17
0.63
0.73
0.36
n.i
1.19
1.35
0.99
n.i
0.39
0.13
0.58
0.95
– 0.13
0.17
0.05
0.17
n.i
0.55
0.16
0.32
– 0.05
0.05
0.05
0.04
0.31
– 0.01
– 0.26
– 0.05
– 0.01
– 0.14
n.i
0.28
0.04
0.09
0.28
0.32
0.19
n.i
0.52
0.61
0.43
n.i
0.21
0.07
0.28
0.54
– 0.07
0.09
0.03
0.09
n.i
0.28
0.09
0.17
0.01
0.03
0.03
0.02
0.09
0.09
– 0.06
table 1
Results of two-point linkage analysis
LOD scores (θ)
Marker 0.0 0.05 0.1 0.2 0.3 0.4
*n.i. = not informative
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Adrenomyodystrophy 300270 –
ALD *300100 Xq28†
Arthrogryposis *301830 –
Arts 301835 Xq21.33-q24
Baar-Gabriel 312890 –
Bertini 26 Xp22.33-pter
Cantu 308830 –
Gustavson *309555 Xq24-q26
Holmes-Gang *309530 –
HSAS *308840 Xq28†
Hunter *309900 Xq27.3-q28†
Juberg-Marsidi/ATR-X *309590 Xq13.3† 
Lenz *309800 –
Lowe *309000 Xq25-q26†
Lesch-Nyhan *308000 Xq26.1†
Menkes *309400 Xq13.3† 
Paine-Seemanova  311400 –
PMD *312080 Xq21-q22†
Pyruvate dehydrogenase deficiency *312170 Xp22†
Schmidley 301790 –
VACTERL with hydrocephalus 314390 –
Wittwer 27 Xp22.3 -pter‡
table 2
X-linked mental retardation disorders associated with neurological features and
early death
MIM/ref. Locus
ALD = adrenoleucodystrophy
PMD = Pelizaeus-Merzbacher disease
ATR-X = α-thalassaemia retardation X-linked
HSAS = hydrocephalus owing to stenosis 
of the aqueduct of Sylvius
† = gene cloned
‡ = tentative assignment
Name
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Discussion
Initially, a severe form of Pelizaeus-Merzbacher disease (PMD) had been suspected
in this family. However, the gene for PMD (PLP) is in Xq21-q22.9 None of the X-
linked neurological disorders with early death has been localised to the pericen-
tromeric region Xp11.3-q12 (table 2). Therefore, it appears that this is the first X-
linked neurodegenerative disorder which maps to the pericentromeric region. The
disorder described here does not show overt clinical resemblance to any of the
other known but as yet unassigned X-linked neurodegenerative disorders. Neither
in reviews of XLMR classified by clinical manifestations3 4 10 nor in the latest
update of XLMR2 could a disorder like the one we describe be found.
Hypomyelination is a feature of PMD and the families reported by Schmidley et
al11 and Arts et al.12 Although clinically different, PMD and Arts syndrome have
been mapped to overlapping X-chromosomal regions, Xq21-q22 and Xq21.33-
q2413 respectively, while in the family of Schmidley et al11 no linkage study was per-
formed. Watanabe et al14 described a family with “Pelizaeus-Merzbacher disease”
with, on neuropathological examination, a surprising amount of preserved myelin
sheaths and mature oligodendrocytes and in which much later a normal PLP gene
was shown.15 It would be interesting to perform linkage analysis in this large fami-
ly to see whether its genetic defect colocalises with that of the family described
here. A spongy state of the central tegmental tract was found by Satoh et al16 in 11
out of 22 necropsied cases with a variety of developmental disabilities and a histo-
ry of infantile spasms, indicating that this change is a secondary and non-specific
phenomenon.
The pericentromeric region harbours many of the syndromal and non-specific
XLMR loci2 and therefore, a considerable proportion of the (unknown) number of
XLMR genes will be in this region. Apart from genes of known syndromes like
Wiskott-Aldrich syndrome and Aarskog syndrome, several genes have been
mapped to the DXS337-PGK1P1 interval, like ARAF1, SYN1 (synapsin1), SYP
(synaptophysin), ELK1, and a cluster of zinc finger genes ZNF21, 41, 81, and 157,
which are all possible candidate genes for neurological/neurodegenerative disor-
ders. A-raf deficient mice displayed neurological and gastrointestinal defects and
early postnatal death.17 Synapsin-I deficient mice showed impairment of axonal
development and of synaptogenesis in hippocampal neurons,18 and impairment of
synaptic vesicle clustering and of synaptic transmission and increased seizure
propensity.19 Synaptophysin is an integral membrane protein of small synaptic
vesicles in brain,20 while ELK121 and ZNF21, 41, 81, and 15722 are as transcription
factors putative candidate genes for developmental disorders. Davies et al23 postu-
lated the presence of a contiguous gene syndrome including an XLMR gene in
Xq11-q12. Recently this gene has been identified as OPHN1.24 Up to now inherited
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neurodegenerative disorders all appeared to be the result of single gene defects.
Therefore, we feel that the disorder in this family is more likely the result of
pleiotropic effects of a single gene.
Sequence tagged sites with expression in brain become increasingly available
and will allow identification of more candidate genes in the defined interval.25
In conclusion we describe a family with a new X-linked neurodegenerative dis-
order with early death which maps to the pericentromeric region.
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6.1 General discussion
6.1.1 Follow up
In chapter 2.1 we described the first large family with FRAXE in which the associa-
tion of FRAXE with mild mental retardation is clearly established. Since then,
other families and patients have been reported. In 6 new families with FRAXE,
Mulley et al. (1995) confirmed the association with mild mental retardation and
discussed 4 factors which may complicate the diagnosis of the disorder and its
phenotypic expression. Firstly, the phenotype can be so mild that only after formal
psychometric assessment the unaffected or affected status can be assigned.
Secondly, phenotypic expression can be influenced by copy number mosaicism
with some fully mutated and some not fully mutated fragments. Thirdly, also
methylation mosaicism with incomplete methylation of fragments with copy num-
bers within the accepted full mutation range and between tissue mosaicism can
modulate the phenotypic expression. Lastly, because of the high prevalence of
mental retardation, phenocopies are often a problem in affected families, as is true
for nonspecific (X-linked) mental retardation in general. The association of FRAXE
with nonspecific mild mental retardation has been confirmed in other families
and patients (Biancala et al., 1996; Knight et al., 1996; Barnicoat et al., 1997; Russo
et al., 1998). In 1996, the FMR2 gene associated with the FRAXE CCG repeat was
identified (Gécz et al., 1996: Gu et al., 1996). It encodes a nuclear protein that may
act as an transcription factor. The gene shows no homology to the FMR1 gene
(Verkerk et al., 1991). It has high expression in fetal and adult brain. As in FRAXA,
repeat expansion above a certain threshold leads to methylation of the promotor
and subsequent silencing of the FMR2 gene. Gécz et al. (1997) provided evidence
for the existence of a premutation in FRAXE by describing a healthy man with an
unmethylated CCG repeat expansion of 0,6 kb and normal FMR2 expression. The
threshold between pre- and full mutation lies at repeat lengths of 0,7-0,8 kb.
FRAXE is a rare disorder. Allingham-Hawkins et al. (1995) found no FRAXE
among 300 FRAXA negative mentally retarded males and Knight et al. (1996)
found 1 in 903 mentally retarded males. Brown (1996) estimated a FRAXE/FRAXA
ratio of ≤1/25. Based on the prevalence figures of FRAXA, this leads to a FRAXE
prevalence of 1 per 100.000-150.000 males in the general population, and to the
conclusion that there is no reason to start a screening program for FRAXE. A third
folate sensitive fragile site in Xq28 (FRAXF) is not associated with a recognizable
phenotype (Parrish et al., 1994). Evidence presented by Ritchie et al. (1997) argues
for the existence of a fourth CGG repeat in Xq28 (4G), but it is not yet clear
whether it has any phenotypic role.
In the family described in chapter 2.2 (MRX41) and the one (MRX48) reported
by des Portes et al. (1997), D’Adamo et al. (1998) found causative mutations in
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RabGDI1, the first gene after FMR2 shown to be involved in nonspecific X-linked
mental retardation. In MRX41, a missense mutation was detected leading to a 
nonconservative amino acid change which resulted in a considerable decrease in
affinity for Rab3a and therefore defective recycling of Rab3a, while in MRX48 a
nonsense mutation gave rise to premature stopcodon resulting in profoundly
reduced activity. Bienvenu et al. (1998) found one other mutation in 164 mentally
retarded non-FRAXA males and estimated the prevalence of RabGDI1 mutations
in nonspecific X-linked mental retardation to be in the order of 0,5-1,0%.
The families with nonspecific X-linked mental retardation described in chapters
2.3 (MRX46), 2.4 (MRX43, 44, 45, 52) and 2.5 (MRX65) are currently being
screened for mutations in candidate genes located in the relevant regions. Kutsche
et al. (1998) reported a candidate gene in Xq26 of which the presumed protein
showed homology to a guanine exchange factor (GEF) for Rho GTPase. MRX46 is
presently being tested for mutations in this candidate gene. In MRX65, no muta-
tion was detected in OPHN1 (MRX65 = F91-09, see Billuart et al., 1998).
By adding a few informative members of the family reported in chapter 3.1 (con-
genital heart defect, cleft palate, short stature, facial anomalies) the maximum LOD
score could be increased to Z = 1.54 at θ = 0.0 for marker DXS441. With DXS426
and DXS3 as closest flanking markers, the underlying defect could be assigned to
the Xp11.3-q21.33 interval. Since publication of this family, no other family with
the same or similar phenotype has been reported. It could well be argued that in
the families described in chapters 3.1 and 3.2 (cleft lip/palate) we are dealing with a
cryptic chromosomal rearrangement. In the meantime, a 22q11 deletion has been
excluded in both families.
By testing of additional markers in the family with isolated growth hormone
deficiency described in chapter 4.1, we were able to increase the LOD score to Z
max = 3.44 at θ = 0.0 for DXS1062 with flanking markers DXS425 and DXS8073,
defining the region Xq25-q27.2. In the meantime, the marker DXS425 has been 
re-assigned from Xq24 to Xq25 (Nelson et al., 1995). A second family with X-
linked mental retardation and isolated growth hormone deficiency was published
in 1998 (Raynaud et al.). Its mapping interval (Xq22.1-q27.2) overlaps the one in
our family (Xq25-q27.2). In 1997, Lagerström-Fermér et al. presented molecular
data on a family with X-linked recessive panhypopituitarism in which affected
males exhibit variable degrees of hypopituitarism and mental retardation. The
Xq25-q26 region showing linkage appeared to be duplicated in affected males and
carriers. This family had been originally published in 1971 by Phelan et al., where 
- surprisingly - mental retardation was not mentioned. In the meantime we have
reexamined our family to answer the following questions: firstly, are we also dealing
with panhypopituitarism instead of isolated growth hormone deficiency, and sec-
ondly, do patients and carriers have a similar duplication in Xq25-q26?
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We reinvestigated patient IV-6 at the age of nearly 18 years. LH, FSH and testos-
teron levels indicated that he is partially hypogonadal. Therefore we think that the
syndromes described by Lagerström-Fermér et al. (1997) and by us are in fact
identical. At the molecular level we could not detect any duplication in Xq25-q26
so far.
Goerss et al. (1993) reported on two brothers with mental retardation and neur-
al tube defect. The oldest of the two had also panhypopituitarism, while the
youngest who had died was short statured. Both appeared to have a duplication of
Xq26-q27 which was also found in their mother and maternal grandmother. Hol et
al. (1998) were able to narrow down each of the two breakpoint regions to 400 kb
intervals. The distal breakpoint region could well harbour a gene predisposing to
neural tube defect, since the human homologue of the Bent tail gene (Bn), which
causes neural tube defects in the mouse, resides in this region (Hol et al., 1994).
Moreover, Fryns et al. (1996) reported a de novo X/autosome translocation
(t(X;22)(q27;q12.1) associated with a neural tube defect. Cloning of the proximal
breakpoint may lead to the detection of the gene which, when defective, causes the
disorder described by Lagerström-Fermér et al. (1997), Raynaud et al. (1998) and
by us (chapter 4.1). However, other mechanisms like dosage and position effects
could be envisaged as well.
In chapter 5.1 we reported the regional assignment of the gene(s) for the Arts
syndrome (ataxia, weakness, hearing impairment, loss of vision, fatal course; Arts et
al., 1993) to Xq21.33-q24. Apart from exclusion of PLP as the causative gene,
involvement of the DDP gene (Jin et al., 1996) could also be excluded.
Finally, the family described in chapter 5.2 with blindness, convulsions, spastici-
ty, mild hypomyelination, early death is remarkable because in this family a signif-
icant LOD score of 3.30 at θ = 0.0 was obtained, although there was only DNA
from a single affected patient, extracted from autopsy material taken more than 20
years before.
6.1.2 Present status
To date, causative genetic defects have been identified for about 24 X-linked mental
retardation syndromes (des Portes et al., 1998; Gleeson et al., 1998; Fox et al., 1998;
Heiss et al., 1998; Lubs et al., 1999). In principle, this means that for patients and
their families with these disorders DNA diagnosis and accurate genetic counselling
have become possible. However, for many of these including Aarskog syndrome
(FGDY), ATR-X (XNP), Coffin-Lowry syndrome (RSK2), Lowe syndrome
(OCLR1), and Opitz BBB syndrome (MID1) DNA diagnosis is not routinely per-
formed in the Netherlands.
So far, 4 genes have been shown to be exclusively involved in nonspecific X-
linked mental retardation: FMR2 (Gu et al., 1996; Gécz et al., 1996), RabGDI1
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(D’Adamo et al., 1998), OPHN1 (Billuart et al., 1998), PAK3 (Allen et al., 1998),
while RSK2 plays a role in both a syndromal (Coffin-Lowry syndrome) and a non-
specific form (Merienne et al., 1999). FMR2 encodes a transcription factor and
RSK2 a protein kinase which is activated by the MAP-kinases. Since a mutation in
RSK2 has been found in nonspecific X-linked mental retardation, it is tempting to
speculate that other syndromal genes might also be involved in nonspecific X-
linked mental retardation. The fact that XNP mutations have been detected in
patients with severe mental retardation and - often rather subtle - hypotonic facial
features (Villard et al., 1999) is in support of this speculation.
Small monomeric GTP-binding proteins apparently play an important func-
tional role in the central nervous system (van Aelst and D’Souza-Schorey, 1997;
Antonarakis and van Aelst, 1998; Woodman, 1998; Ostermeier and Brunger, 1999).
These GTP-binding proteins function as molecular switches that interact with their
target or effector protein only in the activated, GTP-bound state. They are turned
off by hydrolysis of GTP to GDP, causing dissociation of the effector from the G
protein. Several accessory proteins act in this cycle: GAPs (GTPase activating pro-
teins) enhance the intrinsic hydrolytic GTPase activity, thereby inactivating the G
protein; GDIs (GDP-dissociating inhibitors) keep the cytosolic G protein in the
inactive GDP-bound state; GDFs (GDI displacement factors) displace GDI, allow-
ing reactivation of the G protein; and GEFs (guanine exchange factors) catalyze the
exchange of GDP by GTP. Rab proteins are a subgroup of the superfamily of Ras-
like regulatory G proteins and are involved in targeting and regulating vesicular
membrane traffic and possibly also in transport vesicle formation (Wu et al., 1996;
Woodman, 1998). GDI1 encodes a GDI for Rab3A which regulates vesicular trans-
port and neurotransmittor release in synapses (Südhof, 1997; D’Adamo et al., 1998;
Ostermeier and Brunger, 1999). OPHN1 encodes a protein that acts as a GAP for
Rho GTPases, another subfamily of small G proteins (Billuart et al., 1998). Rho
GTPases have been implicated in the control of actin cytoskeletal organization and
in dendrite and synapse formation (van Aelst and D’Souza-Schorey, 1997). PAK3 is
a member of the larger family of p21-activating kinase genes. PAK proteins are
thought to play a role as critical downstream effectors that link Rho GTPases to the
actin cytoskeleton and to MAP-kinase cascades (Allen et al., 1998).
As mentioned above, the 5 genes identified to date account for only a small pro-
portion of nonspecific X-linked mental retardation and consequently, many more
genes - in total maybe up to 100 - still have to be found. This is good news for
reseachers, but bad news for patients and in particular their families as for many of
them accurate genetic counselling including carrier testing and prenatal diagnosis
is still far away. At this stage it is not even feasible to apply the limited available
knowledge in the routine DNA diagnostic laboratory, for several reasons: i. the
diagnostic yield will be low and therefore, few families will benefit from it, i. vast
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numbers of patients are eligible for testing because on clinical grounds, preselec-
tion is not possible, and as a consequence, ii. the cost-benefit ratio will be
extremely unfavourable.
Compared to the number of publications dealing with X-linked nonspecific
mental retardation, there is a surprising scarcity of reports on autosomally inherit-
ed nonspecific mental retardation. X-linkage is the only mode of monogenic inher-
itance which allows for the occurrence of large multigeneration families with men-
tal retardation. Mentally retarded patients carrying an autosomal dominant muta-
tion usually will not have children and for autosomal recessive forms of mental
retardation, the presence of more than one homozygous patient born to heterozy-
gous parents is rare due to small family sizes. Recently, several patients with auto-
somal microdeletions and minimal phenotypic manifestations have been reported
(Flint et al., 1995; Martinez et al., 1999). Also, evidence is accumulating that men-
tally retarded patients carrying apparently balanced de novo autosomal rearrange-
ments may have microdeletions around the breakpoint region(s) (Wirth et al.,
1999). So, there is no doubt that in the future autosomal genes will be found which
play a role in nonspecific autosomal mental retardation.
6.2 Outlook
In spite of the fact that the gene for the fragile X syndrome was already cloned 8
years ago (Verkerk et al., 1991), it is obvious that for nonspecific and other forms of
X-linked mental retardation the molecular era has just begun. Many more candi-
date genes will become available from a multitude of sources: mental retardation-
associated X-chromosomal rearrangements, complete EST/transcript maps of the
X chromosome, genomic sequences, and human homologues of genes that play a
role in CNS development and function in other species. Subsequent mutation
analysis in mentally retarded males and their families, and functional analysis of
detected mutations will clarify the role of candidate genes in mental retardation.
This will be facilitated by the availability of microarray techniques for gene map-
ping, expression profiling and mutation analysis (Shuber et al., 1997; Johnston,
1998). Rapid, cheap and reliable techniques for mutation screening are also a pre-
requisite for their introduction in routine DNA diagnosis; here again, it is likely
that microarrays will play a major role. In order to elucidate the pathophysiology,
not only genetic and biochemical functional studies (Fields, 1997) will be necessary
but also highly accurate neurophysiological and neuroimaging investigations (PET,
SPECT, and functional MRI). Moreover, careful clinical examination of patients,
meticulous description of dysmorphic features and standardized psychometric
assessment will be indispensable for genotype-phenotype analysis. If it is assumed
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that there are about 100 nonspecific X-linked mental retardation genes which all
contribute more or less equally and the goal is to identify all these genes, it can be
calculated that about 500 families with nonspecific X-linked mental retardation are
needed. This is far too much for a single research institute. Therefore, both multi-
disciplinary and international cooperation are needed to achieve the goals of such a
major project.
These efforts will enormously broaden our knowledge concerning the causes
and the pathophysiology of X-linked mental retardation and will pave the way to
understanding the physiology of CNS formation and function. Also, this will great-
ly enhance our diagnostic possibilities, both pre- and postnatally, thereby impro-
ving the accuracy of genetic counselling for the families involved. Finally, at least in
a few of these conditions, these developments will lead to novel therapeutic strate-
gies. Whether these will be conventional ones or whether they will predominantly
involve gene therapy, only time can tell.
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Summary
The definition of mental retardation comprises three criteria: i. IQ≤70, i. signifi-
cant limitations in adaptive functioning, and ii. onset before the age of 18 years.
The most likely prevalence of mental retardation is in the order of 1,5% of which
about 0,5% have an IQ of ≤50. This relatively high prevalence is reflected by the
costs: in 1994, 8,1% of the Dutch health care expenditure was devoted to “Mental
Handicaps”. The two best known and commonest causes are Down syndrome and
the fragile X syndrome. However, in most cases of mental retardation the cause is
still unknown. For management and genetic counselling purposes it is justified to
perform an extensive and comprehensive diagnostic workup of every single case of
mental retardation.
Since many years it is known that there are more males with mental retardation
than females. This is also seen in Dutch schools for children with (severe) learning
difficulties (MLK and ZMLK) with a male-to-female ratio of 1,60 and 1,54, respec-
tively. In schools for children with specific educational needs (LOM) this ratio is
even 2,73, while in institutions for the mentally handicapped this is 1,37. From
these data it seems as if with decreasing severity of the mental impairment the
male-to-female ratio increases. This male excess in mental retardation is explained
by the existence of mutations in X-linked genes, which are involved in central ner-
vous system development and functioning: X-linked mental retardation. The
prevalence of X-linked mental retardation is estimated as 1,8/1000 males. X-linked
genetic defects probably account for 20-25% of all male mental retardation and
10% of mild mental retardation in females. X-linked mental retardation comprises
two groups: i. syndromic, in which other recognizable and consistent features
accompany the mental retardation, and i. nonspecific, in which the mental retar-
dation is the only consistent feature. The best known and most common syn-
dromic form is the fragile X syndrome. However, more than 120 X-linked syn-
dromes have been described, of which mental retardation is an important feature.
Nonspecific X-linked mental retardation can only be diagnosed if there are multi-
ple cases in the family. Nevertheless, it is thought to be three times more frequent
than the fragile X syndrome. Much effort is put in the molecular elucidation of X-
linked mental retardation through different approaches such as linkage analysis
and positional cloning, analysis of candidate genes and the study of patients with
mental retardation and X chromosomal rearrangements. This has already led to the
regional assignment of putative genes and the identification of both syndromal and
nonspecific X-linked mental retardation genes. The latter is a prerequisite for reli-
able diagnosis and genetic counselling, including carrier detection. However, most
of the involved genes still have to be found. This is highly facilitated by the avail-
ability of a large number of clinically and genetically well characterised families.
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Here are reported 13 of such families, 8 with nonspecific and 5 with syndromal X-
linked mental retardation.
In the first family described in chapter 2 FRAXE is segregating. Cytogenetically, it
is characterised by the presence of a fragile site at Xq27-q28, which is indistin-
guishable from the FRAXA fragile site, and molecularly by a GCC repeat expan-
sion, which when passing a certain threshold results via methylation in silencing of
the FMR2 gene. In this large family its association with nonspecific borderline to
mild mental retardation was for the first time clearly shown. In the 7 other families
the putative genetic defect could be assigned to various regions on the X chromo-
some. This allowed the identification of a mutation in the gene RabGDI1 in the
MRX41 family.
In chapter 3 two families are reported, in which the mental retardation is associ-
ated with congenital malformations and facial anomalies. The combination of
mental retardation, congenital heart defect, cleft palate, short stature, and facial
anomalies observed in the first family has not been reported before. Also, the com-
bination of mental retardation, cleft lip/palate and minor facial anomalies as seen
in the second family is here reported for the first time. Only in the second family a
positive and significant LOD score could be reached with assignment of the genetic
defect to Xp11.3-q21.3.
In chapter 4, for the first time a family is described in wich apart from mental
retardation growth hormone deficiency has been diagnosed. The genetic defect
could be assigned to Xq24-q27.3.
In chapter 5 two families with severe neurodegenerative disorders are reported.
In the first family with Arts syndrome the results of linkage analysis are presented,
i.e. localization of the defect in Xq21.33-q24, while the second report comprises the
clinical description of a new X-linked mental retardation disorder with blindness,
convulsions, spasticity, mild hypomyelination, and early death and the results of
linkage analysis, i.e. localization of the defect to the pericentromeric region.
In the first part of chapter 6 - where relevant - an update is presented of the fam-
ilies described in the chapters 2 to 5.
For 24 X-linked mental retardation syndromes causative genetic defects have
been identified to date. Sofar, 5 genes are known to be involved in nonspecific X-
linked mental retardation. These 5 genes account for only a small proportion of
nonspecific X-linked mental retardation. Presently, it is estimated that as much as
100 genes could be involved in nonspecific X-linked mental retardation. For many
of the syndromal and for all 5 nonspecific X-linked mental retardation genes rou-
tine DNA diagnostic use is not possible, because - among others - with the present-
ly available techniques the cost-benefit ratio will be extremely unfavourable.
Though there is a surprising scarcity of publications on autosomally inherited
nonspecific mental retardation, evidence is accumulating that in the - near - future
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autosomal genes will be found which play a role in nonspecific mental retardation.
The molecular era for X-linked mental retardation has in fact just begun. Many
more candidate genes will become available in the near future. The mutational
and functional testing of these genes in patients and families will be facilitated by
the availability of new techniques like microarray techniques which can be used for
gene mapping, expression profiling and mutational analysis. Multidisciplinary and
international cooperation are needed to elucidate the molecular and cell biological
basis of X-linked mental retardation. Eventually, this will i. enormously enhance
understanding of the physiology of central nervous system formation and func-
tion, i. greatly improve pre- and postnatal diagnostic possibilities, and ii. lead to
the development of novel therapeutic strategies in at least a few of these disorders.
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Samenvatting
De definitie van mentale retardatie (verstandelijke handicap) omvat drie criteria:
i. een IQ≤70, i. belangrijke beperkingen in het aanpassend vermogen, en ii. een
aanvang voor het 18e levensjaar. De meest waarschijnlijke prevalentie (voorkomen
in de bevolking) van mentale retardatie ligt in de orde van 1,5%. Hiervan heeft
ongeveer 0,5% betrekking op ernstige mentale retardatie met een IQ≤50. Deze
betrekkelijk hoge prevalentie maakt duidelijk dat het om een belangrijk gezond-
heidszorgprobleem gaat. Dit blijkt ook uit de hoge kosten die ermee gemoeid zijn:
in 1994 werd er in Nederland 8,1% van het gezondheidszorgbudget aan uitgegeven.
De twee bekendste en ook meest voorkomende oorzaken van mentale retardatie
zijn het Down syndroom en het fragiele X syndroom. Echter in de meerderheid
van de gevallen van mentale retardatie is de oorzaak onbekend. Met het oog op de
behandeling in brede zin en erfelijkheidsadvisering is het gerechtvaardigd bij
iedereen met mentale retardatie een uitvoerig onderzoek te doen naar de oorzaak
ervan.
Sinds een groot aantal jaren is het al bekend, dat er meer mannen zijn met men-
tale retardatie dan vrouwen. Dit is ook te zien in de Nederlandse scholen voor spe-
ciaal onderwijs. De man-vrouw verhouding op MLK scholen is 1,60 en op ZMLK
scholen 1,54. Op LOM scholen is dit zelfs 2,73, terwijl in instituten voor ver-
standelijk gehandicapten dit 1,37 bedraagt. Er lijkt dus een omgekeerde relatie te
bestaan tussen de ernst van de mentale handicap en de man-vrouw verhouding.
Dit mannenoverschot wordt verklaard door het bestaan van genen op het X chro-
mosoom die betrokken zijn bij het ontstaan en de werking van het centrale zenuw-
stelsel. Mutaties in zulke genen kunnen bij mannen mentale retardatie tot gevolg
hebben (X-gebonden mentale retardatie), terwijl vrouwen een zekere bescherming
genieten van hun tweede, normale X chromosoom. De prevalentie van de X-
gebonden mentale retardatie wordt geschat op 1,8/1000 mannen. X-gebonden
genetische afwijkingen zijn waarschijnlijk verantwoordelijk voor zo’n 20-25% van
alle mentale retardatie bij mannen en zo’n 10% van de milde mentale retardatie bij
vrouwen. De X-gebonden mentale retardatie wordt in twee groepen onderverdeeld:
i. de syndromale, waarbij behalve de mentale retardatie ook nog andere herkenbare
verschijnselen voorkomen en i. de niet-specifieke, waarbij de mentale retardatie
het enige verschijnsel is. De bekendste en meest voorkomende syndromale vorm is
het fragiele X syndroom; er bestaan echter meer dan 120 X-gebonden mentale
retardatie syndromen. Niet-specifieke X-gebonden mentale retardatie kan alleen
vastgesteld worden als er meerdere aangedane mannen in de familie zijn. Als groep
is de niet-specifieke X-gebonden mentale retardatie drie keer zo frequent als het
fragiele X syndroom. Wereldwijd wordt er veel energie gestoken in de moleculaire
opheldering van de X-gebonden mentale retardatie vanuit verschillende benaderin-
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gen zoals koppelingsonderzoek en positionele klonering, onderzoek van kandi-
daatgenen en onderzoek van patiënten met mentale retardatie en X chromosoma-
le structurele veranderingen. Dit heeft reeds geleid tot de toewijzing van mogelijke
genen aan verschillende gebieden op het X chromosoom en tot de herkenning van
genen, die indien gemuteerd de oorzaak zijn van syndromale en/of niet-specifieke
mentale retardatie. Dit laatste is een voorwaarde om te komen tot een betrouwbare
diagnose en erfelijkheidsadvisering met inbegrip van dragerschapsonderzoek.
Echter de meeste genen moeten nog gevonden worden. Dit zoeken naar de verant-
woordelijke genen wordt aanzienlijk vergemakkelijkt indien grote aantallen klinisch
en genetisch goed onderzochte families beschikbaar zijn. In deze studie wordt ver-
slag gedaan van 13 van zulke families, 8 met niet-specifieke en 5 met syndromale
X-gebonden mentale retardatie.
In de eerste familie van hoofdstuk 2 erft FRAXE over. Bij chromosomenonder-
zoek wordt een breekbare plaats gevonden op Xq27-q28, die niet te onderscheiden
is van de FRAXA breekbare plaats. Moleculair is het wel van FRAXA te onder-
scheiden en wordt het gekenmerkt door een GCC verlenging, die net zoals bij
FRAXA, indien een bepaalde grens overschreden wordt, leidt tot uitschakeling van
het betrokken gen. Klinisch wordt alleen maar een milde tot zeer milde (border-
line) mentale retardatie gezien. In deze grote familie wordt dit verband voor het
eerst goed aangetoond. In de andere 7 families konden de mogelijk betrokken
genen worden toegewezen aan verschillende gebieden op het X chromosoom. Dit
maakte het mogelijk om in de MRX41 familie de oorzakelijke mutatie in het gen
RabGDI1 te vinden.
In hoofdstuk 3 worden twee families beschreven, waarin de mentale retardatie
samengaat met aangeboren afwijkingen. De combinatie van mentale retardatie,
aangeboren hartafwijking, gespleten verhemelte, kleine gestalte en milde afwijkin-
gen in het gezicht, die in de eerste familie voorkwam, werd niet eerder beschreven.
Datzelfde geldt voor de tweede familie met de combinatie van mentale retardatie,
gespleten lip en verhemelte en milde gezichtsafwijkingen. Slechts in de tweede
familie kon met koppelingsonderzoek een significant resultaat verkregen worden
met plaatsing van het genetisch defect in Xp11.3-q21.3.
In hoofdstuk 4 wordt voor het eerst een familie beschreven waarin mentale retar-
datie samengaat met een groeihormoontekort. Het genetisch defect ligt in 
Xq24-q27.3.
In hoofdstuk 5 wordt bericht over twee families met een ernstig neurodegene-
ratief lijden. In de eerste familie met het Arts syndroom kon het genetisch defect
toegewezen worden aan Xq21.33-q24. In de tweede familie komt een nieuw X-
gebonden mentale retardatie syndroom voor met blindheid, epileptische aanvallen,
spasticiteit, milde hypomyelinisatie en vroeg overlijden. Het genetisch defect ligt in
het pericentromere gebied.
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In het eerste gedeelte van hoofdstuk 6 worden, waar dat van belang is, de meest
recente gegevens met betrekking tot de families uit de hoofdstukken 2 tot en met 5
gepresenteerd.
Voor 24 X-gebonden mentale retardatie syndromen zijn thans de oorzakelijke
genen bekend. Voor de niet-specifieke X-gebonden mentale retardatie zijn nu 5
genen bekend. Deze 5 genen blijken verantwoordelijk te zijn voor slechts een klein
deel van de totale niet-specifieke X-gebonden mentale retardatie. Men gaat er nu
vanuit dat er wel 100 genen bij betrokken kunnen zijn. Voor vele van de syndro-
male en voor alle 5 niet-specifieke X-gebonden mentale retardatie genen is routine
onderzoek niet mogelijk, omdat met de huidige technieken de baten in het geheel
niet opwegen tegen de kosten.
Er is een opvallende afwezigheid van publicaties over niet-X-gebonden, maar
wel erfelijke (= autosomale) niet-specifieke mentale retardatie. Er komen echter
steeds meer argumenten om aan te nemen dat ook autosomale genen betrokken
zijn bij het ontstaan van niet-specifieke mentale retardatie.
Het moleculaire tijdperk voor X-gebonden mentale retardatie is echter nog maar
net begonnen. Steeds meer kandidaatgenen zullen binnenkort beschikbaar komen.
Het testen van deze genen in patiënten en families zal worden vergemakkelijkt
doordat nieuwe technieken beschikbaar komen, zoals microarrays die kunnen wor-
den gebruikt voor het localiseren van genen, het vaststellen van hun expressie-
patronen en mutatieonderzoek. Multidisciplinaire en internationale samenwerking
zijn noodzakelijk om de moleculaire en celbiologische grondslag van X-gebonden
mentale retardatie te ontrafelen. Uiteindelijk zal dit leiden tot i. een enorme toe-
name in de kennis over en het begrip van de normale vorming en werking van het
centrale zenuwstelsel, i. sterke verbetering van de pre- en postnatale diagnostische
mogelijkheden en ii. de ontwikkeling van nieuwe therapeutische strategieën in
tenminste een aantal van deze aandoeningen.
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Dankwoord
Zo’n 31 mede-auteurs hebben hun steen bijgedragen aan de totstandkoming van
de 10 in dit proefschrift opgenomen artikelen; 17 van hen zijn van buiten de eigen
afdeling Anthropogenetica afkomstig. Beter kan niet geïllustreerd worden dat een
brede samenwerking aan de basis heeft gelegen van dit boekwerk. Aan hen allen
ben ik dan ook veel dank verschuldigd; sommigen van hen wil ik echter met name
danken. Op de eerste plaats is dat mijn promotor Prof. Hilger Ropers, die de brede
belangstelling in Nijmegen voor het X chromosoom introduceerde. Met grote
nauwgezetheid nam hij keer op keer alle manuscripten door tot ze het door hem
gewenste niveau - bijna -  bereikt hadden. Zonder het enthousiasme van Dr. Arie
Smits was het allemaal niet gebeurd, denk ik. Aan onze gezamenlijke tochtjes door
het land bewaar ik de beste herinneringen. Bellinda van den Helm, die op zeer
kundige wijze heel veel analytisch werk verricht heeft en haar supervisoren Dr.
Edwin Mariman en Dr. Hannie Kremer moeten natuurlijk ook genoemd worden.
Het werken binnen het XLMR-team heb ik altijd zeer inspirerend gevonden, met
name de samenwerking met de huidige kernteamleden, Dr. Hans van Bokhoven,
Drs. Helger Yntema en Drs. Francis Poppelaars.
It is certainly appropriate to mention that the cooperation within the European
XLMR consortium (Dr. Jamel Chelly, Paris; Prof. Jean-Pierre Fryns, Leuven; Prof.
Claude Moraine, Tours; Prof. Hilger Ropers, Berlin) apart from being very pleasant
has appeared to be extremely fruitful.
Voor de sectie Klinische Genetica heb ik geprobeerd de schade beperkt te
houden. Ik vrees dat dat niet altijd even goed gelukt is.
Van de huidige mode om uitgebreid het thuisfront in de volle breedte inclusief
huisdieren in het dankwoord te betrekken zie ik af. Wel dank ik nog apart Marleen
Vis en Cécile Kühne voor hun geweldige bijdragen aan de uitgave van dit boek. Het
spijt me zeer dat mijn vader en mijn zus Mieke van dit alles geen getuigen meer
hebben kunnen zijn. Dat Anne-Marijke de liefste is vertel ik haar zelf nog wel ’n
keer.
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Curriculum vitae
Ben Hamel werd op 15 maart 1944 geboren te Terneuzen. Ondanks het gemis van
een kleuterschoolopleiding werd het eindexamen gymnasium β al in 1962 gehaald
aan het St. Janslyceum te ’s-Hertogenbosch. In datzelfde jaar werd een aarzelende
start gemaakt met de studie Geneeskunde aan de Katholieke Universiteit te
Nijmegen. Wegens iets te grote belangstelling voor het Nijmeegse uitgaansleven
werd het tentamen Genetica in etappes afgelegd. Pas na het kandidaatsexamen
(december 1966) kwam er enig schot in de studie en in februari 1971 werd het arts-
examen met goed gevolg afgelegd. Als voorbereiding op een uitzending naar
Tanzania volgden een wisselassistentschap Gynaecologie/Verloskunde en Chirurgie
in het R.K.Bethlehem Ziekenhuis in ’s-Gravenhage en de Nationale Tropencursus
voor Artsen aan het Koninklijk Instituut voor de Tropen te Amsterdam. Vanaf juli
1972 was hij medical officer in charge van het Igogwe Mission Hospital te Igogwe,
Tanzania. Van 1975 tot 1979 werd in Nijmegen de opleiding tot kinderarts gevolgd
(opleider: Prof.Dr.E.D.A.M.Schretlen). Na een “course in tropical paediatrics” van
een maand in Liverpool, werkte hij gedurende twee jaar als lecturer/consultant
paediatrician in het Muhimbili Medical Center, University of Dar es Salaam te
Tanzania. In het najaar van 1981 volgde een benoeming als staflid van de toen-
malige Nijmeegse Werkgroep Erfelijkheidsadvisering (hoofd: Drs.B.G.A.ter Haar),
waarbij een opleiding klinische genetica “avant la lettre” werd genoten. Na het veel
te vroege en sterk betreurde overlijden van Ben ter Haar werd hij hoofd van wat nu
de sectie Klinische Genetica heet van de afdeling Anthropogenetica (toenmalig
hoofd: Prof.Dr.H.H.Ropers en huidig hoofd: Prof.Dr.H.G.Brunner) van het
Academisch Ziekenhuis te Nijmegen. In mei 1987 werd hij erkend als klinisch
geneticus en begin 1990 als opleider klinische genetica. Enkele van zijn huidige
functies zijn: lid van het dagelijks bestuur van de afdeling Anthropogenetica AZN,
bestuurslid en lid van verschillende commissies van de Vereniging Klinische
Genetica Nederland (VKGN), lid van het concilium van de VKGN, plaatsvervan-
gend lid namens de VKGN van de MSRC, voorzitter van het bestuur van de
Stichting Klinisch Genetisch Centrum Nijmegen e.o., lid van de Commissie
Biowetenschappen van het Katholiek Studie Centrum te Nijmegen, secretaris van
de Begeleidingscommissie Klinische Genetica (Vereniging van Klinisch Genetische
Centra en Zorgverzekeraars Nederland).
Hij heeft een uiterst duurzame relatie met Anne-Marijke Ogier.
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